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  Abstract	  The	   secretion	   of	   chemical	  messengers	   via	   Ca2+-­‐dependent	   exocytosis	   of	   vesicles	   is	  fundamental	   to	   a	   wide-­‐range	   of	   physiological	   events.	   Rab	   GTPases	   and	   SNARE	   proteins	  govern	  the	  temporal	  and	  spatial	  precision	  of	  transmitter	  release.	  Yet,	  little	  is	  known	  about	  their	   role	   in	   specifying	   the	   size	   and	   filling	   kinetics	   of	   functionally	   defined	   vesicle	   pools,	  which	  impact	  the	  strength	  and	  efficiency	  of	  exocytosis.	  	  We	  first	  sought	  to	  delineate	  the	  distinct	  vs.	  overlapping	  roles	  of	  highly	  homologous	  Rab	   GTPase	   proteins,	   Rab3	   and	   Rab27,	   which	   display	   high	   sequence	   homology,	   share	  protein-­‐effectors,	   and	   may	   functionally	   compensate.	   To	   define	   their	   actions,	   we	  overexpressed	  Rab3GAP	  and/or	  EPI64A	  GTPase-­‐activating	  protein	  in	  wild-­‐type	  or	  Rab27-­‐null	   cells	   to	   transit	   the	  Rab3	   family	   or	  Rab27A	   to	   a	  GDP-­‐bound	   inactive	   state.	  We	   found	  Rab27A	  is	  essential	  for	  generation	  of	  the	  functionally	  defined	  immediately	  releasable	  pool,	  Rab3	  is	  essential	  for	  a	  kinetically	  rapid	  filling	  of	  the	  RRP,	  and	  both	  cooperate	  in	  populating	  the	   readily	   releasable	   granule	   pool	   (RRP).	   We	   conclude	   that	   while	   Rab3	   and	   Rab27A	  cooperate	  to	  generate	  release-­‐ready	  vesicles	  in	  β-­‐cells,	  they	  also	  direct	  unique	  kinetic	  and	  functional	  properties	  of	  the	  exocytotic	  pathway.	  We	  also	  investigated	  how	  the	  SNARE	  Tomosyn1	  (Tomo1)	  regulates	  the	  partitioning	  of	   synaptic	  vesicle	   (SV)	  pools	   in	  hippocampal	  neurons.	  Tomo1	   inhibits	  SV	  priming	  at	   the	  plasma	   membrane.	   Yet,	   its	   localization	   to	   SVs	   and	   cytosol	   uniquely	   positions	   it	   to	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coordinate	  SV	  pool	  partitioning.	  We	   that	   find	   that	  Tomo1	  controls	  SV	   transition	  between	  the	   Resting	   Pool	   and	   Total	   Recycling	   Pool	   (TRP),	   and	  modulates	   the	   RRP	   size.	   Tomo1’s	  regulation	   of	   SV	   distribution	   between	   pools	   is	   sensitive	   to	   neural	   activity	   and	   requires	  Cdk5.	  We	  provide	  novel	  evidence	  for	  an	  interaction	  between	  Tomo1	  and	  Rab3A-­‐GTP,	  and	  through	   this	   with	   Synapsin1	   proteins,	   known	   regulators	   of	   SV	   recruitment.	   In	   addition,	  Tomo1	   regulatory	   control	   over	   the	   TRP	   occurred	   independent	   of	   its	   C-­‐terminal	   SNARE	  domain.	  Hence,	  Tomo1	  actions	  on	  neurotransmission	  extend	  beyond	  its	  known	  inhibition	  of	  SV	  priming	  into	  the	  RRP	  and	  may	  involve	  other	  effector	  proteins.	  Altogether,	  our	  results	  advance	   the	   understanding	   of	   how	   Rab	   and	   Tomosyn	   proteins	   coordinate	   steps	   of	   the	  vesicle	  cycle	  that	  lead	  to	  functional	  heterogeneity	  among	  vesicles	  and	  thus	  may	  determine	  modes	  of	  transmitter	  release.	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Chapter	  I:	  
Introduction:	  The	  molecular	  machines	  that	  define	  Ca2+-­‐mediated	  exocytosis	  
	  
1.1 Introduction	  	  The	  secretion	  of	  chemical	  messengers	  via	  Ca2+-­‐dependent	  exocytosis	  of	  vesicles	  or	  dense	   core	   granules	   is	   a	   highly	   specialized	   and	   dynamic	   process	   occurring	   with	   high	  temporal	   and	   spatial	   precision.	   This	   process	   is	   fundamental	   to	   a	   wide-­‐range	   of	  physiological	   processes	   and	   cell	   types,	   these	   include:	   the	   secretion	   of	   insulin	   from	  pancreatic	   β-­‐cells,	   which	   regulates	   blood	   glucose	   level	   [1-­‐3];	   or	   the	   secretion	   of	   lytic	  granules	   from	   cytotoxic	   T-­‐lymphocytes,	   which	   is	   important	   for	   destroying	   target	   cells	  during	  protective	  immune	  responses	  [4,5].	  One	  of	  most	  complex	  secretory	  systems	  is	  that	  of	   the	  nervous	   system,	  which	   secretes	   dozens	   of	   classes	   of	   neurotransmitters,	   hormones	  and	  peptides	   from	  distinct	  neuronal	  cell	   types	  with	  differing	  stimulus	  coupling,	  modes	  of	  release	   and	   with	   functions	   ranging	   from	   sensory/motor	   processing	   to	   learning	   and	  cognition	   [6,7].	  While	   these	   secretory	   systems	   diverge	   greatly	   in	   function	   and	  modes	   of	  secretion,	   many	   commonalities	   exist.	   This	   is	   best	   illustrated	   by	   studies	   that	   show	   how	  perturbations	   of	   molecules	   involved	   in	   Ca2+-­‐dependent	   exocytosis	   lead	   to	   deleterious	  conditions	  affecting	  many	  physiological	  systems	  and	  often	   impacting	  different	  species	  [8-­‐14].	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Ca2+-­‐dependent	   exocytosis	   can	   be	   described	   as	   a	   multi-­‐step	   process	   culminating	  when	  a	  cell	  membrane	  depolarizes	  and	  triggers	  the	  opening	  of	  voltage-­‐gated	  Ca2+	  channels	  (VGCC)	   causing	  a	  brief	   and	   local	   elevation	   in	  Ca2+	  concentrations.	  The	  opening	  of	   a	  VGCC	  causes	  the	  Ca2+	  concentration	  to	  rise	  to	  ~100mM	  within	  a	  20	  nm	  nanodomain	  at	  the	  site	  of	  the	  VGCC	  but	  this	  concentration	  then	  decreases	  within	  mS	  as	  the	  VGCCs	  close;	  at	  200	  nm	  from	  the	  VGCC	  the	  concentration	  is	  closer	  to	  ~10mM	  rising	  and	  falling	  within	  the	  order	  of	  10	  ms	   [15].	   This	   transient	   elevation	   activates	   the	   release	   apparatus,	  which	  mediates	   the	  fusion	  of	  vesicles	  containing	  soluble	  as	  well	  as	  membrane-­‐integral	  proteins	  and	  signaling	  lipids	   with	   the	   plasma	   membrane.	   During	   fusion	   of	   the	   two	   lipid	   bilayers,	   an	   aqueous	  channel	  termed	  the	  fusion	  pore	  (with	  a	  approximate	  4nm	  diameter)	  develops	  allowing	  the	  soluble	  protein	  messengers	  within	   the	  vesicle	   to	  be	   released	   into	   the	  extracellular	   space.	  Opening	   of	   the	   fusion	   pore	   can	   be	   followed	   by	   the	   full-­‐collapse	   of	   the	   vesicle	   into	   the	  plasma	   membrane	   thus	   becoming	   contiguous;	   or	   fusion	   pore	   opening	   can	   be	   transient	  without	  full-­‐collapse.	  Subsequent	  to	  fusion	  and	  release,	  vesicles	  are	  recycled	  via	  one	  of	  two	  major	   routes,	   often	   depending	   on	   the	   cell-­‐type.	   (1)	   Membranes	   and	   proteins	   can	   be	  retrieved	  via	  clathrin-­‐mediated	  endocytosis	  and	  shuttled	  through	  an	  endosomal	  recycling	  pathway	  or,	  (2)	  locally	  recycled	  and	  refilled	  with	  transmitter	  for	  immediate	  reuse.	  In	  some	  cases,	   vesicles	   bypass	   conventional	   routes	   of	   endocytosis	   as	   they	   never	   collapse;	  subsequent	  to	  fusion	  pore	  opening	  and	  closing	  they	  remain	  near	  the	  plasma	  membrane	  in	  a	  release-­‐ready	  state,	   referred	   to	  as	   ‘kiss-­‐and-­‐stay’	   fusion;	  or	   they	  undock	   from	  the	  plasma	  and	  are	  locally	  recycled,	  known	  as	  ‘kiss-­‐and-­‐run’.	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SNARE	  complex	  formation	  The	   fusion	   of	   vesicles	   is	   catalyzed	   by	   the	   formation	   of	   an	   ATP-­‐dependent	  heterotrimeric	   SNARE	   (soluble	   N-­‐ethylmaleimide-­‐sensitive	   factor	   attachment	   protein	  receptor)	  protein	   complex,	  with	   formation	  of	   this	   SNARE	   complex	   constituting	   a	  process	  referred	  to	  as	  priming.	  SNARE	  proteins	  are	  classified	  as	  such	  in	  accordance	  to	  a	  conserved	  coiled-­‐coil	  stretch	  of	  ~70	  residues	  known	  as	  the	  SNARE	  motif.	  They	  are	  further	  subdivided	  as	  R,	  Qa,	  Qb	  or	  Qc	   types	  based	  on	   the	  positioning	  of	   the	  SNARE	  motif	  within	  a	   four-­‐helix	  bundle.	   All	   SNARE	   complexes	   contain	   one	   member	   of	   each	   class	   forming	   into	   multiple	  layers	  of	  hydrophobic	  side	  chains	  and	  one	  central	  polar	  layer	  (called	  the	  zero	  ionic	  layer)	  in	  which	   R-­‐SNAREs	   contribute	   arginine	   residues	   and	   each	   Q-­‐SNARE	   a	   glutamine	   [16].	   In	  neurosecretory	  systems	  and	  in	  insulin	  release	  the	  SNAREs	  are:	  VAMP2	  which	  contains	  an	  R-­‐SNARE,	  Syntaxin1A	  which	  contains	  a	  Qa;	  and	  SNAP25	  which	  contains	  both	  a	  Qb	  and	  Qc.	  However,	   there	  are	  multiple	  variants	  within	   these	  SNARE	  protein	   families	   and	   in	   certain	  cell	   secretory	   processes	   or	   phases	   of	   secretion	   different	   family	   members	   participate	   to	  drive	   membrane	   fusion.	   In	   general,	   vesicle-­‐associated	   proteins	   contain	   R-­‐SNAREs	   while	  plasma	   membrane	   proteins	   contain	   Q-­‐SNAREs.	   The	   formation	   of	   a	   fusiogenic	   SNARE	  complex	   is	  believed	   to	  be	   initiated	  when	  cognate	  SNAREs	  bind	   in	   trans	   at	   the	  N-­‐terminal	  ends	   of	   each	   of	   the	   four	   SNARE	  motifs	   forming	   a	   highly	   stable	   four-­‐helical	   bundle.	   The	  SNARE	  bundle	  then	  progressively	  zippers	  from	  N-­‐	  to	  C-­‐terminus	  bringing	  the	  membranes	  into	   closer	   apposition	   until	   fusion	   is	   catalyzed	   [17].	   After	   fusion,	   the	   fully	   zippered	   cis-­‐SNARE	  complex	  emanating	  from	  the	  plasma	  membrane	  is	  recycled	  by	  NSF	  and	  its	  adaptor	  protein,	  α-­‐SNAP,	  using	  ATP-­‐hydrolysis.	  	  
	  
	   4	  
Calcium-­‐mediated	  triggering	  of	  fusion	  Crucial	   to	   regulated	   exocytosis	   are	  mechanisms	   that	   clamp	   vesicle	   fusion	   (or	   said	  another	  way,	  halt	   the	  progression	  of	  SNARE	  complex	   formation	   from	   trans	   to	  cis)	  until	   a	  signal	   discharges	   or	   triggers	   it.	   The	   temporal	   precision	   of	   vesicle	   release	   then	   becomes	  directly	  proportional	  to	  the	  kinetics	  of	  signal	  onset	  and	  the	  sensitivity	  of	  the	  trigger	  to	  the	  signal.	   The	   best-­‐characterized	   molecular	   trigger	   thus	   far	   has	   been	   the	   Synaptotagmin1	  (Syt1),	  which	  contains	  an	  N-­‐terminal	  transmembrane	  region	  coupling	  it	  onto	  vesicles	  and	  two	  cooperative	  C2	  calcium/phospholipid-­‐binding	  regions	  (C2A	  and	  C2B)	  at	  its	  C-­‐terminus	  [18].	  In	  addition,	  Syt1	  has	  the	  ability	  to	  bind	  to	  Syntaxin1	  and	  SNARE	  complexes	  [19].	  Upon	  VGCC	   opening,	   4-­‐5	   calcium	   ions	   bind	   to	   the	   Syt1	   C2	   domains	   within	   ~200-­‐300	   mS	  triggering	   its	  association	  to	   the	  plasma	  membrane	  and	  zippering	  of	  SNARE	  proteins	  [20].	  Moreover,	   Syt1	   function	  appears	   to	  be	   critical	   for	   limiting	   spontaneous	  vesicle	   release	   in	  neurons	   [21].	   The	   affinity	   for	   calcium	  of	   sensors	   utilized	   in	   exocytosis	   are	   critical	   to	   the	  overall	  function,	  for	  example	  the	  release	  of	  small	  synaptic	  vesicles	  (SV)	  from	  neuronal	  cells	  and	   exocytosis	   of	   large-­‐dense	   core	   vesicles	   (LDCV)	   in	   endocrine	   cells	   occurs	   in	   distinct	  kinetic	   phases	   largely	   determined	   by	   the	   sensitivity	   of	   the	   calcium	   sensors	   and	   their	  positioning	  with	  respect	  to	  the	  Ca2+	  entry	  site.	  With	  some	  exceptions,	  in	  both	  systems,	  Syt1	  predominantly	  mediates	  the	  fast	  or	  immediate	  phase	  of	  release	  as	  it	  is	  a	  low	  affinity	  sensor,	  while	  Syt7	  accounts	  for	  the	  slow	  component	  of	  LDCV	  fusion	  [22,23].	  The	  slower	  component	  of	   SV	   release	   in	  neuronal	   cells	   is	   termed	  asynchronous	  and	  does	  not	   seem	   to	  depend	  on	  Syt1	  function,	  alternative	  calcium	  sensors	  have	  been	  hypothesized	  including	  Syt2,	  Syt7	  and	  Syt9;	  however	  the	  vesicle	  pools	  they	  affect	  and	  the	  specific	  characteristics	  they	  confer	  onto	  release	  modes	  are	  not	  well	  established	  [24,25].	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Recent	  studies	  have	  suggested	  that	  the	  protein	  Complexin	  (Cpx)	  serves	  as	  another	  clamp	   for	   SV	   fusion.	   In	   this	   model,	   Cpx	   inserts	   an	   accessory	   α-­‐helix	   into	   the	   partially	  zippered	  SNARE	  complex	  to	  prevent	  its	  full	  assembly	  and	  clamp	  spontaneous	  fusion.	  Upon	  VGCC	  activation,	  Syt1	  is	  proposed	  to	  displace	  the	  Cpx	  clamp;	  but	  interestingly,	  a	  distinct	  N-­‐terminal	   portion	   of	   Cpx	   then	   interacts	  with	   the	  membrane-­‐insertion	   sequence	   of	   SNARE	  proteins	  and	  is	  believed	  critical	  for	  activating	  the	  force	  transfer	  of	  SNAREs	  [26,27].	  In	  this	  model,	  the	  coordinated	  activities	  of	  Syt	  and	  Cpx	  proteins	  constitute	  a	  central	  clamping	  and	  triggering	  mechanism	  [24,28].	  
	  
Protein	  regulators	  essential	  for	  SNARE	  complex	  formation	  and	  fusion	  	  In	  addition	  to	  SNAREs,	  Munc13	  and	  Munc18	  protein	   families	  are	  also	  essential	   for	  Ca2+-­‐mediated	  exocytosis,	  though	  the	  precise	  reasons	  why	  remains	  unknown.	  The	  absence	  of	  either	  of	  these	  proteins	  results	  in	  near	  complete	  abrogation	  of	  neurotransmitter	  release	  [29-­‐32].	  The	  homologs	  of	  Munc18	  and	  Munc13	   in	  C.	  elegans	   are	  part	  of	   a	   large	   family	  of	  genes	   initially	   identified	   by	   a	   forward	   genetic	   screen	   for	   paralytic	   phenotypes	  (“UNCoordinated”)	  with	  concomitant	  accumulations	  in	  acetylcholine	  suggesting	  deficits	  in	  neurotransmitter	  release	   [33].	  Subsequently,	   the	  mammalian	  unc18	  (Munc18)	  was	   found	  in	   affinity-­‐purified	   Syntaxin	   from	   brain	   lysates	   [34]	   and	   shortly	   after	   Munc13	   was	  identified	  as	  being	  present	  in	  neuronal	  synapses	  [35].	  Although,	  their	  mechanisms	  are	  not	  well	   understood	   they	   are	   generally	   accepted	   to	   be	   essential	   for	   SNARE	   assembly	   and	  fusion.	  Munc18	  binds	  to	  Syntaxin	  in	  two	  distinct	  conformations,	  (1)	  a	  self-­‐inhibited	  ‘closed’	  conformation,	  in	  which	  the	  N-­‐terminal	  Habc-­‐domain	  of	  Syntaxin	  folds	  over	  and	  binds	  to	  the	  SNARE	  motif,	  thus	  hindering	  SNARE	  complex	  formation;	  (2)	  an	  ‘open’	  conformation,	  that	  is	  
	   6	  
receptive	  to	  SNARE	  complex	   formation.	  Early	  studies	  of	  Munc18	  concluded	  that	   it	  served	  an	  inhibitory	  role	  as	  it	  stabilized	  Syntaxin	  in	  a	  closed	  non-­‐fusiogenic	  conformation	  [36,37].	  However,	   other	   studies	   showed	   that	   not	   only	   is	  Munc18	  necessary,	   but	   that	   it	   facilitates	  release	   contradicted	   this	   notion	   [38,39].	   It	   is	   now	   recognized	   that	   Munc18	   remains	   in	  complex	   with	   Syntaxin	   located	   at	   the	   plasma	   membrane	   as	   SNARE	   complexes	   nucleate	  (though	   it	   appears	   it	  may	   change	   its	   binding	   sites	   and	   conformational	   structure)	   [34,40-­‐42].	  Thus,	  current	  models	  suggest	  that	  it	  may	  serve	  to	  select	  the	  right	  R-­‐SNARE	  helix	  and	  prevent	  premature	  SNARE-­‐assembly	  [43].	  Munc13	  is	  thought	  to	  be	  essential	  for	  switching	  Syntaxin	   from	  the	  closed	  to	  open	  conformations	   in	  order	  to	  relieve	  autoinhibition.	  While,	  the	   binding	   affinity	   between	   Munc13	   domains	   and	   various	   Syntaxin	   domains	   are	   weak,	  most	   studies	   suggest	   that	   the	   central	   MUN	   domain	   of	   Munc13	   stimulates	   opening	   of	  Syntaxin	  by	  extracting	  the	  SNARE	  motif.	  In	  fact,	  site-­‐directed	  point	  mutations	  that	  stabilize	  Syntaxin	   in	  an	  open	  conformation	   rescue	   the	  SV	   release	  deficits	   seen	   in	  C.	  elegans	  unc13	  mutants	  {[44,45].	  In	  addition,	  NMR	  and	  fluorescence	  experiments	  show	  that	  expression	  of	  the	   MUN	   domain	   can	   accelerate	   the	   transition	   from	   the	   Munc18-­‐1/closed	   Syntaxin-­‐1	  complex	  to	  the	  Munc18-­‐1/SNARE-­‐complex	  [46].	  Moreover,	  evidence	  suggests	  that	  Munc13	  proteins	  also	  play	  other	  roles,	  which	  coordinate	  the	  trafficking,	  tethering	  and	  positioning	  of	  vesicles	   with	   SNARE	   complex	   formation	   near	   VGCCs	   via	   interaction	   with	   scaffolding	  proteins	  like	  RIM	  and	  vesicle-­‐associated	  proteins	  like	  RabGTPases.	  	  
	  
RIM	  proteins	  coordinate	  vesicles,	  SNARE	  complexes	  and	  VGCCs	  Since	   stimulus-­‐dependent	   calcium	   elevations	   are	   brief	   and	   restricted	   to	   micro	   or	  nanodomains	   (50-­‐100uM),	   the	   positioning	   of	   primed	   vesicles	   near	   calcium	   channels	   is	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necessary	  to	  achieve	  the	  levels	  of	  synchronicity	  between	  VGCC	  activation	  and	  vesicle	  fusion	  onset	   observed	   in	   neuronal	   and	   endocrine	   exocytosis.	   As	   previously	   stated,	   while	   the	  calcium	   affinity	   of	   the	   sensor	   largely	   affects	   this	   coupling	   (i.e.	   Syt2	   leads	   to	  much	   faster	  release	   than	  than	  Syt1	  which	   is	   faster	   than	  Syt7);	  another	  site	  of	  potent	  regulation	   is	   the	  positioning	  of	  the	  sensor	  relative	  to	  the	  calcium	  source.	  At	  large	  synapses	  like	  the	  Calyx	  of	  held,	   VGCC—sensor	   coupling	   distance	   was	   estimated	   to	   be	   ~100	   nm,	   suggesting	   that	  coupling	   is	   loose	  but	   can	   likely	  be	  compensated	  by	   the	   large	  number	  of	  SVs	   in	  a	   readily-­‐releasable	   pool	   (~1,750	   SVs)[47-­‐49];	   while	   at	   smaller	   cortical	   or	   hippocampal-­‐type	  synapses	  (containing	  ~5-­‐10	  readily-­‐releasable	  SVs)	  coupling	  is	  much	  tighter	  with	  only	  10-­‐20	  nm	  distances	  [50,51].	  One	  of	  the	  major	  scaffolding	  proteins	  that	  can	  spatially	  organize	  these	  molecules	  and	  processes	  are	  proteins	  of	  the	  RIM	  gene	  family.	  RIMs	  are	  endowed	  with	  the	  capability	  to	  bind	  and	  thus	  determine	  Ca2+	  channel	  density	  at	  a	  release	  site	  [52,53].	  In	  fact,	   loss	   of	  RIM	  proteins	   in	  Drosophila	   leads	   to	   significant	   reductions	   in	   number	   of	   Ca2+	  channels	   at	   presynaptic	   active	   zones	   and	   concomitant	   decrease	   in	   Ca2+	   influx	   [54].	   They	  were	   initially	   identified	   in	   a	   Rab3	   binding	   screen	   (RabGTPase-­‐interacting	  molecule)	   and	  proposed	   to	   be,	   and	   subsequently	   shown	   to	   be	   important	   in	   docking	   of	   vesicles	   [55,56].	  Moreover,	   they	   have	   also	   been	   proposed	   to	   initiate	   a	   priming	   cascade	   via	   an	   interaction	  with	  Munc13	  via	  an	  N-­‐terminal	  zinc-­‐finger	  motif.	  This	  interaction	  is	  thought	  to	  then	  relieve	  Munc13	   from	   autoinhibitory	   homodimer	   conformations	   that	   consequently	   promotes	  Munc13—Syntaxin	  interactions;	  which	  then	  switches	  Syntaxin	  from	  autoinhibited—closed	  to	  open	  SNARE	  complex-­‐receptive	  conformations	  [56-­‐59].	  The	  capability	  of	  RIM	  proteins	  to	  regulate	   multiple	   steps	   of	   the	   secretory	   pathway	   positions	   them	   to	   strongly	   change	   the	  strength	   and	   efficiency	   of	   secretion.	   	   In	   agreement	  with	   this	   notion,	   it	   is	   known	   that	   the	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level	   of	   RIM	   proteins	   in	   neurons	   are	   strongly	   regulated	   by	   the	   ubiquitin-­‐proteosome	  system	  in	  response	  to	  neural	  activity	  [60];	  and	  its	  functions	  are	  critical	  for	  the	  expression	  of	  several	  types	  of	  presynaptic	  neural	  plasticity,	  though	  the	  precise	  mechanisms	  have	  yet	  to	  be	  identified	  [61-­‐63].	  	  
	  
Vesicle	  recruitment	  to	  release	  sites	  and/or	  active	  zones	  The	  sites	  of	  exocytotic	  activity	  in	  neuronal	  cells	  of	  the	  mammalian	  hippocampus	  are	  localized	  to	  an	  axon	  terminal	  site	  or	  ‘en	  passant’	  axonal	  swellings	  (termed	  boutons).	  These	  are	   distinctly	   characterized	   in	   electron	   micrographs	   by	   an	   accumulation	   or	   cluster	   of	  synaptic	   vesicles	   adjacent	   to	   an	   electron	  dense	   region	   apposed	   to	   the	  plasma	  membrane	  called	  the	  active	  zone	  (AZ).	  The	  AZ	  demarcates	  the	  presynaptic	  release	  sites	  of	  neurons;	  it	  is	  where	  VGCCs	  are	  actively	  localized	  to	  and	  it	  maintains	  a	  network	  of	  molecules	  (including	  RIM)	  that	  coordinates	  with	  vesicle-­‐recruitment	  factors	  in	  order	  to	  dock	  and	  prime	  vesicles	  for	  release.	  In	  fact	  some	  AZs,	  such	  as	  the	  photoreceptor	  ‘ribbon’	  synapses	  or	  the	  Drosophila	  neuromuscular	   junction	   contain	   additional	   specialized	   structures	   (ribbons	   or	   T-­‐bars,	  respectively)	  which	  accelerate	  the	  rate	  at	  which	  synaptic	  vesicles	  can	  be	  recruited	  into	  the	  AZ	   [64].	  Comparatively,	   endocrine	  or	  neuroendocrine	   release	   sites	  do	  not	   contain	   strong	  morphologically	  apparent	  AZ’s	  even	  though	  they	  contain	  most	  of	  the	  same	  molecules	  found	  in	  AZs	  and	  these	  often	  appear	  to	  be	  spatially	  segregated	  on	  the	  PM.	  Perhaps,	  this	  reflects	  a	  morphological	  specialization	  of	  neuronal	  cells	  since	  the	  release	  of	  chemical	  messengers	  is	  highly	   restricted	   to	   small	   regions	   (0.2-­‐0.5	   mm	   diameter)	   directly	   opposite	   the	   post-­‐synaptic	  receptor	  signaling	  region	  (postsynaptic	  density)	  and	  deviations	  from	  this	  strongly	  impact	   its	   excitability	   [65].	   Despite	   lacking	   an	   active	   zone,	   endocrine	   cells	   do	   display	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dynamic	  transport	  of	  LDCVs	  to	  sites	  of	  release,	   in	  fact,	  recent	  studies	  have	  suggested	  that	  continued	  recruitment	  of	  so-­‐called	  “newcomer”	  granules	  which	  display	  minimal	  residence	  at	   the	   plasma	   membrane	   largely	   account	   for	   the	   sustained	   phase	   of	   insulin	   release,	  reviewed	  in	  ([66]).	  Rabs	  are	  a	  class	  of	  small	  G-­‐proteins	  belonging	  to	  the	  Ras	  superfamily,	  of	  which	  there	  exist	  many	  variants	  (>60	  mammalian	  Rabs)	  and	  which	  are	  differentially	  distributed	  across	  many	   organelles	   and	   known	   to	   regulate	   membrane	   trafficking	   between	   different	  subcellular	  compartments	  in	  organisms	  from	  yeast	  to	  humans	  [67].	  The	  central	  regulatory	  feature	  of	  Rabs	  is	  their	  ability	  to	  cycle	  between	  a	  GTP-­‐active	  to	  a	  GDP	  inactive	  state,	  which	  often	  determines	  their	  ability	  to	  bind	  effectors	  and	  associate	  with	  vesicle	  membranes.	  Two	  additional	  regulatory	  proteins	  drive	  GTPase	  activity:	  Rab	  GTPase	  activating	  protein	  (GAP)	  accelerates	   the	   intrinsic	   rate	   of	   GTP	   hydrolysis	   and	   Rab	   GTP	   exchange	   factor	   (GEF)	  stimulates	  GTP	  binding	   [68].	   From	   the	  Rab	   family,	  Rab3A	   is	   predominantly	   expressed	   in	  neurons	  and	  secretory	  cells	  accounting	  for	  ~25%	  of	  GTPase	  activity	  in	  the	  brain	  [69].	  Rab3	  has	  four	  protein	  isoforms	  (A-­‐D),	  which	  appear	  to	  compensate	  for	  one	  another	  functionally;	  deletion	  of	   three	   isoforms	   leads	   to	   lethality	   if	  Rab3A	   is	   one	  of	   the	  deleted	   genes	   in	  mice	  [70].	  Astonishingly,	  Rab3	  proteins	  can	  be	  found	  on	  all	  synaptic	  vesicles	  in	  a	  nerve	  terminal	  at	  rest,	  each	  vesicle	  containing	  approximately	  10	  copies,	  but	   it	   is	  completely	  absent	   from	  the	   plasma	  membrane	   [71,72].	   To	   explain	   this,	   studies	   have	   now	   shown	   via	   optical	   and	  biochemical	   methods	   that	   Rab3	   proteins	   undergo	   GTPase	   activity	   during	   stimulated	  secretion	   and	   consequently	   are	   displaced	   from	   the	   vesicle	   membrane	   [73-­‐75].	  Furthermore,	  one	  recent	  report	  suggests	  that	  this	  is	  due	  to	  the	  ability	  of	  Syt1	  to	  bind	  and	  sequester	  Rab3-­‐GAP,	  thus	  reducing	  GTPase	  activity—only	  upon	  calcium	  binding	  does	  Syt1	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release	  Rab3-­‐GAP	  which	  can	  then	  stimulate	  the	  Rab3	  GTP-­‐GDP	  transition	  [76].	  All	  studies	  to	  date	  suggest	  two	  major	  though	  seemingly	  contradictory	  roles	  for	  Rab3:	  (1)	  Recruitment	  of	   vesicle	   to	   release	   sites	   following	   stimulated	   depletion	   and	   (2)	   a	   molecular	   clamp	   or	  inhibitor	  of	  vesicle	  priming.	  Early	  evidence	  for	  these	  conclusions	  emanated	  from	  studies	  in	  neurosecretory	   cells	   showing	   that	   overexpression	   or	   microinjection	   of	   Rab3A	   or	   a	  constitutively	   GTP-­‐bound	   mutant	   inhibits	   regulated	   exocytosis	   in	   chromaffin	   cells	   and	  PC12	  cells	   [77-­‐80].	   In	  agreement	  with	   this,	   knock-­‐out	  of	   the	  Rab3A	  gene	   in	  hippocampal	  neurons	   led	   to	   an	   enhancement	   in	   Ca2+-­‐dependent	   exocytosis	   with	   no	   changes	   in	   the	  number	  of	  vesicles	   that	  are	  docked,	  and/or	  primed	  release-­‐ready	   [69,81].	  Yet,	  quadruple	  knock-­‐out	   of	   Rab3	   led	   to	   approximately	   a	   30%	   reduction	   in	   evoked	   release,	   with	   no	  changes	  in	  spontaneous	  release	  or	  number	  of	  primed	  readily-­‐releasable	  vesicles	  [70].	  Thus,	  it	  was	  not	  clear,	  was	  Rab3A	  facilitating	  or	  clamping	  secretion?	  Recent	  studies	  have	  offered	  some	  clarification	  of	  these	  discrepancies.	  Four	  separate	  studies	  confirmed	  that	  Rab3A	  was	  critical	   for	   recruitment	   of	   vesicles	   to	   release	   sites	   in	   isolated	   nerve	   terminals	  (synaptosomes),	  clonal	  pancreatic	  β-­‐cells,	  mammalian	  chromaffin	  cells	  and	  photoreceptor	  cells	  of	  the	  tiger	  salamander	  (Ambystoma	  tigrinum)	  [56,82-­‐84].	  One	  revelatory	  conclusion	  from	  these	  studies	  was	  that	  the	  GTPase	  cycling	  of	  Rab3	  serves	  as	  a	  regulatory	  gate	  during	  the	  transitions	  from	  docking	  to	  priming.	  Specifically,	  Rab3-­‐GTP	  is	  critical	  for	  recruiting	  and	  docking	  vesicles	  presumably	  via	  its	  interaction	  with	  RIM	  proteins	  since	  point	  mutations	  in	  RIM	   (E36A/R37S),	   which	   abrogate	   Rab-­‐binding	   lead	   to	   significant	   reductions	   in	   the	  number	  of	  docked	  granules	   [56].	  Moreover,	   it	   is	   known	   that	  Rab3A	  can	   form	  a	   tripartite	  complex	  with	  Rim	  and	  Munc13	  and	  also	  binds	  Munc18	  directly	  when	  it	  is	  associated	  with	  the	   closed	   form	   of	   Syntaxin	   [58,85].	   Thus,	   vesicles	   can	   be	   recruited	   to	   sites	   of	   SNARE	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complex	   formation	   via	   sequencing	   of	   effector	   interactions	   [86].	   One	   of	   the	  most	   critical	  observations	  was	  that	  Rab	  mutants	   inhibited	  the	  subsequent	  Munc13-­‐induced	  transitions	  of	   Syntaxin	   from	  a	   closed	   to	  open	  state	   [56].	  Though	  not	  explicitly	   tested,	   it	   is	  perceived	  that	  Rab3A	  cycling	  from	  GTP	  to	  GDP	  removes	  the	  clamp	  on	  priming	  via	  displacing	  a	  yet	  to	  be	  identified	  repressor	  protein	  and	  permitting	  SNARE	  complex	  formation	  {Muller:2011jv}.	  Moreover,	   these	   findings	   could	   also	   partly	   explain	   why	   not	   all	   granules	   docked	   at	   the	  plasma	  membrane	  are	  primed	  and	  release-­‐ready.	  	  Some	  of	  the	  early	  controversy	  surrounding	  Rab3’s	  inhibitory	  vs.	  enhancing	  roles	  in	  secretion	  likely	  stemmed	  from	  the	  compensatory	  actions	  of	  other	  Rabs.	  For	  one,	  Rab3	  has	  four	  distinct	  isoforms,	  which	  as	  previously	  stated,	  are	  able	  to	  functionally	  compensate	  for	  one	   another.	   Thus,	   early	  work	   in	  C	  elegans,	  which	   contains	   only	   one	  Rab3	   protein	  more	  clearly	  distinguished	  Rab3’s	  role	  in	  vesicle	  recruitment.	  	  This	  study	  observed	  that	  Rab3	  null	  mutants	  in	  C.	  elegans	  have	  fewer	  vesicles	  near	  the	  active	  zone	  suggesting	  an	  involvement	  in	  transport	  and	  docking	  [87].	  Further	  complicating	  the	  study	  of	  Rab3	  was	  that	  another	  highly	  homologous	   Rab,	   which	   also	   appears	   to	   functionally	   compensate	   has	   been	   identified	   in	  both	  neuronal	  and	  endocrine	  secretory	  cells.	  Rab27	  comes	  in	  two	  distinct	   isoforms	  (A,B);	  Rab27B	  is	  predominantly	  localized	  on	  neuronal	  SVs,	  while	  Rab27A	  is	  mainly	  on	  endocrine	  and	   neuroendocrine	   LDCVs	   .	   Very	   few	   studies	   have	   detailed	   the	   role	   of	   Rab27B	   in	  exocytosis,	   though	   it	  was	  discovered	  that	  Rab3A	  and	  Rab27B	  reside	  on	  distinct	  SV	  pools,	  although	  a	  degree	  of	  overlap	  was	  also	  demonstrated	  [75].	  Furthermore,	  while	  Rab3A	  has	  been	   observed	   to	   readily	   disassociate	   from	   vesicles	   upon	   calcium	   induced	   exocytosis,	  Rab27(A,B)	   persists	   for	   a	   longer	   time	   on	   the	   membrane,	   suggesting	   that	   they	   have	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overlapping	   but	   distinct	   functions	   [75,88].	   	   In	   addition,	   Rab27	   is	   rather	   unique	   as	   it	   has	  been	  found	  to	  bind	  effectors	  in	  both	  its	  GTP	  and	  GDP	  bound	  states	  [89-­‐91].	  The	  study	  of	  neuronal	  and	  secretory	  Rabs	  has	  been	  recently	  reinvigorated	  following	  the	   discovery	   of	   a	   second	   partially	   compensatory	   Rab.	   Subsequent	   to	   the	   discovery	   of	  SNARE	   proteins,	   a	   significant	   amount	   of	   enthusiasm	   was	   generated	   for	   discovering	   the	  ‘bridge’	  linking	  vesicle	  recruitment/docking	  to	  the	  release	  machinery.	  This	  enthusiasm	  was	  furthered	  fueled	  by	  the	  exciting	  developments	  in	  model	  systems	  like	  yeast,	  wherein	  among	  many	  other	  discoveries,	  mutations	  of	  the	  GTPase	  Sec4	  caused	  lethality	  and	  was	  associated	  with	   an	   accumulation	   of	   vesicles	   that	   were	   randomly	   distributed	   throughout	   the	   cell,	  implying	   that	  Sec4p	   is	  needed	   for	   the	  polarized	  delivery	  of	   secretory	  vesicles	   to	  budding	  sites	   [92].	   Thus	   the	   initial	   genetic	   studies	   conducted	   in	   mice	   lacking	   all	   forms	   of	   the	  neuronal	   GTPase	   Rab3	   (e.g.	   quadruple	   knock-­‐out)	   were	   met	   with	   a	   certain	   degree	   of	  disappointment	   when	   it	   caused	   very	   mild	   phenotypes	   [70].	   More	   recently,	   the	  identification	   of	   Rab	   GAP,	   GEF	   and	   the	   factor	   that	   dissociates	   Rabs	   from	   vesicles	   GDI	  (GTPase-­‐dissociation	   inhibitor)	   has	   rekindled	   the	   excitement	   since	   their	   perturbation	  affects	  all	  Rab3	  proteins	  and/or	  Rab27	  and	  causes	  severe	  phenotypes.	  First,	  mutations	  in	  the	  Rab	  GDI	  gene	  that	  cause	  either	  a	  premature	  stop-­‐codon	  or	  a	  reduction	  in	  Rab3	  binding	  were	   found	   to	   be	   directly	   responsible	   for	   X-­‐linked	   non-­‐specific	   mental	   retardation	   in	  humans	  [93].	  Next	  Rab3	  GAP	  was	  identified	  and	  mutations	  were	  found	  to	  cause	  Warburg	  Micro	  syndrome	  and	  Martsolf	  syndrome,	  both	  of	  which	  exhibit	  mental	  retardation	  [94-­‐99].	  Importantly,	   these	  perturbations	  mainly	   affect	  Rab3	   since	  Rab27	   is	  paired	  with	  different	  GAPs	  (EPI64A/EPI64B)	  and	  is	  not	  as	  sensitive	  to	  disassociation	  from	  vesicles	  by	  Rab3	  GDI.	  Therefore,	  these	  studies	  suggest	  that	  Rab3	  may	  have	  some	  unique	  function,	  which	  cannot	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be	   compensated	  by	  Rab27.	   In	   contrast,	   both	  Rab3	  and	  Rab27	   share	   the	   same	  GEF	   [100].	  Studies	   conducted	   in	   mice	   deficient	   in	   Rab3	   GEF	   were	   found	   to	   be	   perinatal	   lethal	   and	  showed	  a	  ~10-­‐fold	  reduction	  in	  the	  number	  of	  vesicles	  and	  were	  found	  to	  have	  defective	  neuromuscular	   transmission,	   whereas	   post-­‐synaptic	   function	   was	   normal	   [101].	   In	  accordance,	   studies	   in	  C.	  elegans	   found	   that	  mutations	   in	   the	  Rab3	  GEF	   homolog,	   AEX-­‐3,	  caused	   a	   more	   severe	   synaptic	   transmission	   defect	   not	   seen	   in	   Rab-­‐3	  mutants	   alone—further	  study	  determined	  that	  Rab27	  was	  also	  present	  and	  localized	  to	  nerve	  terminals	  and	  accounted	  for	  the	  non-­‐Rab3	  related	  deficits	  [102].	  Altogether	  these	  data	  suggest	  significant	  roles	   for	  Rab	  GTPases	   in	   regulated	   Ca2+	   evoked	   secretion,	   yet	   given	   the	   number	   of	   Rabs	  present	   and	   the	   number	   of	   effectors	   they	   share,	   distinguishing	   unique	   and	   overlapping	  roles	  has	  remained	  a	  challenge.	  
	  
Vesicles	  coalesce	  into	  distinct	  functionally	  defined	  pools	  All	  discoveries	  in	  the	  field	  of	  secretion	  and	  neurotransmitter	  release	  can	  be	  traced	  back	   to	   the	   discoveries	   by	   Bernard	   Katz	   and	   his	   colleagues	   as	   they	   established	   that	  neurotransmitters	  are	  released	  in	  discrete	  “quanta”	  [103,104].	  Since	  its	  initial	  development	  it	  has	  been	  shown	  that	  this	  theory	  does	  suffer	  some	  limitations,	  for	  example,	  there	  is	  some	  controversy	  regarding	  the	  variability	  in	  quantal	  size	  with	  coefficients	  of	  variation	  ranging	  from	   0.22-­‐0.6—but,	   these	   studies	   are	   technically	   challenging	   and	   more	   clarification	   is	  needed	   [105-­‐109].	   Nonetheless,	   the	   quantal	   model	   has	   been	   extremely	   useful	   and	  furthermore,	   these	  early	  studies	  determined	   that	  Ca2+	   regulates	  neurotransmitter	  release	  since	  reduction	  of	  extracellular	  [Ca2+]	  significantly	  reduced	  the	  number	  of	  quanta	  released	  and	  increased	  the	  rate	  of	  failure	  in	  release.	  In	  addition,	  they	  hypothesized	  that	  presynaptic	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terminals	  contained	  a	  pool	  of	  many	  quanta	  and	  that	  stimulation	  leads	  to	  the	  synchronous	  release	  of	  only	  a	  portion	  of	  this	  pool.	  Subsequent,	  electron-­‐microscopic	  analysis	  of	  release	  sites	   discovered	   that	   what	   was	   referred	   to	   as	   “quanta”	   corresponded	   to	   vesicular	  membranes	   and	   determined	   that	   neurotransmitter	   presynaptic	   boutons	   contain	   up	   to	  ~500,000	  vesicles	  at	  a	   frog	  NMJ	   [110]!	   In	   contrast,	   small	   release	  sites	   in	   the	  mammalian	  CNS	   (e.g.	   cortical,	   hippocampal)	   contain	   usually	   only	   ~100	   but	   up	   to	   ~500	   [111-­‐115].	  Functional	  studies	  then	  began	  to	  observe	  that	  repetitive	  stimulation	  led	  to	  a	  diminution	  in	  the	  amplitude	  of	   the	  post-­‐synaptic	   response,	   suggesting	   that	  only	  a	   fraction	  of	  vesicles	   is	  ‘release-­‐ready’	   [116-­‐118].	   This	   was	   early	   evidence	   that	   not	   all	   vesicles	   share	   the	   same	  propensity	  for	  release	  and	  thus	  may	  be	  functionally	  categorized	  into	  distinct	  pools.	  Today,	  the	   functional	   categorization	   of	   vesicles	   has	   expanded	   to	   many	   different	   pools	   some	   of	  which	  are	  highly	  specialized.	  The	  following	  review	  will	  discuss	  only	  what	  are	  considered	  as	  the	   three	  major	  pools:	  Readily-­‐releasable	  pool	   (RRP),	  Reserve	  Pool	   (RP)	   and	   the	  Resting	  Pool	  (ResP)	  [119].	  For	  a	  full	  account	  of	  other	  SV	  pools	  refer	  to:	  [51,120]	  	  	   RRP-­‐	  The	   readily-­‐releasable	  pool	   is	   composed	  of	   a	   small	   subset	  of	   vesicles	   (5-­‐9	  at	  small-­‐central	   synapses,	   ~5%	   of	   the	   total	   vesicle	   pool)	   docked	   in	   the	   AZ.	   They	   have	   the	  highest	  probability	  of	  release	  (Pr)	  of	  all	  vesicles	  at	  the	  bouton	  and	  thus	  most	  significantly	  impact	  the	  strength	  of	  neurotransmitter	  release	  [121].	  The	  RRP	  can	  be	  depleted	  with	  only	  few	  (5-­‐15)	  high-­‐frequency	  stimuli	  or	  via	  1s	  exposure	  to	  a	  hypertonic	  solution	  (e.g.	  adding	  0.5	  mOsm	  /	  L	  Sucrose),	  the	  latter,	  by	  mechanisms	  that	  are	  not	  well	  understood	  [122-­‐124].	  Full	   replenishment	   of	   the	   RRP	   is	   variable	   and	   is	  modulated	   by	   the	   intracellular	   calcium	  concentration,	   it	   has	   a	   time	   constant	   of	   ~10-­‐30	   sec	   [125].	   The	   size	   of	   the	   RRP	   scales	  proportionally	  with	  the	  size	  of	  the	  AZ,	  as	  do	  the	  number	  of	  docked	  vesicles	  and	  the	  relative	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levels	   of	   immunogold-­‐labeled	   Rim1/2	   proteins	   and	   Cav2.1	   VGCCs,	   leading	   many	   to	  hypothesize	   the	   existence	   of	   a	   limited	   number	   of	   RRP	   ‘slots’	   [126-­‐128].	   Although	   it	   is	  generally	  assumed	   that	  each	  vesicle	   in	   the	  RRP	  has	  an	  equal	  probability	  of	   release,	   some	  studies	   at	   central	   synapses	  have	   shown	  otherwise[129,130].	   This	   is	   certainly	   the	   case	   in	  chromaffin	   and	   β-­‐cells,	   which	   have	   an	   immediately-­‐releasable	   pool	   that	   sustains	   much	  faster	  kinetics	   than	  RRP	  vesicles	   [131-­‐134].	  The	  kinetics	  of	  secretory	  response	  were	  best	  described	  by	  membrane	  capacitance	  recordings	  in	  bovine	  chromaffin	  cells	  with	  millisecond	  time	   resolution	   following	   step-­‐depolarizations	   or	   the	   flash	   photolysis	   of	   caged	   Ca2+	  [135,136].	  These	  studies	  uncovered	  that	  the	  secretory	  response	  could	  be	  characterized	  by	  a	   double-­‐exponential	   fit	  with	   time	   constants	   of	   20–40	  ms	   and	  ~300	  ms	   constituting	   the	  RRP	   and	   Slowly	   Releasable	   Pool	   (SRP),	   respectively	   [137].	   Depletion	   of	   these	   pools	  was	  followed	  by	  a	  sustained	  phase	  that	  is	  proportional	  to	  the	  rate	  of	  vesicle	  refilling	  [138,139].	  	   RP-­‐	   The	   recycling	   pool	   is	   often	   referred	   to	   as	   depot	   pool	   as	   it	   constitutes	   the	  reservoir	  from	  which	  depleted	  RRP	  vesicles	  are	  refilled.	  The	  size	  of	  the	  RP	  and	  the	  kinetics	  at	  which	  an	  RP	  vesicle	  can	  transition	  into	  an	  RRP	  can	  impose	  a	  direct	   limit	  on	  the	  rate	  of	  release	   from	   the	   RRP	   [140].	   Thus,	   during	   periods	   of	   repetitive	   stimulation	   a	   limited	   or	  small	   recycling	   pool	   can	   significantly	   constrain	   rates	   of	   quantal	   neurotransmission	  [125,140].	  In	  the	  CNS,	  the	  RP	  has	  been	  best	  characterized	  for	  hippocampal	  neurons	  where	  on	  average	  it	  accounts	  for	  ~40-­‐50%	  of	  the	  total	  pool	  [111,141-­‐143].	  Transitions	  from	  the	  RP	   to	   the	   RRP	   can	   be	   defined	   by	   the	   rates	   at	  which	   any	   given	   vesicle	   can	   be	   reversibly	  docked	  and	  primed,	  a	  process	  that	  can	  be	  accelerated	  by	  increases	  in	  [Ca2+]	  [125,144-­‐146].	  In	   hippocampal	   neurons	   and	   in	   chromaffin	   cells,	   the	   time	   constant	   for	   refilling	   the	   RRP	  ranges	   from	   5-­‐10	   s	   [140,147].	   Though,	   not	   discussed	   here	   it	   should	   be	   noted	   that	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alternative	  mechanisms	  have	  been	  suggested	  which	  may	  compensate	  for	  a	  small	  RP	  during	  a	  bout	  of	  activity,	   for	  example,	   rapid	  retrieval	  and	  reuse	  of	  SVs	  by	  mechanisms	   including	  kiss-­‐and-­‐run	  (~1s)	  or	  ultrafast	  endocytosis	  (50-­‐100	  ms)	  [148,149].	  Moreover,	  others	  have	  suggested	   that	   what	   is	   rate-­‐limiting	   during	   high	   rates	   of	   activity	   is	   not	   the	   number	   of	  vesicles	  or	  the	  rate	  of	  recycling	  but	  the	  number	  of	  ‘slots’	  available	  for	  priming	  [127].	  	  
ResP-­‐	   The	   RRP	   +	   RP	   fraction	   of	   vesicles	   are	   designated	   the	   Total	   Recycling	   Pool	  (TRP)	  and	  account	  for	  all	  vesicles	  actively	  going	  through	  repeated	  bouts	  of	  exocytosis	  and	  endocytosis.	  Interestingly,	  the	  TRP,	  on	  average	  only	  accounts	  for	  half	  the	  releasable	  quanta	  in	  neuronal	  cells.	  The	  remaining	  vesicles	  are	  recalcitrant	  to	  release	  even	  during	  prolonged	  stimulation	   that	   is	   sufficient	   to	   deplete	   the	   TRP.	   Interest	   and	   study	   of	   the	   ResP	   has	  increased	   significantly	   especially	   as	   optical	   tools	   have	   facilitated	   their	   study.	   Most	  commonly	  used	   are	   the	  pH-­‐sensitive	   fluorescent	  probes	   termed	  pHluorins,	  which	   can	  be	  subcloned	   into	   lumenal	   domains	   of	   vesicle	   proteins,	   for	   example,	   VGLUT,	   VAMP,	   VMAT,	  Synaptophysin	   [150-­‐152].	   Expression	   of	   these	   reporters	   in	   neuronal	   or	   neuroendocrine	  cells	  leads	  to	  minimal	  fluorescence	  at	  rest.	  This	  is	  because	  the	  fluorescence	  of	  pHluorin	  is	  quenched	  in	  acidic	  compartments	  like	  the	  vesicle	  lumen	  (pH	  ~5.5).	  During	  spontaneous	  or	  stimulated	   fusion	   vesicles	   expose	   their	   intralumenal	   proteins	   to	   the	  neutral	   extracellular	  space	  (pH	  ~7.3)	  causing	  a	  conformational	  change	   in	  the	  pHluorin	  molecule	  and	  a	  20-­‐fold	  increase	   in	   fluorescence	   [153].	   In	   addition,	   Styryl	   dyes,	   such	   as	   FM1-­‐43,	   which	   are	  amphipathic	   compounds	   that	   can	   be	   used	   to	   label	   recycling	   synaptic	   vesicle	  membranes	  have	   been	   used	   extensively	   [154].	   Some	   of	   these	   can	   also	   be	   photoconverted	   into	   an	  electron-­‐dense	   material	   for	   further	   high-­‐resolution	   structural	   analysis	   via	   electron	  microscopy	   [115,155].	   From	   these	   studies	   it	   has	   been	   discovered	   that	   the	   ResP	   scales	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dynamically	   in	   response	   to	   many	   physiological	   stimuli	   and	   to	   counteract	   strong	  perturbations.	  For	  example,	  blocking	  endocytosis	  elicits	  an	  unlocking	  of	  ResP	  vesicles	  into	  the	  RP	  [156].	  Vesicle	  are	  also	  shifted	  between	  the	  ResP	  and	  RP	  to	  strengthen	  or	  reduce	  the	  amount	  of	  neurotransmitter	  release	  [141,157-­‐159].	  
	  
Brief	  overview	  of	  modes	  of	  release	  in	  neuronal	  and	  insulin-­‐secreting	  β-­‐cells	  Despite	   the	   fact	   that	   neuronal	   tissue	   is	   derived	   from	   an	   embryonic	   germ	   layer	  distinct	   from	   that	   of	  β-­‐cells	   (i.e.	   ectoderm,	   endoderm,	   respectively),	   they	   contain	  15%	  of	  the	  conserved	  β-­‐cell	  markers	  [160].	  Nonetheless,	  it	  stands	  that	  these	  are	  not	  derived	  from	  common	   tissue,	  which	   has	   lead	   some	   to	   speculate	   that	   strong	   similarities	   in	   physiology,	  development	   and	   gene	   expression	   are	   a	   case	   of	   convergent	   evolution	   [161].	   These	  commonalities,	  especially	  as	  they	  relate	  to	  the	  physiology	  of	  exocytosis,	  provide	  significant	  experimental	  advantages	  as	   they	  permit	   the	  study	  of	  how	  shared	  molecules	   function	  and	  form	   complexes	   that	   can	   produce	   strikingly	   different	   release	   modes	   that	   suit	   an	  evolutionary	  purpose.	  	  Chemical	  transmission	  at	  small	  excitatory	  synapses	  (~1mm3)	  of	  the	  central	  nervous	  system	  occurs	  when	  an	  action	  potential	   (AP)	   invades	   a	  bouton.	  The	   resulting	  membrane	  depolarization	  leads	  to	  the	  opening	  of	  VGCCs	  (primarily	  P/Q	  and	  N-­‐type)	  and	  subsequent	  Ca2+	   influx	   [162].	   This	   triggers	   the	   fusion	   of	   synaptic	   vesicles	   containing	   approximately	  200mM	   glutamate	   which	   then	   activate	   AMPA	   (α-­‐amino-­‐3-­‐hydroxy-­‐5-­‐methylisoxazole-­‐4-­‐propionic	  acid)	  receptors	  of	  a	  post-­‐synaptic	  cell	  ~0.6	  ms	  after	  the	  AP	  [20,163].	  Important	  to	  note,	  AP	  firing	  is	  not	  a	  pre-­‐requisite	  to	  SV	  release,	  for	  example,	  in	  hippocampal	  neurons	  spontaneous	  release	  of	  a	  quantum	  occurs	  on	  ~1-­‐2	  times	  per	  second.	  Their	  mechanism	  for	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release,	  calcium	  sensor	  or	  vesicle	  pool	  source	  is	  still	  being	  determined	  [164,165].	  However,	  compared	   to	   spontaneous	   release,	   upon	   opening	   of	   VGCC’s,	   the	   rate	   of	   vesicle	   release	   is	  increased	  supralinearly,	  over	  100,00	  fold	  [43].	  Evoked	  release	  of	  neurotransmitters	  occurs	  in	  two	  distinct	  phases,	  synchronous	  release	  occurring	  within	  milliseconds	  after	  the	  AP	  (and	  accounting	  for	  >90%	  of	  release);	  while	  asynchronous	  persist	  tens	  of	  millisecond	  and	  event	  up	  to	  tens	  of	  seconds	  [166].	  During	  trains	  of	  APs	  the	  ratio	  of	  synchronous	  to	  asynchronous	  release	   can	   shift	   to	   a	   point	   where	   asynchronous	   dominates	   [167].	   Interestingly,	   studies	  done	  in	  the	  Calyx	  of	  held	  revealed	  that	  both	  types	  of	  release	  exhibit	  similar	  Ca2+	  affinities	  (~40mM)	   but	   have	   different	   Ca2+	  cooperativity,	   which	   is	   a	   measure	   of	   the	   sensitivity	   of	  neurotransmitter	   release	   rate	   to	   changes	   in	   the	   synaptic	  Ca2+	  current	   [168,169].	  This	  has	  led	   to	   a	   dual	   calcium	   sensor	   theory,	   though	   other	   explanations	   include:	   functional	  heterogeneity	   among	   vesicle	   pools,	   distance	   of	   vesicles	   from	   VGCCs,	   number	   of	   formed	  SNARE	  complexes	  and	  differences	  in	  the	  size	  of	  single	  quanta	  [168].	  Finally,	  it	  is	  important	  to	   note	   that	   the	   firing	   of	   an	   AP	   does	   not	   always	   lead	   to	   vesicle	   fusion.	   In	   fact,	   in	  hippocampal	  neurons	  the	  probability	  that	  a	  single	  AP	  will	  elicit	  the	  fusion	  of	  at	  least	  one	  SV,	  termed	   neurotransmitter	   release	   probability	   (Pr)	   is	   generally	   very	   low	   <	   0.3	   [170].	  Moreover,	   Pr	   can	   be	   highly	   variable	   between	   individual	   release	   sites	   from	   any	   given	  neuron,	   several	   electrophysiological	   and	   imaging	   studies	   have	   shown	   that	   synaptic	  terminals	  can	   individually	  and	  dynamically	  set	   their	  Pr	   through	   local	   feedback	  regulation	  [65,123,141,170-­‐173].	  	  Pancreatic	   β-­‐cells	   produce	   insulin	   and	   store	   it	   in	   LDCVs.	   Single	   β-­‐cells	   are	  approximately	   10-­‐12	   micrometers	   in	   diameter	   and	   associate	   in	   clusters	   in	   a	   structure	  called	  the	  islet	  of	  Langerhans	  (named	  after	  the	  discoverer)	  [174].	  As	  in	  neurons,	  exocytosis	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is	  stimulated	  by	  membrane	  depolarization	  but	  in	  this	  case	  induced	  by	  the	  closing	  of	  a	  KATP	  channel	   in	   response	   to	   elevations	   in	   extracellular	   glucose	   concentrations	   (~10mM).	  Specifically,	   increased	   glucose	   uptake	   by	   GLUT2	   transporters	   leads	   to	   metabolic	  degradation	   and	   consequent	   shifts	   in	   the	   intracellular	   ATP/ADP	   ratio.	   The	   subsequent	  membrane	   depolarization	   causes	   the	   activation	   of	   L-­‐type	   VGCC	   (Cav1.3)	   triggering	   a	  transient	   first-­‐phase	   of	   insulin	   secretion	   lasting	   ~10	  minutes.	   The	   first-­‐phase	   of	   insulin	  secretion	  is	  thought	  to	  stem	  from	  release	  of	  RRP	  vesicles.	  Next,	  a	  second,	  prolonged	  phase	  of	  insulin	  secretion,	  which	  can	  last	  up	  to	  hours	  is	  thought	  to	  be	  supplied	  by	  RP	  vesicles	  that	  are	   mobilized	   only	   by	   metabolizable	   stimuli	   and	   ATP-­‐dependent	   reactions.	   The	   second	  phase	   of	   insulin	   is	   thought	   to	   act	   independently	   but	   in	   synergy	   with	   the	   KATP-­‐channel	  pathway.	  Interestingly,	  type-­‐II	  diabetes	  is	  associated	  with	  a	  specific	  loss	  of	  insulin	  secretion	  during	  the	  first-­‐phase.	  Like	  neurons,	  the	  RRP	  of	  β-­‐cells	  is	  thought	  to	  only	  constitute	  ~5%	  of	  the	  total	  pool	  (~13,000	  LDCVs).	  Moreover,	  within	  the	  RRP,	  a	  subset	  of	  more	  highly	  calcium-­‐sensitive	  LDCVs	  releases	  with	  faster	  kinetics.	  The	  distribution	  of	  LDCVs	  has	  been	  examined	  by	   electron	   microscopy	   and	   found	   that	   10%	   of	   granules	   are	   docked	   at	   the	   plasma	  membrane	  while	  up	  to	  30%	  are	  within	  one	  granule	  diameter,	  suggesting	  that	  only	  half	  of	  the	   docked	   granules	   are	   primed	   [174].	   Despite	   an	   abundance	   of	   LDCVs	   near	   the	   plasma	  membrane,	  many	   of	  which	   appear	   to	   be	   docked,	   recent	   experiments	   using	   live	   cell	   TIRF	  microscopy	   have	   uncovered	   that	   glucose	   stimulation	   leads	   to	   fusion	   of	   vesicles	   that	   are	  newly	   recruited	   and	   show	   minimal	   residence	   at	   the	   plasma	   membrane.	   In	   contrast,	  depolarization	  by	  Hi	  K+	  elicits	  fusion	  from	  the	  pool	  of	  vesicles	  that	  is	  already	  docked	  at	  the	  plasma	   membrane	   [56,175].	   Altogether	   this	   suggests	   the	   existence	   of	   distinct	   stimulus-­‐
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secretion	  coupling	  mechanism	  that	  may	   involve	   the	   function	  of	  distinct	  Rab	  proteins	  and	  SNARE	  regulators	  [176].	  
	  
Preview	  to	  the	  dissertation:	  Molecular	  mechanisms	  that	  regulate	  the	  strength	  of	  exocytosis	  Priming	   a	   vesicle	   into	   a	   releasable	   state	   may	   at	   first	   glance	   seem	   as	   a	  straightforward	   process	   based	   on	   the	   SNARE	   hypothesis;	   however,	   if	   one	   considers	   the	  great	  number	  of	  molecules	  that	  have	  to	  act	   in	  the	  right	  time	  and	  place	  the	  challenge	  then	  becomes	   formidable	   and	   highly	   sensitive	   to	   molecular	   regulation.	   This	   concept	   is	   best	  illustrated	   by	   work	   done	   using	   in	   vitro	   reconstituted	   systems,	   which	   have	   shown	   that	  pairing	  of	  cognate	  SNAREs	  while	  sufficient	  to	  fuse	  membranes,	  fails	  to	  replicate	  rates	  and	  extent	  of	  vesicle	  fusion	  seen	  in	  cells.	  Interestingly,	  a	  recent	  in	  vitro	  study	  has	  more	  closely	  approximated	  ‘cellular’	  fusion	  by	  reconstituting	  a	  Rab5	  GTPase	  together	  with	  SNAREs	  thus	  forming	  more	   efficient	  machinery.	  They	   conclude	   that	  Rab	  proteins	   are	   required	   for	   and	  confer	   additional	   specificity	   and	   efficiency	   to	   SNARE	   complex	   formation	   [177].	  Nonetheless,	  even	  in	  this	  study,	  only	  a	  set	  of	  17	  reconstituted	  human	  proteins	  were	  used	  together	  with	   a	   limited	   lipid	   composition	   in	   comparison	  with	   in-­‐cell	   systems	   in	  which	   a	  synaptic	   vesicle	   contains	   ~80	   different	   integral	   proteins	   and	  when	   docked	   is	   associated	  with	  up	  to	  ~269	  proteins	  [72,178].	  	  The	   goals	   of	   these	   investigations	   are	   to	   identify	   some	   of	   the	   critical	   membrane	  organizers,	   which	   can	   confer	   molecular	   specificity	   and	   thus	   coordinate	   docking	   and	  priming.	  Given	  the	  fundamental	  role	  of	  Rab	  GTPases	  in	  targeting	  and	  recruiting	  vesicles	  to	  sites	  of	  release,	  one	  of	  the	  main	  focuses	  of	  this	  dissertation	  was	  to	  try	  to	  resolve	  the	  distinct	  vs.	  overlapping	  roles	  of	  Rab3	  and	  Rab27	  proteins	  in	  vesicle	  exocytosis	  (Chapter	  1).	  These	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studies	   were	   conducted	   using	   membrane	   capacitance	   measurement	   of	   exocytosis	   from	  insulin	   secreting	   β-­‐cells.	   This	   model	   allowed	   us	   to	   precisely	   dissect	   the	   kinetic	  contributions	  of	  each	  Rab	  GTPase	  on	  vesicle	  recruitment	  and	  in	  setting	  the	  size	  of	  vesicle	  pools.	   Moreover,	   results	   gleaned	   from	   these	   studies	   offer	   a	   significant	   mechanistic	  contribution	  that	  may	  eventually	  help	  explain	  deficits	   in	   the	   first-­‐phase	  of	   insulin	  release	  associated	  with	  type-­‐II	  diabetes.	  The	  next	  set	  of	  studies	  (Chapter	  2)	  was	  aimed	  at	  characterizing	  the	  functions	  of	  an	  R-­‐SNARE	   protein	   termed	   Tomosyn.	   	   Unlike	   most	   SNARE	   proteins	   Tomosyn	   is	   not	  membrane	   anchored	   by	   a	   C-­‐terminal	   transmembrane	   region	   [179].	   It	   is	   not	   completely	  unique	  in	  this,	  for	  example	  SNAP25	  also	  does	  not	  have	  a	  C-­‐terminal	  transmembrane	  region	  but	   it	   does	   associate	  with	  membranes	   by	   palmitoylation	   [180].	  Moreover,	   Tomosyn	   is	   a	  very	  large	  protein	  relative	  to	  most	  SNAREs,	  which	  don’t	  carry	  many	  other	  protein	  binding	  domains	  outside	  of	   the	  SNARE	  motif.	  Tomosyn’s	  R-­‐SNARE	  motif	   is	  highly	  homologous	   to	  that	  of	  VAMP2	  and	  thus	  can	  compete	  for	  the	  formation	  of	  trimeric	  SNARE	  complexes	  [181-­‐183].	   In	   contrast	   to,	   VAMP2/Synataxin/SNAP25	   complexes,	   those	   containing	   Tomosyn	  instead	   of	   VAMP2	   are	   non-­‐fusiogenic	   [181,183,184].	   Moreover,	   the	   larger	   N-­‐terminal	  domain	  of	  Tomosyn	  is	  enriched	  with	  WD40-­‐repeats	  that	  are	  predicted	  to	  form	  into	  twin	  β-­‐propeller	  structures	  [179].	  Tomosyn	  proteins	  are	  predicted	  to	  be	  highly	  homologous	  to	  the	  structure	   of	   the	   yeast	   Sro7	   [179,185].	   Interestingly,	  mutations	   in	   the	   yeast	   Sro7	   lead	   to	  lethality	   and	   growth	   defects	   caused	   by	   clustering	   of	   what	   appears	   as	   non-­‐fusiogenic	  vesicles	   [14].	  Many	   studies	   have	   concluded	   that	   Sro7p	   coordinates	  with	   the	  Rab	  GTPase	  Sec4p	  to	  target	  vesicles	  to	  fusion	  sites	  via	  interactions	  with	  the	  SNARE	  Sec9p	  [14,186-­‐188].	  In	  mammals,	  two	  genes	  Tomosyn1	  and	  Tomosyn2	  encode	  7	  differentially	  spliced	  proteins	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and	   have	   been	   localized	   to	   the	   cytosol,	   plasma	  membrane	   and	   both	   synaptic	   as	   well	   as	  insulin-­‐containing	   vesicles	   [189-­‐193].	   Functional	   studies	   in	  mammalian	   and	   invertebrate	  models	   indicate	  that	  Tomosyn1	  is	  an	  inhibitor	  of	  priming,	  though	  the	  specific	  mechanism	  by	  which	   it	   does	   this	   has	   not	   been	   defined	   [8,182,194-­‐201].	   Studies	   done	   using	   in	   vitro	  reconstituted	   fusion	  assays	  or	   lipid	  mixing	  have	  established	   that	  Tomosyn	  does	   compete	  with	   VAMP	   to	   limit	   the	   formation	   of	   SNARE	   complexes	   [183,184].	   However,	   in	   cellular	  systems	   this	   mechanism	   has	   not	   been	   established	   as	   necessary	   or	   sufficient	   to	   inhibit	  exocytosis	  as	  expression	  of	  mutants	   lacking	  the	  C-­‐terminal	  domain	  still	   inhibit	   [179,198].	  In	  C.	  elegans,	  Tomosyn	  has	  been	  established	  as	  a	  direct	  functional	  competitor	  with	  Unc13	  since	   the	   deficits	   caused	   by	   Unc13	   mutations	   can	   be	   rescued	   by	   removing	   Tomosyn	  [197,202].	   This	   suggest	   that	   Tomosyn	   has	   a	   central	   role	   in	   vesicle	   priming,	   a	   conclusion	  which	   was	   further	   strengthened	   by	   studies	   in	   chromaffin	   cells,	   which	   show	   clearly	   that	  Tomosyn1	  expression	  leads	  to	  a	  reduction	  in	  the	  RRP	  size;	  however	   in	  addition	  they	  find	  that	  refilling	  of	  the	  RRP	  is	  also	  strongly	  reduced	  [194].	  Thus	  it	  remains	  unclear,	  how	  does	  Tomosyn	  inhibit	  and	  does	  it	  inhibit	  only	  RRP	  formation	  via	  SNARE	  mediated	  clamping?	  Or	  is	  it	  an	  active	  regulator	  of	  vesicle	  recruitment	  upstream	  of	  SNARE	  complex	  formation?	  	  To	   answer	   some	   of	   these	   questions	   we	   conducted	   a	   series	   of	   studies	   in	   rat	  hippocampal	   release	   sites	   where	   vesicle	   pool	   sizes	   have	   been	   well	   characterized	   and	  measurements	   of	   the	   dynamics	   of	   each	   pool	   are	   accessible	   via	   fluorescent	   reporters.	   By	  studying	  the	  role	  of	  Tomosyn	  in	  vesicle	  pool	  partitioning	  we	  are	  able	  to	  uncover	  whether	  its	  regulation	  is	  limited	  to	  only	  the	  final	  steps	  is	  SV	  priming.	  Moreover,	  based	  on	  the	  high	  homology	  with	   the	   yeast	   protein	   Sro7p,	   our	   experiments	   sought	   to	   uncover	   if	   Tomosyn	  proteins	  can	  also	  coordinate	  with	  Rab	  GTPases	  and	  may	  account	  for	  how	  Tomosyn	  proteins	  
	   23	  
can	   render	   vesicles	   recalcitrant	   to	   release.	   Finally,	   given	   the	  dynamic	  nature	  of	  neuronal	  neurotransmission	  we	  investigated	  the	  role	  of	  Tomosyn	  in	  the	  activity-­‐dependent	  tuning	  of	  neurotransmitter	  release	  strength.	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Chapter	  II	  
Distinct	  actions	  of	  Rab3	  and	  Rab27	  GTPases	  on	  late	  stages	  of	  exocytosis	  of	  insulin	  
	  
	  
2.1	  Abstract	  Rab	  GTPases	  associated	  with	  insulin-­‐containing	  secretory	  granules	  (SGs)	  are	  key	  in	  targeting,	   docking	   and	   assembly	   of	   molecular	   complexes	   governing	   pancreatic	   β-­‐cell	  exocytosis.	  Four	  Rab3	  isoforms	  along	  with	  Rab27A	  are	  associated	  with	  insulin	  granules,	  yet	  elucidation	   of	   the	   distinct	   roles	   of	   these	   Rab	   families	   on	   exocytosis	   remains	   unclear.	   To	  define	  specific	  actions	  of	  these	  Rab	  families	  we	  employ	  Rab3GAP	  and/or	  EPI64A	  GTPase-­‐activating	   protein	   overexpression	   in	   β-­‐cells	   from	  wild-­‐type	   or	   Ashen	  mice	   to	   selectively	  transit	   the	   entire	   Rab3	   fam-­‐	   ily	   or	   Rab27A	   to	   a	   GDP-­‐bound	   state.	   Ashen	   mice	   carry	   a	  sponta-­‐	  neous	  mutation	  that	  eliminates	  Rab27A	  expression.	  Using	  membrane	  capacitance	  measurements	   we	   find	   that	   GTP/GDP	   nucleotide	   cycling	   of	   Rab27A	   is	   essential	   for	  generation	   of	   the	   functionally	   defined	   immediately	   releasable	   pool	   (IRP)	   and	   central	   to	  regulating	  the	  size	  of	  the	  eadily	  releasable	  pool	  (RRP).	  By	  comparison,	  nucleotide	  cycling	  of	  Rab3	  GTPases,	  but	  not	  of	  Rab27A,	  is	  essential	  for	  a	  kinetically	  rapid	  filling	  of	  the	  RRP	  with	  SGs.	   Aside	   from	   these	   distinct	   functions,	   Rab3	   and	   Rab27A	   GTPases	   demonstrate	  considerable	   functional	   overlap	   in	   building	   the	   readily	   releasable	   granule	   pool.	   Hence,
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while	  Rab3	  and	  Rab27A	  cooperate	  to	  generate	  release-­‐ready	  SGs	  in	  β-­‐cells,	  they	  also	  direct	  unique	  kinetic	  and	  functional	  properties	  of	  the	  exocytotic	  pathway.	  	  	  
2.2	  Introduction	  Insulin	  secretion	   from	  endocrine	  pancreatic	  β-­‐cells	   is	  essential	   in	  regulating	  blood	  glucose	   levels.	   Key	   to	   this	   secretion	   is	   highly	   regulated	   membrane	   trafficking	   and	  exocytotic	  pathways	  of	  insulin-­‐containing	  secretory	  granules	  (SGs).	  Defects	  in	  the	  process	  of	   insulin	  production,	   trafficking	   and	   secretion	   can	   lead	   to	  profound	  metabolic	  disorders	  and	   diabetes	  mellitus	   (1).	   Physiologically,	   insulin	   secretion	   is	   typically	   triggered	   from	  β-­‐cells	   in	   response	   to	   elevated	  blood	   glucose	   concentrations,	  which	   raises	   the	   intracellular	  ATP/ADP	   concentration	   ratio	   and	   drives	   closure	   of	   KATP	   channels	   leading	   to	   a	  depolarization	   of	   the	   plasma	   membrane.	   Depolarization	   of	   the	   β-­‐cell	   membrane	   then	  triggers	   activation	   of	   voltage-­‐gated	   Ca2+	   channels,	   wherein	   Ca2+	   influx	   results	   in	   an	  induction	   of	   exocytosis	   of	   the	   insulin	   SGs	   (2).	   Prolonged	   glucose	   activation	   of	   β-­‐cells	  induces	  a	  second	  sustained	  phase	  of	  exocytotic	  insulin	  secretion,	  the	  mechanisms	  of	  which	  are	  less	  well	  understood	  (3	  –	  6).	  In	  addition,	  incretins	  such	  as	  glucagon-­‐like	  peptide-­‐1	  and	  glucose-­‐dependent	   insulinotropic	   polypeptide	   strongly	   potentiate	   insulin	   secretion	   via	  cAMP	   signaling.	   Central	   to	   exocytosis	   of	   insulin	   SGs	   is	   the	   assembly/disassembly	   of	  molecular	   complexes	   that	   direct	   SG	   membrane	   targeting,	   tethering	   and	   biochemical	  competency	   for	   undergoing	   membrane	   fusion	   (7–9).	   While	   evolutionarily	   conserved	  SNARE	  pro-­‐	  teins	  and	  regulators	  of	  SNARE	  complex	  assembly	  define	  the	  priming	  and	  fusion	  process,	  Rab	  GTPases	  are	  believed	  to	  be	  critical	  determinants	  of	  organelle	  identity,	  vesicle	  targeting,	  membrane	  tethering	  and	  SNARE	  complex	  formation	  (10,11).	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Rab3A	  was	   the	   first	  Rab	  GTPase	   identified	  on	   insulin-­‐containing	  SGs	   (12).	  Genetic	  studies	  using	  Rab3A	  knockout	  mice	  (13,14)	  as	  well	  as	  investigations	  examining	  the	  effects	  of	   overexpression	   of	   Rab3A	  mutants	   (15	   –	   19)	   demonstrate	   that	   Rab3A	   is	   required	   for	  normal	   levels	   of	   insulin	   secretion	   and	   control	   of	   plasma	   glucose	   levels.	   More	   recently,	  Rab27A,	  a	   close	  evolutionary	   relative	  of	  Rab3,	  has	  also	  been	   found	   to	  be	  associated	  with	  these	  SGs	  (20	  –	  22).	  Similarly,	  functional	  studies	  of	  Rab27A-­‐deficient	  mice	  (13,23,24)	  and	  overexpression	  of	  Rab27A	  mutants	  (21,25)	  have	  determined	  that	  Rab27A	  exerts	  regulatory	  activity	  over	  the	  exocytotic	  release	  of	  insulin.	  Although	  recent	  studies	  have	  confirmed	  that	  Rab3	  and	  Rab27	  are	  commonly	  colocalized	  on	  SGs	  and	  neuronal	  synaptic	  vesicles	  (26),	  the	  precise	   mechanisms	   by	   which	   they	   regulate	   late	   stages	   of	   exocytosis	   and	   the	   degree	   to	  which	   they	  exert	   functional	  overlap	  during	  vesicle	  priming	  and	  exocytosis	   remain	  poorly	  defined.	   Assigning	   specific	   roles	   to	   these	   Rabs	   has	   been	   complicated	   by	   their	   high	  structural	   homology	   and	   the	   promiscuity	   of	   effectors	   between	   the	   Rab3/Rab27	   families.	  Moreover,	   knockout	   mice	   where	   three	   Rab3	   isoforms	   are	   deleted	   do	   not	   survive	   when	  Rab3A	  is	  one	  of	   the	  deleted	   isoforms	  (14),	   further	  complicating	  studies	  assigning	  specific	  actions	  of	  Rab3	  proteins	  versus	  Rab27	  within	  the	  exocytotic	  pathway.	  	  The	  subfamily	  of	  Rab3	  consists	  of	  four	  isoforms	  (Rab3A–D),	  with	  each	  being	  present	  in	  pancreatic	  β-­‐cells	  and	  in	  part	  associated	  with	  SGs	  (27).	  By	  comparison,	  Rab27	  consists	  of	  two	  isoforms	  (Rab27A,B),	  but	  only	  Rab27A	  is	  expressed	  and	  targeted	  to	  insulin-­‐containing	  SGs	  (24).	  The	  activity	  of	  Rab3	  and	  Rab27	  family	  proteins,	  like	  other	  GTPases,	  is	  determined	  by	  their	  cycling	  between	  a	  GDP-­‐bound	  mostly	  inactive	  and	  cytosolic	  form	  and	  a	  GTP-­‐bound	  active	  and	  membrane-­‐bound	  form.	  Transitions	  between	  GTP/GDP	  states	  are	  mediated	  by	  guanine	   nucleotide	   exchange	   factors	   (GEFs)	   that	   stimulate	   the	   binding	   of	   GTP,	   and	   by	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GTPase-­‐activating	  proteins	  (GAPs)	  that	  accelerate	  the	  intrinsic	  rate	  of	  Rab-­‐GTP	  hydrolysis	  and	  return	   the	  Rab	  protein	   to	  an	   inactive	   state	   (28).	  While	  greater	   than	  60	  Rab	  proteins	  have	   been	   identified	   in	  mammalian	   cells,	   comparatively	   fewer	   regulatory	   Rab	   GEFs	   and	  Rab	  GAPs	   have	   been	   identified.	   Indeed,	   GTP	  binding	   of	   both	  Rab3	   and	  Rab27	   families	   is	  promoted	   by	   a	   single	   Rab	   GEF,	   termed	   Rab3GEP	   (29),	   suggesting	   a	   potential	   for	  commonality	  in	  their	  activation.	  Yet,	  return	  to	  a	  GDP-­‐bound	  state	  for	  these	  Rabs	  is	  driven	  by	  distinct	  GAPs	  (Rab3GAP	  and	  EPI64,	  respectively)	  (30,31).	  Differences	  in	  regulated	  GAP	  inactivation	   likely	   lead	   to	   characteristic	   rates	  of	  GTP/GDP	  cycling	  and	  granule	   residency.	  Notably,	   fluorescence	   imaging	   of	  Rab3A	   and	  Rab27A	  on	   SGs	  has	   demonstrated	   that	   they	  exhibit	   kinetic	   differences	   in	   granule	   membrane	   association	   (26,32).	   For	   example,	  activation	   of	   secretion	   is	   often	   accompanied	   by	   rapid	   dissociation	   of	   Rab3A	   from	   the	  exocytic	  vesicles,	  while	  Rab27A	  appears	  to	  be	  largely	  maintained	  on	  SGs	  throughout	  fusion	  and	  early	  stages	  of	  endocytosis	  (33,34).	  These	  results	  are	  consistent	  with	  studies	  showing	  that	  association	  between	  Rab3	  and	  the	  SG	  membrane	  is	  rigorously	  correlated	  with	  Rab3’s	  GTP-­‐bound	  state,	  while	  Rab27	  appears	  to	  be	  able	  to	  associate	  with	  granules	  in	  both	  GDP-­‐	  and	  GTP-­‐bound	  states	  (35,36).	  	  Multiple	  effectors	  have	  been	  reported	   for	   the	  Rab3	  and	  Rab27	  GTPases,	  which	   fall	  largely	   within	   four	   groups	   including,	   Rab-­‐interacting	   molecules	   (RIMs	   and	   RIM-­‐like	  proteins);	   synaptotagmin-­‐like	   proteins	   (Slp	   and	   rabphilin);	   Slp-­‐like	   proteins	   lacking	   C2	  homologous	  regions	  (Slac	  and	  Noc2);	  and	  a	  vesicle	  priming	  protein	  Munc13-­‐4	  (37,38).	  For	  these	  effector	  families,	  RIM	  proteins	  interact	  with	  all	  isoforms	  of	  Rab3	  but	  apparently	  not	  Rab27.	   Conversely,	   Slp1,	   Slp2-­‐a,	   Slp3-­‐a,	   Slp5	   and	   Slac2-­‐a–c	   interact	   specifically	   with	  Rab27A/B	  but	  not	  Rab3.	  By	  comparison,	  Slp4A,	  rabphilin	  and	  no	  C2	  domain	  protein	  (Noc2)	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interact	   with	   Rab27A/B,	   Rab3s	   and	   Rab8	   in	   vitro;	   however,	   binding	   affinities	   suggest	  preference	  for	  interaction	  with	  Rab27s	  in	  vivo	  (38,39).	  Finally,	  Munc13-­‐4,	  a	  member	  of	  the	  Munc13	   family	   that	   participates	   in	   exocytotic	   priming,	   has	   been	   reported	   to	   interact	  specifically	   with	   Rab27	   (40).	   Importantly,	   Rab	   effectors	   may	   show	   cycling	   on/off	  membranes	   that	   differ	   kinetically	   from	   the	   Rabs	   themselves,	   suggesting	   that	   effector	  interactions	  with	  Rab	  GTPases	  may	  exhibit	   temporal	   and	   spatial	  differences	  and	   support	  distinct	   roles	   in	   the	   exocytic	   pathway	   (41).	   Although	   Rab3	   and	   Rab27	   are	   important	  regulators	   of	   secretory	   activity	   their	   functional	   specificity	   remains	  poorly	   understood,	   in	  part	  as	  a	  result	  of	  effector	  overlap.	  	  In	   this	   study,	  we	   identify	   distinct	   roles	   of	   Rab3	   and	  Rab27	   family	   proteins	   in	   the	  final	   stages	   of	   the	   exocytotic	   pathway	   for	   insulin	   secretion	   from	   pancreatic	   β-­‐cells.	   The	  investigations	  are	  novel	   in	  employing	   selective	  overexpression	  of	   the	   catalytic	   subunit	  of	  Rab3GAP	  and/or	  EPI64A	  to	  specifically	  activate	  GTP	  hydrolysis	  and	  respectively	  deactivate	  Rab3	   and/or	  Rab27	   family	   proteins.	  Whole-­‐cell	   capacitance	  measurements	  were	  used	   to	  evoke	  and	  measure	  exocytotic	  activity	  and	  to	  assign	  specific	  actions	  of	  the	  Rab	  families	  on	  functionally	   distinct	   vesicle	   pools	   of	   β-­‐cells	   in	   pancreatic	   islet	   slices.	   Furthermore,	   we	  employed	  total	   internal	  reflection	  fluorescence	  (TIRF)	  microscopy	  of	   fluorescently	  tagged	  insulin-­‐containing	   SGs	   to	   examine	   GAP	   overexpression	   effects	   on	   SG	   plasma	   membrane	  targeting	   and	   on	   juxtamembrane	   mobility.	   Our	   results	   provide	   the	   first	   quantitative	  evidence	   to	   distinguish	   largely	   differential	   roles	   of	   these	   Rab	   GTPase	   families	   in	   the	  priming	  of	  SGs	  into	  the	  immediately	  and	  readily	  releasable	  SG	  pools.	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2.3	  Results	  To	  determine	  the	  sites	  of	  action	  and	  to	  differentiate	  distinct	  roles	  of	  Rab3	  and	  Rab27	  proteins	  on	  exocytosis	  in	  β-­‐cells,	  experiments	  were	  performed	  using	  pancreatic	  islet	  slices	  from	   wild-­‐type	   (wt)	   or	   Ashen	   mice.	   In	   addition,	   overexpression	   of	   GAPs,	   specifically	  Rab3GAP	  or	  EPI64A,	  was	  used	  to	  deactivate	  all	  isoforms	  of	  the	  Rab3	  and/or	  Rab27	  family,	  respectively.	   Islet	  slices,	  as	  opposed	  to	   isolated	  β-­‐cells,	  were	  used	  to	  (i)	  retain	   the	  spatial	  and	  physiological	   characteristics	  of	   the	  exocytotic	  machinery	  and	  gap	   junctions	  of	  β-­‐cells	  found	   in	   intact	   islet	   tissue;	   (ii)	   facilitate	   the	  maintenance	   of	   glucose	   responsiveness	   and	  electrical	  and	  secretory	  characteristics	  through	  organotypic	  tissue	  culture,	  while	  allowing	  efficient	   viral	   infection;	   and	   (iii)	   promote	   a	   tissue	   platform	   allowing	   stable	   long-­‐term	  recording	  of	  membrane	  capacitance	  measurements	  from	  β-­‐cells	  under	  a	  whole-­‐cell	  voltage-­‐clamp	  configuration.	  	  As	  shown	  in	  Figure	  1,	  cultured	  pancreatic	   islet	  slices	  allow	  effective	   infection	  with	  adenovirus	   for	   protein	   expression	   and	   provide	   excellent	   visualization	   of	   individual	   islet	  cells.	  The	  islet	  cell	  type	  specific	  to	  each	  electrophysiological	  recording	  was	  distinguished	  by	  measuring	   steady-­‐state	   voltage-­‐dependent	   inactivation	   properties	   of	   voltage-­‐gated	   Na+	  channels.	   Mouse	   β-­‐cells	   contain	   a	   voltage-­‐gated	   Na+	   current	   whose	   steady-­‐state	  inactivation	   properties	   are	   strongly	   left	   voltage	   shifted	   with	   respect	   to	   the	   inactivation	  properties	  of	  Na+	  currents	  of	  α-­‐	  and	  δ-­‐cells	  (Figure	  1B)	  (42,43).	  The	  use	  of	  pancreatic	  islet	  slices	  also	  allows	  electrophysiological	  current-­‐clamp	  recording	  of	  oscillations	   in	  electrical	  activity	  from	  individual	  β-­‐cells,	  termed	  bursting,	  when	  the	  slices	  are	  exposed	  to	  stimulatory	  levels	   of	   glucose	   in	   the	   bathing	   media.	   Notably,	   this	   glucose-­‐induced	   electrical	   bursting	  behavior	   was	   retained	   for	   at	   least	   3	   days	   in	   cultured	   slices,	   suggesting	   that	   normal	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phenotypic	   characteristics	   are	  maintained	   during	   organotypic	   slice	   culture	   on	   supported	  membranes	  (Figure	  1C).	  Moreover,	  this	  glucose-­‐induced	  bursting	  behavior	  was	  observed	  in	  cultures	  of	  slices	  from	  both	  wt	  and	  Ashen	  mice.	  	  Rab3GAP	  and	  EPI64A	  have	  been	  characterized	  to	  exhibit	  Rab	  GAP	  activity	  specific	  to	  members	  of	   the	  Rab3	   family	  and	  Rab27A	   (31,44).	  The	  effectiveness	  of	  overexpression	  of	  these	   GAPs	   to	   selectively	   shift	   the	   nucleotide-­‐bound	   state	   of	   Rab3	   or	   Rab27	   proteins	   in	  insulin-­‐secreting	   cells	   (Min6)	   was	   confirmed	   using	   a	   series	   of	   fluorescent	   imaging	  experiments	  (Figure	  2).	  Notably,	  CFP-­‐Rab3A	  or	  CFP-­‐Rab27A	  expression	  exhibited	  punctate	  patterning	   of	   fluorescence	   that	   colocalized	   with	   a	   SG	   luminal	   reporter	   [neuropeptide	   Y	  (NPY)-­‐mCH,	   Figure	  2A]	   as	   confirmed	  by	   colocalization	   analysis	   (Figure	  2B).	   Importantly,	  the	   punctate	   pattern	   of	   CFP-­‐Rab3A	   or	   CFP-­‐Rab3D	   was	   completely	   eliminated	   upon	   co-­‐expression	   of	   mYFP-­‐Rab3GAP	   but	   not	   with	   mYFP-­‐EPI64A	   (Figure	   2C).	   By	   comparison,	  punctate	   localization	   of	   CFP-­‐Rab27A	   was	   retained	   upon	   co-­‐expression	   of	   Rab	   GAPs	  (Rab3GAP	  or	  EPI64A,	  Figure	  2D),	  a	  result	  consistent	  with	  reports	   indicating	  that	  Rab27A	  associates	  with	  SGs	  in	  both	  GDP-­‐	  and	  GTP-­‐bound	  states	  (35,36).	  To	  confirm	  that	  GAP	  over-­‐	  expression	   effectively	   transitions	   these	   Rab	   GTPases	   into	   their	   GDP-­‐bound	   state,	  irrespective	   of	   subcellular	   distribution,	   we	   next	   determined	   the	   effect	   of	   GAP	  overexpression	  on	  GTP-­‐dependent	  Rab3A	  and	  Rab27A	  effector	  interactions	  (35).	  RIM2α(1-­‐179)	   is	   a	   splice	   variant	   that	   specifically	   interacts	   with	   GTP-­‐bound	   Rab3	   (18),	   whereas	  Slp4A(AGAAAY)	  is	  a	  mutant	  that	  interacts	  exclusively	  with	  the	  GTP-­‐bound	  form	  of	  Rab27A	  (35).	  As	  shown	  in	  Figure	  2E,	  co-­‐expression	  of	  CFP-­‐Rab3	  and	  cYFP-­‐RIM2α(1-­‐179)	  results	  in	  colocalization	   of	   punctate	   fluorescence,	   which	   was	   lost	   when	   mCH-­‐Rab3GAP	   was	   co-­‐expressed.	   Co-­‐expression	   of	   CFP-­‐Rab27A	   with	   cYFP-­‐Slp4A(AGAAAY)	   also	   demonstrated	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overlapping	   punctate	   fluorescence,	   which	   was	   lost	   with	   the	   added	   expression	   of	   mCH-­‐EPI64A	   (Figure	   2F).	   Taken	   together	   these	   results	   confirm	   that	   (i)	   Rab3GAP	   and	   EPI64A	  transition	   Rab3	   and	   Rab27A,	   respectively,	   into	   their	   GDP-­‐bound	   states;	   (ii)	   Rab27A	  localization	   to	   granules	   can	   be	   retained	   even	   in	   its	   GDP-­‐bound	   form;	   and	   (iii)	  overexpression	   of	   GAPs	   strongly	   reduces	   Rab3	   and	   Rab27A	   GTP-­‐dependent	   effector	  interactions.	  	  Docking	  of	  SGs	  at	  the	  plasma	  membrane	  is	  a	  key	  step	  in	  regulated	  exocytosis,	  as	  this	  is	  proposed	  necessary	  for	  the	  formation	  of	  trans-­‐SNARE	  core	  complexes	  (vesicle	  priming).	  Not	  surprisingly,	  Rab3	  and,	  more	  recently,	  Rab27	  GTPases	  have	  been	  reported	  as	  central	  to	  targeting	  and	  docking	  secretory	  vesicles	  in	  β-­‐cells	  (19,24),	  yeast	  (45),	  neuroendocrine	  cells	  [PC12	  (46)	  and	  chromaffin	  cells	  (47)]	  and	  synaptic	  vesicles	  in	  Caenorhabditis	  elegans	  (48)	  and	   mammalian	   nerve	   terminals	   (49,50).	   Therefore,	   we	   next	   determined	   whether	  overexpression	  of	  the	  Rab	  GAP	  proteins	  exerted	  specific	  actions	  on	  insulin	  granule	  docking	  or	   on	   the	   mobility	   of	   insulin	   SGs	   directly	   adjacent	   to	   the	   plasma	   membrane.	   To	   assess	  effects	  of	  GAP	  over-­‐	  expression	  on	  docking	  we	  used	  TIRF	  microscopy	  of	  a	  co-­‐expressed	  SG	  luminal	  tag	  (NPY-­‐mCH)	  in	  Min6	  cells	  to	  visualize	  single	  SGs	  and	  quantify	  their	  density	  just	  beneath	  the	  plasma	  membrane.	  Min6	  cells	  were	  used	  as	  they	  retain	  glucose-­‐induced	  insulin	  secretion,	  aggregate	   in	  cell	   clusters	  and	  TIRF	  microscopy	  of	  β-­‐cells	   in	   islet	   slices	  was	  not	  achievable.	   Representative	   images	   of	   NPY-­‐mCH-­‐tagged	   insulin	   SGs	   expressing	   only	   NPY-­‐mCH	  or	  when	  co-­‐expressed	  with	  Rab3GAP,	  EPI64A	  or	  with	  both	  Rab	  GAPs	  are	   shown	   in	  Figure	  3A.	  As	  evident	  from	  the	  micrographs,	  no	  differences	  were	  observed	  in	  individual	  SG	  size	  or	  shape	  upon	  expression	  of	  the	  GAPs.	  In	  addition,	  SG	  density	  exhibited	  no	  significant	  differences	  between	  the	  different	  expression	  conditions	  (Figure	  3B).	  These	  data	  differ	  from	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reported	   differences	   in	   SG	   docking	   observed	   with	   Rab3	   and/or	   Rab27A	   knockdown	  (46,51,52)	   and	   suggest	   that	   Rab	   GAP	   overexpression,	   while	   strongly	   shifting	   nucleotide	  equilibrium	  of	  the	  associated	  GTPases	  to	  a	  GDP-­‐bound	  state,	  may	  not	  completely	  preclude	  rapid	   pas-­‐	   sage	   of	   the	   GTPases	   through	   GTP-­‐bound	   states	   to	   drive	   certain	   effector	  interactions	  important	  for	  SG	  docking.	  	  Rab3	  GTPases	  are	  believed	  to	  remain	  associated	  with	  docked	  SGs	  up	  until	  the	  final	  exocytotic	   steps	   leading	   to	   membrane	   fusion.	   By	   comparison,	   Rab27	   may	   remain	  associated	   with	   vesicles	   throughout	   the	   exo-­‐endocytotic	   process	   with	   its	   GTP/GDP	  nucleotide	   state	  being	   selectively	   regulated	  during	  passage	   through	   the	  exocytotic	   fusion	  and	  subsequent	  membrane	  recycling	  (35,36).	  While	  the	  functional	  role(s)	  of	  Rabs	  following	  granule	  tethering/	  docking	  are	  poorly	  understood,	  progression	  of	  vesicle	  priming	  following	  docking	   is	   commonly	  believed	   to	   lead	   to	   stable	  membrane	  association	  and	  an	  associated	  strong	  reduction	   in	  granule	  motion.	   Indeed,	  TIRF	   imaging	  of	  SGs	   immediately	  adjacent	  to	  the	   plasma	  membrane	   has	   repeatedly	   demonstrated	   that	   they	   are	   highly	   constrained	   in	  motion	  (53–57).	  To	  determine	  if	  a	  shift	  in	  nucleotide	  state	  equilibrium	  of	  Rabs	  may	  alone	  modulate	  motion	  of	  docked	  SGs	  we	  next	  performed	  time-­‐lapse	  TIRF	  imaging	  of	  control	  and	  Rab	   GAP-­‐transfected	   Min6	   cells.	   Imaging	   was	   performed	   on	   cells	   held	   in	   physiological	  saline	   containing	   3mM	   glucose	   to	   reduce	   effects	   of	   secretion	   and	   activated	   granule	  recruitment	   on	   measures	   of	   docked	   granule	   mobility.	   The	   x–y	   (ΔR)2	   and	   axial	   (ΔZ)2	  mobility	  of	  individual	  docked	  SGs	  for	  each	  condition	  was	  determined.	  As	  shown	  in	  Figure	  4,	  the	  measured	  (ΔR)2	  and	  (ΔZ)2	  cumulative	  probability	  of	  SG	  mobility	  in	  cells	  co-­‐transfected	  with	  Rab3GAP,	  EPI64A	  or	  Rab3GAP	  +	  EPI64A,	  as	  well	  as	  NPY-­‐mCH	  showed	  no	  significant	  differences	   from	   those	   of	   control	   cells	   (NPY-­‐mCH	   only).	   These	   data	   suggest	   that	   Rab–
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effector	   interactions	   are	  not	   essential	   to	  maintenance	  of	   the	   stable	   and	   largely	   immobile	  population	  of	  docked	  SGs.	  	  To	  identify	  specific	  Rab3	  and	  Rab27A	  GTPase	  activities	  during	  the	  final	  steps	  of	  the	  regulated	   exocytotic	   pathway	  we	   employed	   highly	   time-­‐resolved	  membrane	   capacitance	  (Cm)	  measurements	  from	  β-­‐cells	  within	  islet	  tissue	  slices	  of	  wt	  control	  (C3H/He)	  or	  Ashen	  mice	  as	  well	  as	   from	  β-­‐cells	   in	  the	  slices	   infected	  with	  Rab3GAP	  or	  EPI64A.	  Pancreatic	  β-­‐cells	   contain	   well-­‐described	   SG	   pools,	   including	   a	   large	   reserve	   pool	   (RP),	   a	   readily	  releasable	  pool	   (RRP),	  a	  small	   subset	  of	   the	  RRP	  termed	  the	   immediately	  releasable	  pool	  (IRP)	   and	   a	   highly	   calcium-­‐sensitive	   pool	   (4,13,58	   –	   62).	   The	   IRP	   size	   is	   small	   and	  immediately	  released	  in	  response	  to	  a	  stimulus.	  If	  the	  stimulus	  is	  strong	  or	  prolonged	  and	  the	  IRP	  is	  depleted	  release	  then	  occurs	  from	  the	  RRP.	  The	  IRP	  is	  refilled	  from	  the	  RRP	  and	  the	  RRP	  from	  the	  RP.	  To	  elicit	  release	  and	  measure	  the	  size	  of	  the	  IRP	  and	  RRP	  a	  succession	  of	   step	   depolarizations	   (−80	   mV	   holding	   potential	   to	   0	   mV	   step	   potential)	   was	   applied	  under	  whole-­‐cell	  voltage	  clamp.	  Release	  and	  depletion	  of	   the	   IRP	  was	  accomplished	  by	  a	  series	   of	   five	   50-­‐millisecond	   step	   depolarizations,	   while	   the	   RRP	   was	   released	   using	   10	  500-­‐millisecond	   step	   depolarizations,	   with	   each	   series	   using	   100-­‐millisecond	   inter-­‐	   step	  intervals.	   As	   Rab	   GTPases	   have	   been	   reported	   key	   for	   vesicle	   targeting,	   docking	   and	  priming	  we	  also	  deter-­‐	  mined	  the	  actions	  that	  Rab3	  and	  Rab27A	  proteins	  exert	  on	  refilling	  of	  the	  IRP	  and	  RRP	  following	  their	  depletion.	  To	  measure	  Rab	  protein	  effects	  on	  refilling	  of	  the	  IRP	  and	  RRP	  a	  second	  train	  of	  successive	  step	  depolarizations	  was	  applied	  20	  seconds	  following	  cessation	  of	  the	  initial	  train	  of	  depolarizing	  stimuli.	  	  In	  wt	  control	  β-­‐cells,	   the	  first	  train	  of	  step	  depolarizations	  resulted	  in	  an	  averaged	  ΔCm	  of	   20	   fF	   (fempto-­‐Farads)	   corresponding	   to	   the	   IRP	   and	   250	   fF	   for	   the	   RRP	   (Figure	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5A,C,	   black).	   Based	   on	   estimates	   of	   1.7	   fF	   per	   granule	   these	   ΔCm	   values	   indicate	   IRP	   in	  control	  conditions	  to	  be	  ≈12	  granules	  and	  the	  RRP	  to	  be	  ≈147	  granules.	  Interestingly,	  these	  values	   for	   the	   IRP	   and	  RRP	   are	   approximately	   twice	   those	  we	   previously	   reported	   from	  isolated	  pancreatic	  β-­‐cells	  (13),	  indicating	  that	  the	  more	  integrative	  character	  of	  islet	  slices	  likely	  retains	  more	  physiologically	  robust	  secretory	  responses	  in	  culture.	  Importantly,	  ΔCm	  responses	  to	  a	  second	  train	  of	  step	  depolarizations	  applied	  20	  seconds	  after	  completion	  of	  the	  first	  train	  demonstrated	  only	  45%	  recovery	  of	  the	  IRP	  while	  the	  RRP	  recovered	  to	  85%	  of	  its	  initial	  value	  (Figure	  5B,C,	  gray).	  This	  20-­‐second	  refilling	  interval,	  whereby	  incomplete	  refilling	  of	  the	  IRP	  and	  RRP	  was	  demonstrated	  in	  wt	  control	  cells,	  is	  used	  in	  the	  following	  experiments	  as	  a	  reference	  when	  evaluating	  effects	  of	  Rab	  protein	  nucleotide	  state	  on	  their	  capacities	  to	  direct	  SG	  pool	  refilling.	  	  To	  confirm	  that	  the	  voltage-­‐step-­‐evoked	  ΔCm	  of	  the	  β-­‐cells	  reflect	  Ca2+-­‐dependent	  exocytotic	  activity	  we	  also	  tested	  for	  ΔCm	  to	  successive	  step	  depolarizations	  from	  a	  −80	  mV	  holding	  potential	  to	  +40	  mV,	  a	  value	  closer	  to	  the	  expected	  Ca2+	  equilibrium	  potential	  and	  strongly	  reduced	  voltage-­‐gated	  Ca2+	  current.	  As	  shown	  (Figure	  5A	  –	  C,	  blue)	  steps	  to	  this	  potential	  resulted	  in	  significantly	  smaller	  evoked	  averaged	  ΔCm	  response	  (9	  fF	  IRP	  and	  20	  fF	  RRP).	  	  Figure	  5D	  compares	  representative	  macroscopic	  β-­‐cell	  currents	   in	  response	  to	   the	  initial	   50-­‐millisecond	   voltage	   step	   during	   the	   first	   (black)	   and	   second	   (red)	   train	   of	   step	  depolarizations	   from	  −80	   to	   0mV.	  Note	   that	   the	   current	   responses	   to	   each	   applied	   train	  were	  equivalent,	  suggesting	  that	  differences	  in	  ΔCm	  responses	  between	  the	  trains	  are	  not	  the	  result	  of	  inadequate	  recovery	  or	  of	  rundown	  of	  the	  evoked	  current.	  Most	  of	  the	  β-­‐cells	  demon-­‐	   strated	  a	   rapid	   inward	   followed	  by	  a	   strongly	   reduced	   sustained	   inward	   current	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following	   the	   step	  depolarizations	   that	   likely	   reflect	   voltage-­‐gated	  Na+	   and	  Ca2+	   current	  components	  (Figure	  5D,	  lower).	  Interestingly,	  in	  a	  small	  subset	  of	  β-­‐cells	  only	  the	  sustained	  current,	   most	   likely	   representing	   Ca2+	   influx,	   was	   observed,	   which	   also	   demonstrated	  complete	  recovery	  during	  the	  intertrain	  interval	  (Figure	  5D,	  upper).	  Indeed,	  voltage	  steps	  to	  0mV	  from	  a	  −50mV	  holding	  poten-­‐	  tial,	  where	  voltage-­‐gated	  Na+	  channels	  in	  β-­‐cells	  are	  inactivated,	  resulted	  in	  a	  sustained	  inward	  Ca2+	  cur-­‐	  rent	  with	  amplitudes	  close	  to	  that	  of	  the	  sustained	  current	  observed	  upon	  steps	  to	  0mV	  from	  a	  −80mV	  holding	  potential	  (Figure	  5E).	  	   Insulin-­‐containing	   SGs	   in	   wt	   control	   β-­‐cells	   possess	   both	   Rab27A	   and	   the	   four	  isoforms	  of	  Rab3	  (A,	  B,	  C	  and	  D)	  GTPases	  (20	  –	  22,	  63,	  27).	  As	  a	  test	  for	  distinct	  as	  well	  as	  complimentary	  actions	  of	  these	  GTPases	  we	  initially	  examined	  the	  effects	  of	  Rab27A	  on	  IRP	  and	  RRP	   sizes	   and	   on	   pool	   refilling	   using	   three	   separate	   experimental	   conditions.	   These	  conditions	  include	  exocytotic	  measurements	  from	  β-­‐cells	  in	  islet	  slices	  of	  the	  Ashen	  mouse	  (i.e.	  Rab27A-­‐deficient)	   and	  of	   β-­‐cells	   following	  EPI64A	  adenoviral	   infection	  of	   islet	   slices	  isolated	  from	  Ashen	  and	  wt	  mice.	  As	  shown	  in	  Figure	  6,	  the	  averaged	  initial	   IRP	  and	  RRP	  exocytotic	   responses	   measured	   from	   β-­‐cells	   under	   each	   of	   these	   three	   conditions	   were	  significantly	  reduced	  from	  those	  of	  wt	  mice	  (control	  response,	  dashed	  line,	  Figure	  6B).	  The	  IRP	   from	   β-­‐cells	   of	   Ashen	   mice	   was	   most	   strongly	   affected	   (∼90%	   reduction),	   whereas	  overexpression	   of	   EPI64A	   in	   β-­‐cells	   of	   Ashen	   or	   wt	   control	   slices	   resulted	   in	   an	  approximately	   50%	   reduction	   in	   IRP	   from	   control.	   The	   reduced	   effect	   on	   IRP	   size	   with	  EPI64A	  over-­‐	  expression	  in	  Ashen	  β-­‐cells	  suggests	  that	  EPI64A	  exerts	  Rab27A-­‐independent	  effects	   on	   secretion.	   Indeed,	   EPI64A	   has	   also	   been	   characterized	   as	   a	   binding	   protein	   of	  EBP50,	  which	  participates	   in	  actin	  bundling	  at	   the	   cell	  periphery	   (64).	  By	   comparison	   to	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the	  substantial	  reduction	  of	  the	  IRP	  from	  wt	  control	  with	  loss	  of	  Rab27	  or	  Rab27-­‐GTP,	  the	  RRP	   for	   each	   condition	   (Ashen,	  Ashen	  +	  EPI64A	  and	   control	   +	  EPI64A)	  was	   significantly	  reduced,	  but	  only	  by	  approximately	  25%.	  Note	  that	  measured	  differences	  in	  IRP	  and	  RRP	  pool	  sizes	  of	  control	  and	  Ashen	  β-­‐cells	  were	  not	  associated	  with	  changes	  in	  voltage-­‐gated	  integrated	   Ca2+	   influx	   (Figure	   6C).	   Moreover,	   while	   expression	   of	   EPI64A	   resulted	   in	   a	  reduced	   Ca2+	   influx,	   diminution	   in	   ΔCm	   responses	   was	   not	   greater	   than	   observed	   for	  Ashen-­‐only	  β-­‐cells.	  	  Rab27A	  effects	  on	  refilling	  of	  the	  IRP	  and	  RRP	  were	  determined	  through	  application	  of	   a	   second	   train	   of	   step	   depolarizations	   following	   a	   20-­‐second	   recovery	   interval.	  Measurement	   of	   the	   ΔCm	   responses	   showed	   that	   in	   Ashen	   β-­‐cells	   the	   reduced	   IRP	  completely	   refilled,	   while	   the	   RRP	   refilled	   to	   approximately	   the	   same	   percentage	   as	  observed	   for	  wt	  β-­‐cell	  controls	  (Figure	  6B).	  By	  comparison,	  Ashen	  β-­‐cells	  overexpressing	  EPI64A	   demonstrated	   complete	   refilling	   of	   both	   the	   IRP	   and	   RRP,	   whereas	   the	  overexpression	  of	  EPI64A	   in	   control	   cells	   led	   to	   incomplete	   refilling	  of	   the	   IRP	   and	  RRP.	  EPI64A	   facilitation	   of	   RRP	   pool	   refilling	   in	   the	   absence	   of	   Rab27A,	   but	   not	   in	   Rab27A	  containing	   control	   cells,	   suggests	   that	   alternative	   actions	   of	   EPI64A	   in	   the	   exocytotic	  pathway	  may	  be	  enhanced	  when	  functional	  competition	  with	  Rab27A	  is	  absent.	  Overall,	  the	  data	  indicate	  that	  Rab27A-­‐GTP	  is	  critically	  important	  in	  enhancing	  the	  size	  of	  the	  IRP	  and	  that	   this	   is	   independent	  of	  effects	  on	   the	   rate	  of	   IRP	  pool	   refilling.	  Rab27A-­‐GTP	  was	  also	  observed	   integral	   to	   setting	   the	   overall	   RRP	   size,	   but	   without	   substantial	   effect	   on	   pool	  refilling.	  	  As	  a	  test	  for	  distinct	  functional	  effects	  between	  Rab27A	  and	  the	  Rab3	  GTPase	  family	  we	  next	  determined	  the	  effects	  of	  overexpression	  of	  Rab3GAP	  on	  IRP	  and	  RRP	  sizes	  and	  on	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pool	  refilling	  in	  pancreatic	  β-­‐cells.	  As	  demonstrated	  above,	  Rab3GAP	  specifically	  targets	  the	  Rab3	   isoforms	   without	   notable	   effect	   on	   Rab27A-­‐GTP.	   As	   shown	   in	   Figure	   7A,C,	  overexpression	  of	  Rab3GAP	  in	  wt	  β-­‐cells	  results	  in	  an	  approximately	  50%	  reduction	  in	  the	  IRP	   from	  wt	  control.	  By	  comparison,	  Rab3GAP	  overexpression	  exerted	   little	  effect	  on	   the	  RRP	   when	   compared	   with	   control	   wt	   β-­‐cells	   (Figure	   7C).	   Importantly,	   the	   predominate	  shift	  in	  Rab3	  isoforms	  to	  the	  GDP-­‐bound	  state	  through	  Rab3GAP	  overexpression	  resulted	  in	  a	   substantial	   deficit	   in	   refilling	   of	   the	   IRP	   and	   RRP	   as	   defined	   by	   ΔCm	   responses	   to	   the	  subsequent	  train	  of	  step	  depolarizations	  (Figure	  7A,C).	  Therefore,	  it	   is	  clear	  that	  the	  GTP-­‐bound	  state	  of	  Rab3	  isoforms,	  but	  not	  of	  Rab27A,	  are	  key	  to	  rapid	  refilling	  of	  both	  the	  IRP	  and	  RRP.	  Although	  Rab3GAP	  overexpression	  reduced	  integrated	  Ca2+	  influx	  from	  levels	  of	  wt	  β-­‐cell	  controls	  no	  significant	  differences	  were	  observed	  on	  the	  influx	  between	  Rab3GAP-­‐overexpressing	  control	  or	  Ashen	  cells	   (Figure	  7E),	  or	  with	  EPI64A-­‐overexpressing	  β-­‐cells	  (Figure	   6C).	   These	   data	   suggest	   that	   the	   specific	   deficit	   in	   pool	   refilling	   upon	   Rab3GAP	  overexpression	  is	  not	  attributable	  to	  reduced	  Ca2+	  influx.	  	  To	   identify	  potential	   compensatory	   functions	  of	  Rab27A	  and	  Rab3	   isoforms	   in	   the	  final	   stages	   of	   exocytosis	   we	   next	   evaluated	   the	   effects	   of	   combined	   deficit	   of	   Rab27A	  activity	  and	  GTP-­‐bound	  Rab3	  isoforms	  through	  overexpression	  of	  Rab3GAP	  in	  the	  Ashen	  β-­‐cells.	  Ashen	  cells	  were	  used	  instead	  of	  EPI64A	  co-­‐expression	  to	  mitigate	  alternative	  actions	  of	   EPI64A	   in	   the	   exocytotic	   pathway.	   Under	   these	   conditions	   we	   again	   observed	   a	  reduction	   in	   the	   IRP	   similar	   to	   that	   seen	   upon	   independent	   reduction	   of	   the	   GTP-­‐bound	  state	   of	   Rab3	   isoforms	   by	   Rab3GAP	   overexpression	   in	  wt	   β-­‐cells	   (Figure	   7B,C).	   Notably,	  overexpression	  of	  Rab3GAP	  in	  Ashen	  cells	  demonstrated	  an	  increased	  IRP	  size	  relative	  to	  Ashen	   alone.	   This	   paradoxical	   result	   may	   indicate	   that	   enhanced	   Rab3GAP	   GTP/GDP	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cycling	  of	  Rab3s	  may	  partially	  offset	  a	  Rab27	  deficit	  on	  the	  IRP.	  By	  comparison,	  RRP	  size	  in	  the	   absence	   of	   Rab3-­‐GTP	   and	   Rab27A	  was	   observed	   to	   exhibit	   a	   substantial	   and	   signifi-­‐	  cant	   reduction	   greater	   than	   that	   exhibited	   by	   Ashen	   cells	   or	   Rab3GAP	   overexpression	  alone.	   In	   addition,	   loss	   of	   functionally	   active	   Rab3-­‐GTP	   and	   Rab27A	   resulted	   in	   strongly	  reduced	  refilling	  of	  the	  IRP	  and	  RRP	  (Figure	  7C).	  When	  considered	  with	  the	  findings	  above,	  these	  data	  demonstrate	  that	  GAP	  overexpression	  targeting	  either	  or	  both	  Rab27A	  or	  Rab3	  proteins	  reduces	   IRP	  size	  by	  approximately	  50%	  of	  wt	  control.	   In	  comparison,	   individual	  expression	  of	  Rab27A	  or	  Rab3	  GAP	  proteins	  resulted	  in	  a	  smaller	  effect	  on	  the	  initial	  size	  of	  the	  RRP,	  while	  combined	  loss	  of	  Rab27A	  and	  Rab3-­‐GTP	  isoforms	  strongly	  reduced	  the	  size	  of	  the	  RRP.	  A	  likely	  interpretation	  is	  that	  Rab27A	  and	  Rab3	  perform	  compensatory	  roles	  in	  filling	  of	  the	  IRP	  and	  RRP	  pools.	  Yet,	  comparison	  of	  the	  kinetics	  of	  refilling	  of	  the	  IRP	  and	  RRP	   pools	   following	   depletion	   indicates	   that	   Rab3-­‐GTP	   isoforms,	   but	   not	   Rab27A,	   drive	  rapid	  refilling	  of	  exocytotic	  SG	  pools.	  	  Ca2+-­‐triggered	   insulin	   secretion	   from	   β-­‐cells	   is	   potently	   amplified	   by	   increased	  subplasma	   membrane	   cAMP.	   In	   addition,	   the	   insulinotropic	   actions	   of	   glucagon	   and	  incretin	  hormones	  are	   largely	  mediated	  via	   increased	  cAMP	   levels,	  with	  protein	  kinase	  A	  (PKA)	   and	   cAMP-­‐regulated	   GEF	   cAMP-­‐GEFII	   (also	   termed	   Epac2)	   serving	   as	   primary	  downstream	  cAMP	  effectors	   (65–69).	  Rab3GAP,	  but	  not	  EPI64A,	   overexpression	   strongly	  dimin-­‐	  ished	  the	  rapid	  refilling	  of	  the	  IRP	  and	  RRP	  following	  initial	  depletion.	  Therefore,	  we	  next	   tested	   if	   GTP-­‐bound	   Rab3	   isoforms	   were	   required	   for	   cAMP	   to	   enhance	   the	   initial	  secretory	  response,	  and	  if	  cAMP	  signaling	  was	  able	  to	  offset	  the	  Rab3GAP-­‐induced	  deficit	  in	  rapid	  refilling	  of	  the	  IRP	  and	  RRP.	  For	  this	  analysis,	  the	  whole-­‐cell	  recording	  patch	  pipettes	  contained	   100	   μM	   cAMP	   and	   evaluation	   of	   β-­‐cell	   SG	   pool	   parameters	   of	   Rab3GAP-­‐
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overexpressing	   cells	   commenced,	   as	   above,	   90	   seconds	   after	   attaining	   the	   whole-­‐cell	  configuration.	  As	  shown	  in	  Figure	  8,	  inclusion	  of	  cAMP	  resulted	  in	  a	  significant	  increase	  in	  initial	   ΔCm	   responses	   associated	   with	   the	   IRP	   and	   RRP	   compared	   with	   Rab3GAP	  overexpression	   in	  wt	   β-­‐cells.	   In	   spite	   of	   this	   cAMP-­‐driven	   increase	   in	   IRP	   and	   RRP	   size,	  refilling	  of	  the	  pools	  remained	  significantly	  incomplete	  to	  the	  standard	  20-­‐second	  recovery	  period.	   Also,	   although	   cAMP	   treatment	   increased	   integrated	   Ca2+	   influx	   relative	   to	   cells	  treated	  with	  Rab3GAP	  alone	   (39.3±6.1	  pC,	  Rab3GAP;	  84.1±15.9	  pC,	  Rab3GAP+cAMP)	   the	  enhanced	   influx	   did	   not	   overcome	   a	   Rab3GAP-­‐mediated	   deficit	   in	   IRP	   and	   RRP	   pool	  refilling.	  	  	  
2.4	  Discussion	  The	   results	   of	   this	   study	   are	   among	   the	   first	   to	   identify	   and	   establish	   unique	  functional	  activities	  of	  Rab3	  and	  Rab27	  proteins	  on	  late	  stages	  of	  the	  exocytotic	  pathway,	  while	  also	   identifying	   functional	  overlap.	  Notably,	  we	  find	  that	  establishment	  of	  an	  IRP	   is	  completely	   dependent	   upon	   the	   presence	   of	   Rab27A	   GTPase	   in	   β-­‐cells	  maintained	   in	   an	  islet	   architecture,	   as	   the	   IRP	   was	   completely	   lacking	   in	   Ashen	   β-­‐cells.	   Rab27A	   was	   also	  found	   to	   participate	   in	   setting	   the	   RRP	   size	   under	   steady-­‐state	   conditions,	   as	   the	   RRP	  response	  to	  an	  initial	  evoked	  secretory	  response	  was	  significantly	  reduced	  in	  size	  in	  Ashen	  β-­‐cells	   as	  well	   as	   in	  wt	   β-­‐cells	   overexpressing	   the	   Rab27A	   GAP	   EPI64A.	   By	   comparison,	  overexpression	  of	  Rab3GAP	  exerted	  little	  effect	  on	  RRP	  size	  under	  steady-­‐state	  conditions,	  although	   Rab3	   GTPases	   appeared	   to	   cooperate	   with	   Rab27A	   in	   setting	   the	   IRP	   size.	  Remarkably,	  however,	  Rab3,	  but	  not	  Rab27A,	  GTPases	  exert	  a	  key	  and	  prominent	  role	   to	  rapidly	  refill	   the	  IRP	  and	  RRP.	  Assignment	  of	   this	  kinetic	  effect	   to	  Rab3	  GTPases	  resulted	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from	   an	   observed	   strong	   deficit	   in	   rapid	   refilling	   of	   the	   RRP	   upon	   overexpression	   of	  Rab3GAP,	   and	   because	   neither	  Ashen	   β-­‐cells	   nor	   overexpression	   of	   EPI64A	   in	  wt	   β-­‐cells	  demonstrated	  a	  kinetic	  deficit	   in	  IRP	  and	  RRP	  refilling.	   Interestingly,	   the	  kinetic	  deficit	   in	  Rab3GAP-­‐overexpressing	   β-­‐cells	   did	   not	   mitigate	   cAMP	   from	   strongly	   potentiating	   the	  steady-­‐state	  IRP	  and	  RRP	  size,	  although	  notably,	  refilling	  of	  these	  pools	  following	  depletion	  remained	  incomplete.	  Our	  experimental	  conditions	  do	  not	  exclude	  the	  possibility	  that	  the	  Rab3GAP-­‐mediated	  slowing	  of	  refilling	  is	  independent	  of	  Rab3.	  However,	  previous	  studies	  have	   demonstrated	   that	   loss	   of	   Rab3GAP	   results	   in	   no	   changes	   in	   the	   levels	   of	   key	  exocytotic	  proteins	  or	  morphology	  of	  release	  sites	  (70,71).	  Moreover,	  Müller	  et	  al.	  showed	  that	  Rab3	  specifically	  mediated	  a	  deficit	  in	  compensatory	  synaptic	  exocytosis	  in	  Rab3GAP	  mutant	   synapses.	   Taken	   together,	   these	   data	   support	   that	  Rab3GAP	   actions	   on	   secretion	  being	   directly	   related	   to	   perturbations	   in	   the	   activity	   of	   Rab3	   GTPases.	   Finally,	   the	  combined	  loss	  of	  active	  Rab3	  GTPases	  with	  Rab27A	  resulted	  in	  an	  RRP	  size	  that	  was	  more	  severely	  reduced	  than	  observed	  in	  Ashen	  β-­‐cells.	  Notably,	  the	  present	  results	  complement	  our	   initial	   report	   that	   established	   incomplete	   refilling	   of	   the	   RRP	   following	   its	   evoked	  depletion	  in	  isolated	  and	  cultured	  Ashen	  β-­‐cells	  (13).	  In	  addition,	  we	  reported	  that	  β-­‐cells	  lacking	   only	   the	   Rab3A	   isoform	   displayed	   normal	   IRP	   and	   RRP	   refilling,	   which	   together	  with	  the	  present	  results	  suggest	  that	  other	  Rab3	  isoforms	  are	  able	  to	  fully	  compensate	  for	  loss	   of	   Rab3A.	   The	   present	   data	   demonstrate	   distinct	   functional	   and	   kinetic	   regulatory	  activities	  of	  Rab3	  and	  Rab27A	  GTPases	  on	  SG	  transition	  to	   fusion	  competency,	  while	  also	  providing	   evidence	   that	   full	   development	  of	   β-­‐cell	   secretory	   activity	   requires	   convergent	  actions	  of	  Rab3	  and	  Rab27A	  GTPases.	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An	  important	  feature	  of	  this	  study	  is	  that	  we	  have	  identified	  unique	  roles	  for	  Rab27	  and	  Rab3	  GTPases.	  Rab27	  GTPases	  are	  necessary	   for	   the	   formation	  of	  an	   IRP.	  This	  was	  a	  surprising	  result	  given	  the	  extensive	  literature	  linking	  Rab3/RIM	  complexes	  with	  docking	  near	   calcium	   channels,	   as	   required	   for	   the	   IRP	   (19,72	   –	   74).	   Nonetheless,	   our	   results	  suggest	   that	   Rab27	   is	   a	   limiting	   factor	   for	   the	   formation	   of	   the	   IRP,	   which	   could	   be	  mediated	  by	  Rab27	  unfettering	  of	  Rab3-­‐clamped	  granules	   through	  stimulation	  of	  GTPase	  activity	  (75),	  or	  via	  Rab27	  complexes	  with	  Slp4A/Munc18-­‐1/Syntaxin	  (76).	  Rab3A	  GTPases	  exert	  a	  unique	  role	  on	  the	  rapid	  repopulation	  of	  the	  IRP	  and	  RRP	  in	  pancreatic	  β-­‐cells.	  Yet,	  the	   mechanism	   by	   which	   Rab3	   GTPases	   exert	   this	   action	   remains	   unanswered.	   Bio-­‐	  chemical,	   genetic	   and	   live	   cell	   imaging	   have	   demonstrated	   that	   targeting/docking	   and	  priming	   functions	   of	   Rab	   GTPases	   involve	   a	   sequencing	   of	   effector	   interactions	   (77).	   In	  addition,	  multiple	   lines	   of	   evidence	   have	   indicated	   that	   docked	   SGs	  may	   be	   the	   primary	  location	  of	  Rab3	  GTPase	  priming	  actions,	  because	  Rab3GAP	  hydrolyzes	  Rab3-­‐GTP	  to	  Rab3-­‐GDP	   concurrently	   with	   Ca2+	   -­‐triggered	   vesicle	   fusion	   (77	   –	   79).	   This	   catalytic	   event	   is	  believed	  to	  occur	  after	  vesicle	  docking/tethering	  but	  prior	  to	  endocytosis,	  as	  Rab3	  is	  absent	  from	   clathrin-­‐containing	   vesicles	   (80).	   Rab	   effectors	   interact	   directly,	   or	   in	   molecular	  scaffolds,	  with	  other	  mediators	  of	  vesicle	  priming	  and	  membrane	  fusion.	  For	  example,	  Rab3	  GTPase	   effectors	   include	   rabphilin	   (17),	   Noc2	   (39),	   Slp4	   (35),	   Munc18-­‐1	   (81)	   and	  RIM1α/2α	   (18).	  Notably,	   RIM1α/2α	   bind	  with	   the	   priming	   factor	  Munc13-­‐1	   and	   nuclear	  magnetic	   resonance	   spectroscopy	   has	   established	   that	   Rab3-­‐GTP,	   Rim2α	   and	   Munc13-­‐1	  can	  assemble	  into	  a	  tripartite	  complex	  (82).	  RIM	  has	  been	  established	  to	  exert	  a	  key	  role	  in	  insulin	   secretion	   (83)	  and	  be	  associated	  with	  both	  Rab3-­‐GTP	  on	   the	   insulin	  granule	   (19)	  and	  L-­‐type	  Ca2+	  channels	  on	  the	  plasma	  membrane	  (84).	  In	  addition	  to	  effector	  interaction	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with	   RIM,	   Rab3-­‐GTP	   interactions	   with	   Munc18-­‐1	   or	   rabphilin	   may	   serve	   as	   the	   link	  between	   granule	   docking	   and	   priming	   reactions	   with	   SNARE	   proteins	   (81,85).	   These	  results	  have	  led	  to	  a	  model	  whereby	  a	  secretory	  stimulus	  enhances	  GTP	  hydrolysis	  to	  elicit	  disassembly	   of	   the	   GTP-­‐bound	   Rab–effector	   complexes,	   thereby	   allowing	   the	   spatially	  localized	   interaction	   of	   Rab	   effectors	   with	   downstream	   mediators	   required	   for	   vesicle	  priming/fusion	   and	   formation	   of	   the	   SNARE	   complex	   (77,	   78,	   86,	   87).	   Moreover,	   recent	  reconstitution	  of	  Rab5	  with	   its	  cognate	  SNARE-­‐dependent	  membrane	  fusion	  pathway	  has	  demonstrated	  that	  Rab	  and	  SNARE	  machineries	  act	  coordinately	  to	  facilitate	  the	  process	  of	  membrane	   tethering/docking	   and	   fusion	   (88).	   Importantly,	   although	   Rab3	   GTPases	  may	  serve	  as	  gatekeepers	  regulating	  transition	  of	  docked	  SGs	  into	  primed	  releasable	  pools,	  the	  specific	  SGs	  on	  which	  Rab3	  acts	  to	  rapidly	  refill	  the	  RRP	  remain	  unknown,	  particularly	  as	  insulin	   SGs	   are	   subject	   to	   rapid	   recruitment	   and	   priming	   during	   sustained	   glucose-­‐stimulated	  insulin	  secretion	  (89,90).	  	  Glucose-­‐stimulated	   β-­‐cell	   secretion	   is	   biphasic,	   consisting	   of	   a	   rapid	   and	   a	   slower	  more	  prolonged	  phase	  of	  insulin	  release.	  The	  initial	  phase	  has	  generally	  been	  equated	  with	  the	  IRP,	  which	  is	  completely	  released	  over	  milliseconds	  in	  response	  to	  step	  depolarization	  under	  voltage	  clamp	  (91).	  This	  association	  is	  based	  on	  the	  number	  of	  SGs	  released,	  and	  on	  timing	  differences	  between	  the	  direct	  electrical-­‐	  and	  glucose-­‐evoked	  release	  resulting	  from	  the	   immedi-­‐	   acy	   of	   membrane	   potential	   changes	   versus	   glucose	   diffusion,	   uptake	   and	  metabolism	  and	  insulin	  diffusion	  from	  an	  intact	  tissue.	  In	  addition,	  molecular	  scaffolding	  of	  a	  small	  set	  of	  SGs	  to	  voltage-­‐gated	  calcium	  channels,	  and	  of	  insensitivity	  of	  fusion	  of	  the	  IRP	  by	   the	   Ca2+	   chelator	   EGTA,	   but	   not	   the	   kinetically	   faster	   chelator	   BAPTA,	   have	   strongly	  indicated	   that	   the	   IRP	  consists	  of	  docked	  SGs.	  Moreover,	  TIRF	   imaging	  of	   insulin	  SGs	  has	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demonstrated	   that	   the	   initial	   rapid	   fusion	   events	   result	   largely	   from	   membrane	  adjacent/docked	   SGs	   (92	   –	   94).	   Taken	   together,	   release	   from	   the	   IRP	   is	   likely	   to	   be	  completely	  accounted	  for	  by	  fusion	  of	  membrane-­‐docked	  SGs.	  	  By	  comparison,	  the	  source	  of	  SGs	  that	  comprise	  the	  RRP	  (generally	  assigned	  to	  the	  second	   phase	   of	   glucose-­‐stimulated	   insulin	   secretion)	   is	   less	   concretely	   identified.	   This	  pool	  likely	  is	  composed	  of	  docked	  (or	  membrane	  resident)	  SGs	  as	  well	  as	  a	  set	  of	  newcomer	  granules	  that	  have	  more	  recently	  been	  identified	  to	  cycle	  rapidly	  from	  the	  RP	  to	  undergo	  membrane	   fusion	  (95).	  Previous	   findings	  have	  established	   that	  Rab3	  and	  Rab27	  GTPases	  coordinately	  regulate	  the	  docking	  of	  dense	  core	  SGs	  (46)	  while	  also	  differing	  in	  membrane	  cycling	   dynamics	   (32).	   Our	   data	   demonstrate	   that	   the	   formation	   of	   an	   IRP	   is	   completely	  dependent	   upon	   Rab27A,	  with	   active	   Rab3	   GTPases	   exerting	   a	  modulatory	   role.	   For	   the	  RRP,	  active	  Rab3	  GTPases	  exert	  a	  critical	  role	  on	  rapid	  refilling	  of	  the	  RRP	  following	  initial	  depletion,	  while	  GTP-­‐bound	  Rab27A	  appears	   important	   in	  defining	  the	  overall	  size	  of	   the	  RRP.	   Thus,	   although	   overexpression	   of	   Rab3GAP	   slowed	   RRP	   refilling	   it	   did	   not	   notably	  affect	  RRP	  size.	  The	  divergent	  actions	  of	  these	  Rab	  GTPases	  may	  correlate	  with	  differences	  reported	   in	   their	   dynamic	   association	  with	   SGs	   (32,33,96).	  The	  Rab3A	  pool,	  which	   likely	  reflects	   similar	   behavior	   of	   the	   other	   Rab3	   GTPases,	   demonstrates	   a	   rapid	   exchange	  between	  the	  SGs	  and	  cytosol,	  whereas	  Rab27A	  has	  demonstrated	  little	  exchange	  associated	  with	   the	   exocytotic	   event	   (32,33).	   The	   rapid	   exchange	  of	  Rab3	  GTPases	  may	   account	   for	  their	  ability	  to	  kinetically	  facilitate	  RRP	  refilling	  as	  they	  are	  able	  to	  quickly	  cycle	  onto	  SGs	  and	  recruit	  appropriate	  effectors	  that	  promote	  SG	  recruitment	  to	  the	  plasma	  membrane	  as	  well	   as	   subsequent	   tethering/docking	   and	   priming	   processes.	   Not	   only	   is	   rapid	  granule/cytosolic	   exchange	   lacking	   for	   Rab27A,	   fluorescence	   recovery	   after	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photobleaching	  studies	  have	  indicated	  that	  once	  it	  associates	  with	  newly	  synthesized	  SGs	  it	  becomes	   non-­‐exchangeable,	   perhaps	   as	   a	   result	   of	   low	   inherent	   GTPase	   activity	   (32).	   In	  support	  of	   its	   low	  GTPase	  activity,	   a	  high	  percentage	  of	  Rab27A	  has	  been	  reported	   to	  be	  GTP-­‐bound	  and	  membrane-­‐associated,	  even	  in	  unstimulated	  pituitary,	  platelet,	  pancreatic	  acinar	   and	   insulin-­‐secreting	   Min6	   cells	   (20,97,98).	   Yet,	   GTPase	   activity	   appears	   key	   to	  regulation	  of	  insulin	  secretion	  because	  Rab27A,	  unlike	  most	  GTPases,	  has	  been	  reported	  to	  bind	   effectors	   in	   both	   the	   GDP-­‐	   and	   GTP-­‐bound	   states.	   In	   its	   GDP-­‐bound	   state,	   Rab27A	  recruits	   and	   inter-­‐	   acts	  with	   Slp4A	   (37).	   Slp4A	   (also	   termed	   granuphilin)	  was	   originally	  identified	  in	  pancreatic	  β-­‐cells	  as	  a	  protein	  that	  binds	  to	  the	  closed	  form	  of	  syntaxin1A	  and	  Rab27A-­‐GDP	  to	  participate	  in	  docking	  of	  the	  insulin	  granules	  (20,99,100).	  Yet,	  this	  Rab27A-­‐GDP-­‐directed	   docking	   complex	   has	   been	   reported	   to	   be	   extremely	   stable	   and	   strongly	  inhibitory	  to	  the	  progression	  of	  SG	  priming	  and	  membrane	  fusion	  (35,101).	  Release	  of	  this	  clamp	  on	  granule	  priming	  is	  believed	  to	  require	  the	  transition	  of	  Rab27A	  to	  its	  GTP-­‐bound	  state,	   although	   Rab27A-­‐GTP	   retains	   high-­‐affinity	   Slp4A	   binding.	   Interestingly,	   the	  Rab27A/granuphilin/syntaxin1A	   complex	   may	   also	   con-­‐	   tain	   Munc18	   (99),	   an	   apparent	  regulator	  with	  Munc13	  of	  SNARE	  complex	  assembly,	  suggesting	  that	  transition	  of	  Rab27A	  from	   GDP-­‐	   to	   GTP-­‐bound	   state	  may	   also	   allow	   initiation	   of	   priming	   processes.	   Our	   data	  demonstrating	   a	   reduction	   in	   RRP	   size	   in	   Ashen	   β-­‐cells	   are	   consistent	   with	   Rab27A	  promoting	   stability	   of	   SG	   tethering/docking	   and	   priming	   into	   the	   RRP.	   In	   addition,	  complete	   elimi-­‐	   nation	   of	   the	   IRP	   in	   Ashen	   β-­‐cells	   suggests	   that	   Rab27A	   may	   also	   be	  important	   in	   targeting	   insulin	   SGs	   to	  membrane	   nanodomains	   adjacent	   to	   voltage-­‐gated	  calcium	  channels.	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While	   glucose	   stimulation	   of	   β-­‐cells	   may	   facilitate	   transition	   of	   Rab27A	   from	   its	  GDP-­‐	   to	  GTP-­‐bound	  state	  and	  pro-­‐	  mote	  vesicle	  priming,	   it	  also	  drives	  Rab3-­‐GTP	  binding	  (75),	  vesicle	  fusion	  and	  a	  coincident	  cycling	  of	  Rab27A	  back	  to	  a	  GDP-­‐bound	  state.	  Unlike	  Rab3	  GTPases,	  post-­‐fusion	  membrane-­‐associated	  Rab27-­‐GDP	  in	  pancreatic	  β-­‐cells	  does	  not	  rapidly	   exchange	   into	   the	   cytosol,	   but	   rather	   acts	   to	   recruit	   and	   activate	   the	   endocytotic	  regulators	   coronin3	  and	  Cdc42-­‐GTP-­‐bound	   IQGAP1	   (34,102).	  The	   interaction	  of	  Rab27A-­‐GDP	   with	   coronin3,	   a	   promoter	   of	   F-­‐actin	   bundling,	   in	   complex	   with	   IQGAP1	   has	   been	  reported	   essential	   for	   endocytosis	   of	   insulin	   secretory	   membrane.	   Moreover,	  overexpression	   of	   EPI64A	   in	   β-­‐cells	   has	   previously	   been	   found	   to	   reproduce	   glucose-­‐dependent	   translocation	   of	   coronin3	   (103),	   likely	   resulting	   from	   GTP	   hydrolysis	   and	  production	   of	   Rab27A-­‐GDP.	   The	   negative	   clamp	   on	   exocytotic	   activity	   of	   Rab27A-­‐GDP	  through	  Slp4A	  interaction,	  and	  its	  slow	  exchange	  into	  the	  cytosol	  following	  exocytosis	  may	  account	   for	   its	   kinetically	   slower	   action	   on	   refilling	   of	   the	   vesicle	   pools	   from	   newcomer	  granules	  than	  that	  of	  Rab3.	  	  It	  is	  important	  to	  note	  that	  while	  we	  have	  identified	  distinct	  functional	  activities	  of	  Rab3	   and	  Rab27	  GTPases	   in	   the	   exocytotic	   pathway,	   these	  GTPases	   also	  demonstrated	   a	  high	  degree	  of	   functional	   commonality.	  For	  example,	   the	  RRP,	  while	   reduced	   in	  Ashen	  β-­‐cells	  as	  well	  as	  in	  wt	  β-­‐cells	  overexpressing	  EPI64A,	  remained	  present	  and	  rapidly	  refilled	  following	   the	   depolarization-­‐evoked	   depletion	   protocol.	   Rab3	   GTPases	   also	   largely	  compensated	  for	  Rab27	  absence,	  as	  evidenced	  by	  an	  even	  stronger	  reduction	   in	  RRP	  size	  and	  pool	  refilling	  upon	  Rab3GAP	  overexpression	  in	  Ashen	  β-­‐cells.	  Conversely,	  Rab27A	  also	  appears	   to	   exert	   substantial	   functional	   compensation	  when	  Rab3	  GTPases	   are	   shifted	   to	  their	  GDP-­‐bound	  state	  by	  Rab3GAP	  overexpression,	  as	  there	  was	   little	  effect	  on	  RRP	  size,	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although	   the	   rate	   of	   refilling	   was	   significantly	   slowed.	   This	   functional	   overlap	   is	   likely	  based	  on	  the	  high	  homology	  between	  Rab3	  and	  Rab27	  (57%	  by	  amino	  acid	  sequence)	  that	  leads	   to	   sharing	   of	   a	   number	   of	   effectors	   (rabphilin,	   Noc2	   and	   Slp4A).	   Also,	   even	  where	  Rab3	   and	   Rab27A	   exhibit	   effector	   selectivity	   (Rab3,	   RIM1/2a,	   Rab27A,	   Slac2-­‐C	   and	  Munc13-­‐4)	   the	   effectors	   demonstrate	   overlap	   in	   their	   reported	   functional	   activities	  (19,21,40).	  	  In	  summary,	  our	  data	  are	  novel	  in	  identifying	  unique	  func-­‐	  tional	  activities	  of	  Rab3	  and	  Rab27	  GTPases	  within	  the	  exocytotic	  pathway.	  Identification	  of	  the	  precise	  pathways	  that	  govern	  these	  mechanistic	  differences	  requires	  further	   investigation.	  Our	  data	  further	  suggest	  that	  Rab3	  GTPases	  act	  to	  rapidly	  refill	  releasable	  granule	  pools	  but	  that	  Rab27	  may	  demarcate	  and	  define	  the	  quantity	  of	  releasable	  sites	  as	  well	  as	  be	  required	  to	  populate	  the	  IRP.	  The	  linear	  sequencing	  of	  SGs	  from	  the	  RRP	  to	  IRP	  suggests	  a	  dynamic	  coordination	  in	  GTPase	   activity	   and/or	   effector	   switching	   during	   secretagogue	   stimulation.	   In	   addition,	  while	   functional	   diversity	   is	   distinguishable,	   there	   remain	   considerable	   compensatory	  actions	  between	   these	  GTPases,	  which	   likely	   result	   from	   the	   cooperative	  use	  of	   effectors	  and/or	   specificity	   in	   effectors	   with	   functional	   similarity.	   Future	   investigations	   require	  evaluating	  whether	   all	   the	   isoforms	  of	  Rab3	  participate	   in	   rapid	   refilling	   of	   the	  RRP	   and	  identifying	  which	  most	  effectively	  compensates	  for	  loss	  of	  Rab27A.	  	  	  
2.5	  Materials	  and	  Methods	  
Mice	  and	  pancreatic	  islet	  slice	  preparation	  	  All	   experiments	   were	   approved	   by	   the	   University	   Committee	   on	   Use	   and	   Care	   of	  Animals	  (UCUCA)	  and	  appropriate	  measures	  were	  taken	  to	  reduce	  the	  pain	  of	  experimental	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animals.	  Mice	   carrying	   a	   spontaneous	   A	   to	   T	   transversion	  mutation	   in	   the	   Rab27A	   gene	  (ash/ash;	  C3H/He	  back-­‐	  ground)	  lead	  to	  the	  production	  of	  a	  non-­‐functional	  Rab27A	  protein	  that	   lacks	   critical	   domains	   of	   the	   GTP-­‐binding	   pocket.	   These	   Ashen	   mice	   were	   initially	  supplied	   by	   N.	   A.	   Jenkins	   (National	   Cancer	   Institute)	   in	   cooperation	   with	   Jackson	  Laboratories.	   Gender-­‐	   and	   age-­‐matched	   mice	   of	   the	   same	   background	   strain	   variant	  (C3H/HeSnJ)	   were	   used	   as	   con-­‐	   trols.	   Mice	   were	   sacrificed	   by	   CO2	   asphyxiation,	  decapitated	   and	   the	   pancreas	   sterilely	   removed	   for	   preparation	   of	   isolated	   islets.	  Collagenase	   P	   (1mg/mL,	   Roche	   Diagnostics),	   soybean	   trypsin	   inhibitor	   (0.1mg/mL)	   and	  neutralized	   bovine	   serum	   albumin	   (2.5	   mg/mL)	   dissolved	   in	   5	   mL	   of	   5%	   CO2/95%	   O2	  gassed	   F12K	  Nutrient	   Kaighn’s	  media	  were	   immediately	   injected	   into	   the	   pancreas	   until	  well	  distended.	  Following	  injection,	  the	  pancreas	  and	  remaining	  collagenase	  solution	  were	  placed	  in	  a	  25-­‐mL	  Erlenmeyer	  flask,	  gassed	  with	  5%	  CO2/95%	  O2	  and	  placed	  into	  a	  37∘C	  oscillating	  water	  bath	  (100	  cycles/min)	  for	  10	  min.	  Following	  this	  period,	  free	  collagenase	  solution	  surrounding	  the	  pancreas	  was	  removed	  and	  replaced	  with	  a	  fresh	  5-­‐mL	  aliquot	  of	  collagenase	  solution	  and	  the	  flask	  returned	  to	  the	  oscillating	  water	  bath	  for	  an	  additional	  15	  min.	  Dispersion	  of	  the	  pancreas	  to	  generate	  isolated	  islets	  and	  acini	  was	  then	  performed	  by	   sequential	   passage	   through	   polypropylene	   pipettes	   of	   decreasing	   tip	   diameter.	   The	  resulting	   cell	   suspension	   was	   transferred	   to	   a	   10-­‐cm	   culture	   plate	   and	   individual	   intact	  islets	  identified	  using	  an	  inverted	  microscope	  were	  removed	  by	  hand	  micropipetting	  into	  a	  F12K	  media-­‐containing	  collection	  dish.	  The	   isolated	   islets	  were	  then	  collected	  and	  placed	  into	  37∘C	  liquid	  agarose	  (low	  melting	  point)	  and	  centrifuged	  at	  1700	  ×	  g	  at	  25∘C	  for	  2	  min.	  Horizontal	   slices	   (150	   μm)	   were	   then	   cut	   from	   the	   islets	   concentrated	   at	   the	   tip	   of	   the	  solidified	   agarose	   and	   transferred	   to	   millicell-­‐supported	   membranes	   (0.4	   μm	   pore;	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Millipore,	   Cork	   IRL)	   in	   culture	   media	   (DMEM,	   15%	   heat-­‐inactivated	   FBS,	   0.0005%	   β-­‐mercaptoethanol,	  50	  U/mL	  peni-­‐	  cillin,	  50	  μg/mL	  streptomycin	  and	  0.05	  mg/mL	  soybean	  trypsin	  inhibitor)	  for	  1–3	  days	  of	  organ	  culture.	  	  
	  
Expression	  constructs	  and	  viral	  infection	  	  Expression	   of	   exogenously	   introduced	   transgenes	   in	   cells	   of	   cultured	   islets	   was	  accomplished	  using	   adenoviral	   infection.	   The	   vector	   pAdTrack-­‐CMV	   (Addgene)	  was	  used	  for	   subcloning	   into	   and	   for	   infection	   and	   expression	   of	   the	   catalytic	   subunit	   of	  Rab3GAP	  (Yoshimi	  Takai,	   Kobe	  University),	   EPI64A	   (Open	  Biosystems,	   Thermo	  Scientific)	   or	   β-­‐Gal	  (control).	   The	   sequence	   fidelity	   of	   all	   constructs	   was	   confirmed	   by	   DNA	   sequencing	  (University	   of	   Michigan	   DNA	   Sequencing	   Core).	   Islets	   were	   infected	   with	   viral	   aliquots	  sufficient	  to	  infect	  approximately	  20%	  of	  the	  surface	  layer	  of	  cells	  within	  a	  slice.	  Virus	  was	  diluted	   in	  media	   and	  applied	  directly	  onto	   the	   islets	   and	   into	   the	   small	   volume	  of	  media	  resident	  on	  the	  millicell	  membrane	  surface.	  After	  12	  h	  the	  media	  were	  exchanged	  for	  fresh	  culture	   media.	   To	   identify	   infected	   cells	   the	   pAdTrack	   contained	   an	   independent	   CMV	  promoter	  driving	  expression	  of	  the	  fluorescent	  EGFP	  tracer.	  	  	  
Islet	  slice	  electrophysiology	  	  Islet	   slices	   surrounded	   by	   the	   agarose	  matrix	  were	   transferred	   to	   a	   continuously	  perfused	   and	   temperature-­‐controlled	   (31∘C)	   recording	   chamber	   (Warner	   Instruments)	  that	  was	  mounted	  on	  an	  upright	  Nikon	  EF-­‐89	  microscope	  and	  equipped	  with	  a	  40×	  water	  immersion	   lens	   (NA	   1.2)	   for	   viewing	   of	   individual	   cells.	   Whole-­‐cell	   patch-­‐clamp	  experiments	  were	  performed	  on	  cells	  within	  islet	  slices	  using	  an	  EPC-­‐9	  or	  EPC-­‐10	  amplifier	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and	   PATCHMASTER	   acquisition	   software	   (HEKA	   Elektronik).	   Patch	   pipettes	   with	   a	  resistance	   of	   3–6	   MΩ	   when	   filled	   with	   the	   pipette	   solution	   were	   pulled	   from	   Schott	  capillary	  glass	   containing	  a	  microfiber	   (AM	  Systems)	  and	   then	  coated	  with	  Sylgard	   (Dow	  Corning)	   to	   reduce	   capacitance	   transients.	   Currents	   underlying	   test	   pulses	   and	   I–V	  relationships	  were	  compensated	  for	  linear	  leak	  current	  using	  a	  P/4	  protocol.	  	  Evoked	   changes	   in	   cell	   capacitance	   associated	   with	   exocytotic	   activity	   were	  measured	  using	  the	  PATCHMASTER	  software	   lock-­‐in	  extension	  (sine	  +	  DC)	  with	  a	  30-­‐mV	  peak	   sinusoid	   signal	   applied	   at	   a	   frequency	   of	   1.8	   kHz.	   Data	   were	   analyzed	   only	   if	   the	  resulting	  Rs	  maintained	  <20	  MΩ.	  Although	  β-­‐cells	  are	  electrically	  coupled,	  previous	  reports	  have	  estab-­‐	  lished	  that	  only	  1.5%	  of	  the	  current	  response	  to	  the	  sine	  wave	  originates	  from	  neighboring	  cells	   (104).	   In	  addition,	  although	  changes	   in	  membrane	  capacitance	  reflect	  a	  net	   measurement	   of	   exocytotic	   and	   endocytotic	   activity,	   endocytosis	   operates	   at	   a	  significantly	  slower	  rate	  than	  exocytosis,	  suggesting	  that	  the	  rapid	  sequential	  voltage-­‐step-­‐evoked	  responses	  largely	  represent	  exocytotic	  activity.	  The	  standard	  extracellular	  solution	  contained	  (mM):	  135	  NaCl,	  2.5	  KCl,	  1.25	  NaH2PO4,	  2	  sodium	  pyruvate,	  0.5	  ascorbic	  acid,	  1	  MgCl2,	  2	  CaCl2,	  3	  glucose	  and	  26	  NaHCO3.	  The	  solution	  was	  gassed	  continuously	  with	  5%	  CO2/95%	  O2	  for	  a	  pH	  of	  7.4.	   In	  experiments	  where	  glucose	  concentration	  was	  raised	  the	  NaCl	   was	   reduced	   to	   maintain	   an	   equivalent	   osmolality	   (290	   mOsmol/L).	   The	   pipette	  solution	  used	  for	  whole-­‐cell	  recording	  contained	  (mM):	  120	  Cs-­‐glutamate,	  10	  NaCl,	  10	  KCl,	  1	  MgCl2	  ,	  10	  HEPES	  (pH	  7.15	  with	  CsOH),	  0.05	  EGTA,	  3	  Mg-­‐ATP	  and	  0.2	  Na-­‐GTP.	  Current-­‐clamp	   recordings	   from	   β-­‐cells	   in	   islet	   slices	   were	   performed	   using	   amphotericin	   (250	  μg/mL)-­‐perforated	   patch-­‐clamp	   conditions	  with	   the	   following	   pipette	   solution	   (mM):	   76	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K2SO4,	  5	  NaCl,	  10	  KCl,	  1	  MgCl2,	  0.2	  EGTA	  and	  10	  HEPES	  (pH	  7.35	  with	  KOH).	  All	  reagents	  were	  from	  Sigma	  unless	  stated	  otherwise.	  	  
	  
Confocal	  microscopy	  	  Confocal	   imaging	   was	   performed	   on	   an	   Olympus	   IX81	   disc-­‐spinning	   con-­‐	   focal	  microscope	  using	  a	  Plan-­‐Apochromat	  100×	  oil	   immersion	  objective	   (1.4	  NA).	  Fluorescent	  illumination	  was	   provided	   by	   a	   Lambda	   LS	   300-­‐W	   xenon	   arc	   lamp	   (Sutter	   Instruments)	  coupled	   to	   a	   shuttered	   liquid	   light	   guide	   for	   controlled	   transmission	   of	   light	   to	   the	  microscope	   optics.	   Images	   were	   acquired	   using	   an	   electron	   multiplying	   charge-­‐coupled	  device	   (EM-­‐CCD)	   Hamamatsu	   (ImagEM)	   camera	   and	   a	   2×	   optical	   zoom	   (Optem).	  Monomeric	  versions	  of	  mCH,	  YFP,	  Citrine	  (a	  YFP	  derivative	  of	  reduced	  pH	  sensitivity),	  CFP,	  Cerulean	  or	  EGFP	  N-­‐terminal	  fluoroprotein-­‐tagged	  fusion	  proteins	  were	  imaged	  using	  the	  following	   excitation/emission	   filter	   sets:	   Ex	   472/30;	   562/40;	   501/18;	   416/25	   and	   Em:	  520/35;	  641/75;	  547/31;	  464/23,	  respectively.	  Prior	  to	  image	  acquisition	  the	  illumination	  intensity/camera	  gain	  of	  each	  fluorescence	  channel	  was	  optimized	  to	  ensure	  a	  full	  dynamic	  range	   (16-­‐bit	   image).	   Once	   acquisition	   parameters	   were	   determined,	   identical	   set-­‐	   tings	  were	   used	   for	   each	   condition	   being	   compared.	   Cytofluorograms	   for	   Rab	   GTPases	   versus	  granules	   (NPY-­‐mCH),	   see	   Figure	   2B,	   were	   constructed	   by	   taking	   background-­‐subtracted	  (rolling-­‐ball	   radius	   filter	   =	   100	   pixels)	   intensities	   of	   each	   pixel	   per	   channel	   and	   plotting	  them	   against	   one	   another.	   A	   Pearson’s	   r	   correlation	   coefficient	   was	   then	   calculated	   to	  indicate	  the	  degree	  of	  colocalization	  between	  Rabs	  and	  granules.	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Total	  internal	  reflection	  fluorescence	  microscopy	  	  TIRF	   imaging	   of	   SG	   mobility	   in	   transfected	   MIN6	   cells	   was	   performed	   on	   an	  Olympus	   IX71	  microscope	   equipped	  with	   a	   60×	   oil	   immersion	   objective	   (1.49	  NA).	   Cells	  were	  co-­‐transfected	  with	  Citrine	  (control)	  or	  a	  N-­‐terminal	  Citrine-­‐tagged	  Rab3GAP	  and/or	  EPI64A	  along	  with	  NPY-­‐mCH	  to	  label	  the	  lumen	  of	  insulin-­‐containing	  SGs.	  TIRF	  imaging	  of	  MIN6	   cells	  was	   performed	   in	   a	   physiological	   saline	   containing	   (mM):	   135	  NaCl,	   5	   KCl,	   1	  MgCl2,	  2	  CaCl2,	  3	  glucose	  and	  10	  HEPES	  (pH7.4).	  For	   illumination,	   two	   lasers	   including	  a	  50-­‐mW	  diode-­‐pumped	  solid-­‐state	  laser	  operating	  at	  a	  fixed	  wavelength	  of	  594	  nm	  (Cobolt	  Mambo)	  and	  a	  225-­‐mW	  Argon-­‐ion	  laser	  (National	  Laser	  Company)	  beam	  (selected	  488-­‐nm	  laser	  line)	  were	  passed	  through	  a	  acousto-­‐optic	  tunable	  filter	  (AOTF)	  to	  select	  the	  passing	  laser	  line	  and	  adjust	  illumination	  power.	  Out-­‐	  put	  of	  the	  AOTF	  was	  coupled	  to	  a	  unimodal	  fiber	   optic	   that	  was	   directed	   through	   beam	   expansion	   optics	   immediately	   prior	   to	   being	  reflected	  into	  the	  microscope	  body	  by	  a	  mirror	  mounted	  on	  a	  galvanometer	  to	  position	  the	  laser	  illumination	  in	  the	  back	  focal	  plane	  of	  the	  objective.	  The	  position	  of	  the	  488-­‐nm	  laser	  line	   in	   the	  back	   focal	  plane	  was	  adjusted	   to	  set	  a	   resulting	  evanescent	   field	  depth	  of	  100	  nm.	   An	   additional	   achromatic	   lens	   between	   the	   mirror	   and	   the	   microscope	   objective	  focused	   the	   laser	   on	   the	   back	   focal	   plane	   of	   the	   objective.	   The	   microscopes	   filter	   cube	  assembly	   contains	   a	   laser	   clean-­‐up	   filter	   (488	   ±	   10	   nm),	   dichroic	  mirror	   (z488rdc)	   and	  emitter	  (HQ525/50).	  All	  filters	  were	  laser	  grade	  from	  Chroma	  Technologies.	  Fluorescence	  emission	   images	   were	   acquired	   with	   a	   16-­‐bit,	   512	   ×	   512	   pixel	   Photometrics	   QuantEM	  512SC	  EM-­‐CCD	  camera	   (Roper	  Scientific)	  with	  16	  ×	  16	  μm	  pixel	   size.	  To	  achieve	  Nyquist	  sampling,	  emission	  was	  submitted	  to	  additional	  magnification	  from	  a	  1.6×	  magnifier	  on	  the	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IX71	  and	  a	  2.5×	  beam	  expander.	  The	   laser	   lines,	   laser	  powers,	   incident	  angle	  and	  camera	  were	  controlled	  using	  METAMORPH	  software	  (Molecular	  Devices).	  	  Images	  were	   acquired	   at	   20Hz	   and	  with	  mobility	   in	   x–y	  and	   axial	   (z)	   dimensions	  determined	  by	  tracking	  granules	  that	  were	  present	  through-­‐	  out	  the	  entire	  image	  series	  in	  each	   cell	   using	   custom-­‐written	  MATLAB	   scripts.	   Granule	   detection	  was	   accomplished	   by	  applying	   a	   binary	   mask	   to	   each	   image,	   with	   the	   default	   masking	   threshold	   set	   to	   15	  standard	   deviations	   above	   the	   mean	   of	   a	   background	   region	   of	   interest.	   The	   centroid	  coordinates	  of	  each	  granule	  in	  each	  masked	  image	  were	  determined	  and	  a	  comparison	  of	  granule	  centroids	  across	  frames	  was	  used	  to	  identify	  those	  SGs	  that	  remained	  throughout	  the	  complete	   image	  series.	  Each	  of	   these	  SGs	  was	  then	  individually	  tracked	  by	  applying	  a	  2D	  Gaussian	  fit	  for	  the	  granule	  in	  its	  first	  frame,	  and	  then	  searching	  a	  12	  ×	  12	  pixel	  region	  sur-­‐	   rounding	   the	   granule’s	   fitted	   center	   coordinates	   in	   the	   next	   frame,	   for	   a	   similar	  Gaussian	  fit.	  Specific	  limits	  were	  set	  for	  acceptable	  changes	  in	  x	  –	  y	  position	  and	  minimum	  time	   spent	   at	   a	  position	   for	   a	   given	  granule	   to	  be	   considered	   the	   same.	  Granule	   tracking	  was	  terminated	  if	  two	  unique	  granules	  collided.	  Changes	  in	  x	  –	  y	  position	  between	  frames	  for	   each	   granule	   were	   determined	   using	   its	   center	   coordinates.	   For	   axial	   motion,	  fluorescence	  intensity	  for	  each	  tracked	  granule	  per	  frame	  was	  determined	  using	  a	  granule’s	  center	   coordinates	   to	   center	   a	   3	   ×	   3	   pixel	   mask	   and	  mea-­‐	   sure	   averaged	   intensity.	   The	  apparent	  interframe	  fluctuations	  in	  central	  x	  –	  y	  positions	  (ΔR)2	  and	  fluorescence	  intensity	  (ΔZ′	  )2	  were	  determined	  as	  previously	  described	  (105),	  with	  apparent	  integrated	  intensity	  fluctuations	   occurring	   between	   frames	   for	   individual	   granules	   (ΔZ′)2	   corrected	   for	  instrumental	   noise	   (shot	   noise	   and	   EM-­‐CCD	   camera	   noise)	   by	   imaging	   tetraspeck	   beads	  adhered	   to	   a	   glass	   coverslip	   to	   generate	   corrected	   (ΔZ)2.	   Interframe	   x–y	   mobility	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represented	  by	  (ΔR)2	  was	  calculated	  by:	  (ΔR)2	  =	  ((x2	  −	  x1	  )2	  +	  (y2	  −	  y1	  )2	  )*83.3	  nm/pixel,	  where	  x	  and	  y	  represent	  the	  centroid	  position	  between	  paired	  interframe	  intervals	  1	  and	  2.	  Apparent	  interframe	  axial	  mobility	  (ΔZ′)2	  is	  based	  on	  background-­‐subtracted	  intensities	  (I)	  in	  successive	  frames	  (1	  and	  2)	  and	  with	  z=0	  defined	  as	  the	  brightest	  intensity	  granule	  (Io)	  per	  cell.	  Characteristic	  TIRF	  depth	  (Dp)	  was	  set	  at	  100nm.	  For	  each	  frame	  (i)	  the	  apparent	  intensity	   (Ii′	   )	   is	   calculated	   as:	   Ii′	   =	   Ioe−z′i∕Dp,	   which	   upon	   rearranging	   results	   in:	  
z′=−Dpln(I′∕I).	  	  
	  
Statistics	  	  All	   statistical	   analysis	  was	  done	  using	  GraphPad	  Prism.	  Where	   indicated,	   one-­‐way	  analysis	  of	  variance	  (ANOVA)	  was	  used	  to	  test	  for	  significant	  differences	  (significance	  was	  set	  to	  a	  p	  <	  0.05).	  Post	  hoc	  Bonferroni	  protected	  t-­‐tests	  were	  used	  for	  comparisons	  between	  specific	   groups.	   To	   test	   whether	   cumulative	   frequency	   distributions	   of	   granule	   mobility	  were	   significantly	   different,	   we	   employed	   the	   Kolmogorov–Smirnov	   test.	   Statistical	  significance	  at	  a	  p<0.05	  is	  noted	  within	  figures	  by	  an	  asterisk	  (*).	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Figure	   2.1:	   Adeno	   viral	   infection	   of	   pancreatic	   islet	   slices	   and	   electrophysiological	  
identification	  of	  𝛃-­‐cells.	  A)Fluorescent	  micrograph	  of	  islet	  slice	  infected	  with	  pAdTrack-­‐CMV-­‐EGFP	   adenovirus	   (upper)	   that	   is	   overlayed	   on	   a	   differential	   interference	   contrast	  image	   of	   the	   slice	   (lower).	   B)	   Normalized	   averaged	   steady-­‐state	   voltage-­‐dependent	   Na+	  inactivation	  relationships	  recorded	  under	  voltage	  clamp	  from	  infected	  pancreatic	  islet	  cells	  (mean	  ±	  SEM;	  N	  =	  α,	  3;	  β,	  8;	  δ,	  3).	   Inactivation	  voltage-­‐clamp	  protocol:	  holding	  potential,	  −70	  mV;	  prepulse	  voltages	  of	  200-­‐millisecond	  duration	  ranged	  from	  −150	  to	  0	  mV	  in	  10-­‐mV	   increments;	  pulse	  potential,	  0	  mV	   for	  10	  milliseconds;	   interpulse	   interval,	  5	   seconds.	  Inset,	   representative	   voltage-­‐dependent	   current	   from	   β-­‐cell	   when	   held	   at	   prepulse	  potentials	   of	   −100	   and	   −40	   mV.	   C)	   Current-­‐clamp	   recordings	   of	   glucose-­‐stimulated	   (11	  mM)	   action-­‐potential	   bursting	   behavior	   from	  β-­‐cells	   in	  wt	   control	   (C3He/Sn)	   and	  Ashen	  islet	  slices	   that	  were	  subjected	  to	  3	  days	  organotypic	   tissue	  culture.	  Slices	  were	  perfused	  with	   normal	   extracellular	   solution	   containing	   3	   mM	   glucose	   for	   at	   least	   5	   min	   prior	   to	  glucose	  stimulation.	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Figure	   2.2:	   Expression	   of	   Rab	   GAPs	   transitions	   Rab3	   and	   Rab27	   into	   GDP-­‐bound	  
states.	  A)	  Confocal	   images	  of	  Min6	  cells	  co-­‐expressing	  CFP-­‐Rab3A	  or	  CFP-­‐Rab27A	  with	  a	  SG	   lumen	  marker	   (NPY-­‐mCH).	   B)	   Cytofluorograms	   showing	   correlation	   of	   pixel	   by	   pixel	  intensities	   (It;	   N	   =	   4	   Rab3A;	   N	   =	   5	   Rab27A).	   C)	   Representative	   images	   of	   Rab3GAP	   and	  EPI64A	  co-­‐expressed	  with	  Rab3A	  or	  Rab3D.	  Note	  that	  vesicular	  localization	  of	  Rab3D	  was	  retained	   in	   an	   adjacent	   non-­‐Rab3GAP	   transfected	   cell	   (arrowhead).	   D)	   Co-­‐expression	   of	  GAP	  proteins	  with	  Rab27A	  had	  no	  apparent	  effect	  on	  Rab27A’s	  association	  with	  SGs.	  E)	  Co-­‐expression	   of	   CFP-­‐Rab3A	   +	   cYFP-­‐Rim2α(1-­‐179)	   demonstrates	   colocalization	   of	   punctate	  fluorescence	   (upper)	   that	   is	   lost	  with	  added	  expression	  of	  mCH-­‐Rab3GAP	  (lower).	  F)	  Co-­‐expression	   of	   CFP-­‐Rab27A	  +	   cYFP-­‐Slp4A(AGAAAY),	   denoted	   on	   figure	   as	   YFP-­‐Slp4A(AG),	  demonstrates	   colocalization	   of	   punctate	   fluorescence	   (upper)	   that	   is	   lost	   with	   added	  expression	   of	   mCH-­‐EPI64A	   (lower).	   Scale	   bar	   =	   5	   μm,	   within	   each	   figure	   insets	   show	  expanded	  view	  of	  a	  region	  of	  the	  cell	  (outlined	  in	  white-­‐dashed	  line)	  .	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Figure	   2.3:	   Overexpression	   of	   Rab	   GAP	   proteins	   does	   not	   alter	   density	   of	   SGs	  
adjacent	  to	  plasma	  membrane.	  A)	  TIRF	  micrographs	  of	  SGs	  in	  Min6	  cells	  transfected	  with	  NPY-­‐mCH,	   a	   fluorescent	   lumenal	  marker	  of	   SGs,	   alone	   (control)	  or	   in	   combi-­‐	  nation	  with	  EPI64A	   (upper	   right),	   Rab3GAP	   (lower	   left)	   or	   EPI64A	   and	   Rab3GAP	   (lower	   right).	   B)	  Averaged	  measured	  density	  of	  SGs	  for	  each	  condition	  (mean	  ±	  SEM;	  N	  =	  number	  of	  cells).	  Scale	  bar	  below	  images	  =	  5	  μm.	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Figure	   2.4:	  Mobility	   of	  membrane	   adjacent	   SGs	   is	   unaffected	   by	   overexpression	   of	  
GAP	   proteins.	   A	   and	   B)	   Averaged	   cumulative	   probability	   distributions	   of	   apparent	  interframe	   fluctuations	   in	   central	   x–y	   positions	   (ΔR)2	   (A)	   or	   axial	   position	   (ΔZ)2	   (B)	   of	  membrane	  adjacent	  SGs	   in	  Min6	  cells	   transfected	  with	   the	  granule	   lumenal	  marker	  NPY-­‐mCH	   and	   co-­‐transfected	   with	   Citrine	   (control),	   Citrine–EPI64A,	   Citrine–Rab3GAP	   or	  Citrine–EPI64A+Citrine–Rab3GAP.	  The	  control	  (ΔR)2	  and	  (ΔZ)2	  data	  are	  included	  on	  each	  appropriate	  graph	   to	  allow	  comparison	   to	   the	  GAP	  treatments.	  Measurements	  made	  only	  on	  membrane	   adjacent	   SGs	   that	   were	   present	   throughout	   the	   entire	   10-­‐second	   imaging	  stream.	  Data	  are	  presented	  as	  mean	  ±	  SEM;	  control,	  7	  cells,	  86	  granules;	  EPI64A,	  5	  cells,	  98	  granules;	  Rab3GAP,	  7	  cells,	  150	  granules;	  EPI64A	  +	  RabGAP,	  7	  cells,	  131	  granules.	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Figure	   2.5:	   Determination	   of	   IRP	   and	   RRP	   size	   to	   sequentially	   applied	   step-­‐
depolarization	   pulse	   protocols	   in	   EGFP-­‐infected	  𝛃-­‐cells.	  A)	  Averaged	  ΔCm	  to	  applied	  pulse	  protocol	  from	  EGFP-­‐infected	  cells.	  Depolarization	  steps	  were	  from	  a	  holding	  potential	  of	  −80	  mV	  to	  0	  mV	  (black)	  or	  to	  +50	  mV	  (blue).	  Pulse	  protocol	  pattern	  is	  illustrated	  above	  ΔCm.	  B)	  Averaged	  ΔCm	   to	   repeat	  application	  of	  pulse	  protocols	   (step	   to	  0	  mV,	  gray;	  +50	  mV,	   light	   blue)	   applied	   to	   the	   same	   cells	   as	   in	   part	   A	   20	   seconds	   following	   the	   initial	  protocol.	  C)	  Averaged	  IRP	  (left)	  and	  RRP	  (right)	  pool	  sizes	  and	  recovery	  of	  granule	  pools	  following	   the	   20-­‐second	   non-­‐stimulus	   interval.	  Mean	   ±	   SEM;	   N	   =	   19	   cells,	   4	   animals.	   D)	  Representative	  inward	  current	  to	  first	  step	  depolarization	  (holding	  potential	  −80	  mV,	  step	  potential	  0	  mV)	  of	   initial	  (black)	  and	  second	  (red)	  applied	  pulse	  protocols.	  Currents	  from	  two	   different	   β-­‐cells	   are	   shown	   (upper,	   lower)	   to	   illustrate	   interpulse	   interval	   protocol	  allows	   complete	   recovery	   of	   voltage-­‐gated	   Ca2+	   current	   (upper)	   and	   of	   Na+	   and	   Ca2+	  current	   (lower).	   E)	   Averaged	   voltage-­‐gated	   Ca2+	   current	   from	   β-­‐cells	   used	   for	   ΔCm	  analysis	  measured	  on	  step	  to	  0	  mV	  from	  a	  holding	  potential	  (−50	  mV)	  where	  voltage-­‐gated	  Na+	  channels	  are	  inactivated.	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Figure	  2.6:	  Rab27A	  is	  essential	  to	  development	  of	  IRP	  and	  key	  to	  defining	  RRP	  size	  in	  𝛃-­‐cells.	   A)	   Comparison	   of	   averaged	   ΔCm	   to	   sequentially	   applied	   pulse	   protocols	   (20-­‐second	  interval)	  from	  pAdTrack	  EGFP-­‐infected	  Ashen	  β-­‐cells	  (upper,	  green,	  N	  =	  22	  cells,	  4	  animals),	   pAdTrack	   EPI64A/EGFP-­‐infected	   Ashen	   β-­‐cells	   (middle,	   red,	   N	   =	   17	   cells,	   3	  animals)	   and	   pAdTrack	   EPI64A/EGFP-­‐infected	   wt	   β-­‐cells	   (lower,	   violet,	   N	   =	   11	   cells,	   3	  animals).	  ΔCm	  to	  first	  applied	  protocol	  shown	  in	  darker	  color.	  B)	  Averaged	  size	  of	  IRP	  (left)	  and	  RRP	   (right)	   for	   each	   condition	   to	   each	   applied	   pulse	   protocol.	   Dashed	   line	   indicates	  average	  size	  of	  IRP	  and	  RRP	  to	  first	  pulse	  protocol	  under	  control	  conditions	  (EGFP-­‐infected	  wt	  β-­‐cells,	  Figure	  4).	  Asterisk	  on	  dashed	  line	  indicates	  significance	  from	  conditions	  below.	  C)	  Averaged	  voltage-­‐gated	  Ca2+	  current	   (holding	  potential	  −50	  mV,	   step	  potential	  0	  mV)	  from	  β-­‐cells	  used	  for	  each	  ΔCm	  analysis	  (left).	  Averaged	  time-­‐integrated	  Ca2+	   influx	  (pC)	  for	  each	  condition	  as	  measured	  from	  inward	  current	  evoked	  on	  step	  to	  0	  mV	  from	  −50	  mV	  holding	  potential	  (right,	  N	  =	  control,	  11;	  Ashen,	  15;	  Ashen	  +	  EPI64A,	  8;	  control	  +	  EPI64A,	  3).	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Figure	   2.7:	   Rab3	   exerts	   a	   central	   role	   in	   rapid	   refilling	   of	   RRP	   in	   𝛃-­‐cells.	   A)	  Comparison	  of	  averaged	  ΔCm	  to	  sequentially	  applied	  pulse	  protocols	  (20-­‐second	  interval)	  from	  pAdTrack	  Rab3GAP/EGFP-­‐infected	  wt	  β-­‐cells	   (brown,	  N	  =	  15	  cells,	  4	  animals),	  with	  darker	   color	   showing	   data	   from	   first	   pulse	   protocol.	   B)	   Averaged	   ΔCm	   responses	   from	  pAdTrack	   Rab3GAP/EGFP-­‐infected	   Ashen	   β-­‐cells	   (blue,	   N	   =	   15	   cells,	   3	   animals).	   Darker	  color	  shows	  data	  from	  first	  pulse	  protocol.	  C)	  Averaged	  size	  of	  IRP	  (left)	  and	  RRP	  (right)	  for	  each	  condition	  determined	  from	  each	  applied	  pulse	  protocol.	  Dashed	  lines	  indicate	  average	  size	  of	   IRP	  and	  RRP	   to	   first	  pulse	  protocol	  under	   control	   conditions	   (EGFP-­‐infected	  wt	  β	  cells)	   and	   in	   Ashen	   cells.	   D)	   Averaged	   Ca2+	   current	   from	   Ashen	   β-­‐cells	   infected	   with	  pAdTrack	  Rab3GAP/EGFP	  used	  for	  ΔCm	  analysis.	  E)	  Averaged	  Ca2+	  influx	  (pC)	  for	  β-­‐cells	  from	  wt	  (control)	  and	  Ashen	  mice	  infected	  with	  pAdTrack	  Rab3GAP/EGFP	  (N	  =	  control	  +	  Rab3GAP,	  5;	  Ashen	  +	  Rab3GAP,	  9).	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Figure	   2.8:	   Rab3	   actions	   on	   rapid	   refilling	   of	   RRP	   are	   downstream	   of	   cAMP	  
enhancement	   of	   IRP	   and	   RRP	   size.	   A)	   Averaged	   ΔCm	   to	   sequentially	   applied	   pulse	  protocols	   from	   pAdTrack	   Rab3GAP/EGFP-­‐infected	   wt	   β-­‐cells	   (brown,	   N	   =	   9	   cells,	   3	  animals)	   in	  which	   the	   patch	  pipette	   solution	   contained	  100	  μM	   cAMP,	  with	   darker	   color	  showing	  data	   from	  first	  pulse	  protocol.	  B)	  Averaged	  size	  of	   IRP	  (left)	  and	  RRP	  (right)	   for	  the	  cAMP	  recorded	  pAdTrack	  Rab3GAP/EGFP-­‐infected	  wt	  β-­‐cells.	  Average	  results	  from	  the	  non-­‐cAMP	  Rab3GAP	  condition	  (Figure	  7)	  are	  shown	  for	  comparison.	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Figure	   2.9:	   Summary	   of	   Chapter	   2	   findings.	   Rab	   GTPases	   associated	   with	   insulin-­‐containing	   secretory	   granules	   (SGs)	   are	   key	   in	   targeting,	   docking	   and	   assembly	   of	  molecular	   complexes	   governing	   pancreatic	   β-­‐cell	   exocytosis.	   Four	   Rab3	   isoforms	   along	  with	  Rab27A	  are	   associated	  with	   insulin	   granules,	   yet	   elucidation	  of	   the	  distinct	   roles	   of	  these	  Rab	   families	  on	  exocytosis	   remains	  unclear.	  To	  define	   specific	  actions	  of	   these	  Rab	  families	  we	  employ	  Rab3GAP	  and/or	  EPI64A	  GTPase-­‐activating	  protein	  overexpression	  in	  β-­‐cells	   from	   wild-­‐type	   or	   Ashen	   mice	   to	   selectively	   transit	   the	   entire	   Rab3	   family	   or	  Rab27A	   to	  a	  GDP-­‐bound	  state.	  Ashen	  mice	   carry	  a	   spontaneous	  mutation	   that	  eliminates	  Rab27A	   expression.	   Using	   membrane	   capacitance	   measurements	   we	   find	   that	   GTP/GDP	  nucleotide	   cycling	   of	   Rab27A	   is	   essential	   for	   generation	   of	   the	   functionally	   defined	  immediately	   releasable	   pool	   (IRP)	   and	   central	   to	   regulating	   the	   size	   of	   the	   readily	  releasable	   pool	   (RRP).	   By	   comparison,	   nucleotide	   cycling	   of	   Rab3	   GTPases,	   but	   not	   of	  Rab27A,	   is	   essential	   for	   a	   kinetically	   rapid	   filling	   of	   the	   RRP	  with	   SGs.	   Aside	   from	   these	  distinct	  functions,	  Rab3	  and	  Rab27A	  GTPases	  demonstrate	  considerable	  functional	  overlap	  in	  building	  the	  readily	  releasable	  granule	  pool.	  Hence,	  while	  Rab3	  and	  Rab27A	  cooperate	  to	  generate	   release-­‐ready	   SGs	   in	   β-­‐cells,	   they	   also	   direct	   unique	   kinetic	   and	   functional	  properties	  of	  the	  exocytotic	  pathway.	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3.1	  Abstract	  Neural	   networks	   often	   engage	   in	   high-­‐frequency	   activity	   that	   relies	   on	   highly	   regulated	  vesicle	   fusion	   from	   distinct	   functional	   synaptic	   vesicle	   (SV)	   pools.	   In	   this	   study	   we	  investigated	  the	  role	  that	  the	  soluble	  SNARE	  Tomosyn1	  (Tomo1)	  may	  exert	  on	  presynaptic	  SV	   pools	   at	   hippocampal	   synapses.	   By	   controlling	   Tomosyn1	   expression	   at	   hippocampal	  synapses	  together	  with	  use	  of	  V-­‐Glut1-­‐pHluorin	  (vGpH)	  as	  a	  direct	  reporter	  of	  presynaptic	  vesicle	  fusion	  and	  dynamics	  we	  find	  that	  Tomo1	  acts	  as	  a	  central	  regulator	  on	  transition	  of	  SVs	   between	   the	   Total	   Recycling	   Pool	   (TRP)	   and	   Resting	   Pool	   (ResP),	   as	   well	   as	   on	   the	  Readily-­‐Releasable	   Pool	   (RRP).	   	   Tomo1’s	   regulation	   of	   the	   fractional	   distribution	   of	   SVs	  between	   the	   TRP	   and	  ResP	   is	   sensitive	   to	   neural	   activity	   and	   requires	   Cdk5.	  We	   further	  demonstrate	   that	   Tomo1	   is	   a	   direct	   substrate	   of	   Cdk5	   phosphorylation	   and	   correlate	  changes	  in	  its	  level	  of	  phosphorylation	  to	  alterations	  in	  neural	  activity.	  While	  mechanistic	  details	   by	   which	   Tomo1	   participates	   in	   reallocation	   of	   SVs	   between	   TRP	   and	   ResP	   at	  presynaptic	   terminals	   remain	   to	   be	   elaborated,	   we	   provide	   initial	   evidence	   that	   Tomo1	  specifically	  interacts	  with	  GTP	  bound	  Rab3A,	  and	  through	  this	  interaction	  with	  Synapsin1	  proteins.	  The	  latter	  interaction	  is	  notable	  as	  Synapsin	  proteins	  have	  been	  well	  established
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  to	   restrict	   vesicle	   release	   via	   interaction	   with	   the	   presynaptic	   actin	   cytoskeleton	   and,	  interestingly,	  also	  recently	  reported	  to	  be	  associated	  with	  Cdk5	  modulation	  of	  the	  TRP.	  In	  addition,	   our	   results	   show	   that	   Tomo1	   regulatory	   control	   over	   the	   TRP	   occurred	  independent	   of	   its	   C-­‐terminal	   SNARE	   domain,	   demonstrating	   that	   Tomo1	   actions	   on	  neurotransmission	  extend	  well	  beyond	  inhibition	  of	  SV	  priming	  into	  the	  RRP.	  We	  conclude	  that	  Tomo1	  is	  a	  critical	  modulator	  of	  SV	  distribution	  among	  functionally	  defined	  pools,	  with	  its	   actions	   being	   sensitive	   to	   neural	   activity	   indicating	   it	   may	   be	   a	   key	  mediator	   in	   use	  dependent	  changes	  in	  presynaptic	  release	  probability.	  
	  
3.2	  Introduction:	  	  The	  passage	  of	   information	  fundamental	  to	  neural	  circuitry	  within	  the	  mammalian	  central	   nervous	   system	   occurs	   primarily	   at	   chemical	   synapses,	   which	   are	   comprised	   of	  structurally	   and	   functionally	   polarized	   and	   highly	   dynamic	   pre-­‐	   and	   post-­‐synaptic	  elements.	  With	   regard	   to	   presynaptic	   compartments,	   transmitter	   release	   closely	   follows	  action	   potential	   invasion,	   activation	   of	   voltage-­‐gated	   Ca2+	   channels	   and	   SNARE	   protein	  mediated	   synaptic	   vesicle	   (SV)	   fusion.	   The	   regulation	   of	   neurotransmitter	   containing	  synaptic	   vesicles	   (SVs)	   is	   essential	   to	   the	   functional	   dynamics	   of	   synapses	   since	   SVs	  immediately	   competent	   for	   release	   are	   highly	   restricted	   to	   a	   small	   set	   of	   SVs	   within	   a	  readily	  releasable	  pool	  (RRP)	  at	   the	  presynaptic	  active	  zone	  (AZ).	  The	   limited	  capacity	  of	  the	   RRP	   suggests	   that	   under	   physiological	   conditions,	   such	   as	   during	   bursts	   of	   action	  potentials	   in	   spiking	   neurons,	   sustained	   release	   requires	   the	   recruitment	   of	   SVs	   into	   the	  RRP	   from	   other	   functionally	   distinct	   pool(s)	   of	   SVs	   within	   the	   presynaptic	   bouton.	   The	  importance	   of	   this	   recruitment	   and	   cycling	   of	   presynaptic	   SVs	   to	   neurotransmission	   is	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evidenced	  by	  the	  relationship	  of	  specific	  forms	  of	  short-­‐term	  synaptic	  plasticity	  to	  speed	  of	  vesicle	  recruitment,	  development	  of	  release	  competency	  and/or	  depletion	  of	   the	  RRP	  [1].	  In	  addition,	  synchronous	  and	  asynchronous	  release	  evoked	  by	  action	  potentials	  has	  been	  suggested	  to	  result	  from	  different	  sets	  of	  SVs	  and/or	  SVs	  differing	  in	  calcium	  sensitivity	  and	  release	   probability	   [2,3].	   Defining	   the	   regulatory	   controls	   on	   transition	   of	   SVs	   between	  functionally	   distinct	   SV	   pools	   is,	   therefore,	   of	   key	   importance	   to	   understanding	   use-­‐dependent	   changes	   in	   the	   probability	   of	   vesicle	   release	   (Pr),	   as	   well	   as	   changes	   in	   the	  efficacy	  of	  presynaptic	  release	  that	  accompanies	  synaptic	  plasticity.	  	  Within	   mammalian	   hippocampal	   neurons	   SVs	   have	   been	   found	   to	   occupy	   three	  functionally	  distinct	  pools	   that	   include	  a	  RRP,	   comprised	  of	  only	  a	   few	  SVs	   (5-­‐8	  vesicles)	  docked	  at	  the	  AZ	  and	  fully	  primed	  for	  immediate	  release,	  a	  substantively	  larger	  Recycling	  Pool	   (RP;	  ~20	   to	   60%	  of	   SVs)	   that	   undergoes	   continuous	   exocytotic/endocytotic	   cycling	  and	  a	  Resting	  Pool	  (ResP),	  which	  often	  represent	  a	  significant	  population	  (up	  to	  40-­‐80%)	  that	  mostly	  appear	  recalcitrant	  to	  activity	  driven	  exocytotic/endocytotic	  cycling	  [4,5].	  The	  RRP	   together	   with	   the	   RP	   form	   the	   total	   recycling	   pool	   (TRP)	   of	   SVs.	   Reallocation	   of	  vesicles	   among	   these	   functionally	   defined	   pools	  may	   serve	   to	  modify	   activity-­‐dependent	  changes	   in	   synaptic	   strength,	  which	   is	  defined	  as	   the	  product	  of	   individual	  vesicle	   fusion	  probability	   and	   the	   number	   of	   release	   ready	   vesicles	   (or	   the	   RRP).	   Indeed,	   the	   RRP	   has	  been	   shown	   to	   scale	   with	   the	   size	   of	   the	   RP	   during	   high-­‐frequency	   AP	   firing	   [6],	   and	  recruitment	   of	   ResP	   vesicles	   into	   the	   RP	   has	   been	   reported	   to	   impact	   the	   expression	   of	  Hebbian	   as	  well	   as	   homeostatic	   forms	   of	   synaptic	   plasticity	   at	   cortical	   and	   hippocampal	  synapses	  [7-­‐10].	  In	  addition,	  release	  reluctant	  vesicles	  have	  been	  suggested	  to	  participate	  in	   SV	   recycling	   by	   serving	   as	   a	   protein	   sink	   [11];	   facilitate	   vesicle	   interchange	   between	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boutons	  of	  a	  given	  neuron	  [12,13];	  serve	  as	  a	  depot	  pool	  for	  immature	  synapses	  [8,14];	  or	  a	  SV	  pool	  for	  spontaneous	  fusion	  events	  [15,16],	  although	  this	  latter	  view	  remains	  contested	  [17-­‐19].	   Thus	   SV	   recruitment	   from	   the	   ResP	   appears	   to	   be	   dynamic	   and	   important	   for	  synapse	  function.	  Yet,	  the	  molecular	  mechanisms	  that	  clamps	  or	  promotes	  the	  transition	  of	  SVs	  from	  the	  inactive	  non-­‐cycling	  ResP	  to	  active	  and	  cycling	  TRP	  are	  not	  well	  understood.	  Recently,	  in	  hippocampal	  synapses,	  cyclin-­‐dependent	  kinase	  5	  (Cdk5)	  has	  been	  recognized	  as	  a	  signal	  for	  inducing	  changes	  in	  TRP/ResP	  partitioning	  since	  pharmacological	  or	  genetic	  ablation	   led	   to	   the	   unfettering	   of	   a	   significant	   portion	   of	   ResP	   SVs	   into	   the	   mobile	   and	  release	  active	  TRP[9].	  Moreover,	  while	  some	  studies	  have	  shown	  that	  Synapsin1	  and	  actin	  can	  arrest	  SVs	   in	  a	  non-­‐releasable	  state,	  others	  have	  shown	  that	  pool	  partitioning	  occurs	  independent	  of	  actin	  dynamics	  suggesting	  that	  additional	  molecular	  mechanisms	  may	  exist	  [20-­‐22].	  Taken	   together,	   these	   findings	  suggest	   that	  distribution	  of	  SVs	  among	   functional	  pools	   may	   be	   sensitive	   to	   phosphorylation	   state	   of	   particular	   effectors,	   although	   the	  specific	  effectors	  involved	  and	  the	  signaling	  cascades	  have	  not	  been	  defined.	  In	  this	  study	  we	  investigated	  the	  role	  of	  the	  inhibitory	  protein	  Tomosyn1	  (Tomo1)	  in	  defining	  SV	  distribution	  among	  presynaptic	  SV	  pools	  at	  hippocampal	  synapses.	  Tomo1	  proteins	   contain	   a	   C-­‐terminal	   SNARE	   domain	   that	   is	   homologous	   to	   the	   vesicle	   SNARE	  synaptobrevin/	   VAMP-­‐2.	   Thus,	   it	   competes	  with	   VAMP	   and	  Munc18	   for	   interaction	  with	  reactive	   Syntaxin	   and	   SNAP25	   to	   form	   to	   non-­‐fusogenic	   SNARE	   complexes	   [23-­‐26].	   As	   a	  result,	   Tomo1	   acts	   a	   potent	   inhibitor	   of	   evoked	   release	   from	   the	   RRP	   [27,28]	   and	  alterations	   in	   Tomosyn	   expression	   result	   in	   behavioral	   defects	   in	   mice	   [29],	   Drosophila	  [30]	  and	  C.	  elegans	  [31].	  	  However,	  Tomo1	  may	  exert	  effects	  on	  SVs	  outside	  of	  priming	  into	  the	   RRP	   as	   suggested	   from	   membrane	   capacitance	   monitoring	   of	   exocytotic	   activity	   in	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bovine	   chromaffin	   cells	   to	   sustained	   elevated	   calcium.	   	   Under	   these	   stimulus	   conditions,	  Tomo1	   overexpression	   led	   to	   a	   50%	   reduction	   in	   the	   RRP	   size	   and	   an	   accompanying	  decrease	   in	   Pr,	   but	   importantly,	   also	   impaired	  maturation	   of	   vesicles	   into	   the	   RRP	   [27].	  Similarly,	   at	  Drosophila	   and	  C.	   elegans	  neuromuscular	   junctions	   (NMJ)	   a	   loss	   of	   function	  mutation	   of	   Tomosyn	   or	   targeted	   knockdown	   of	   its	   expression	   led	   to	   enhanced	  neurotransmitter	  release	   from	  a	  pool	  of	  vesicles	   that	  supplies	  delayed	  release	  and	   is	   less	  calcium	  sensitive[30,32].	   	  In	  addition,	  the	  Tomosyn	  homologs	  in	  yeast,	  Sro7p	  and	  Sro77p,	  interact	  with	  the	  vesicle	  GTPase	  Sec4	  and	  when	  overexpressed	  results	  in	  the	  accumulation	  of	  non-­‐fusiogenic	  vesicle	  clusters	  [33-­‐35].	  Thus	  it	  appears	  that	  Tomosyn	  proteins	  may	  play	  a	  more	  central	  role	  in	  regulating	  release	  from	  multiple	  pools	  to	  impact	  synaptic	  strength.	  	  The	   purpose	   of	   these	   investigations	   were	   to	   determine	   it	   Tomo1	   exerts	   distinct	  mechanistic	   functions	   on	   distribution	   of	   SVs	   among	   functional	   pools,	   beyond	   that	  characterized	   for	   the	   RRP	   Our	   results	   uncover	   a	   novel	   site	   and	   mechanism	   for	   Tomo1	  inhibition	  of	  SV	  release.	  We	  find	  that	  in	  addition	  to	  inhibiting	  priming	  of	  SVs	  into	  the	  RRP,	  Tomo1	  clamps	  SVs	  in	  the	  ResP	  preventing	  transition	  into	  the	  TRP	  independently	  of	   its	  R-­‐SNARE	   motif.	   Moreover,	   our	   results	   suggest	   that	   Tomo1	   is	   an	   activity-­‐dependent	  phosphorylation	   substrate	   of	   Cdk5	   and	   that	   it	   requires	   its	   catalytic	   activity	   to	   exert	  regulatory	   control	   over	   the	   TRP/ResP	   partitions.	   The	   clamping	   of	   SVs	   in	   the	   ResP	   by	  Tomo1	   appears	   to	   occur	   via	   an	   identified	   	   novel	   interaction	   between	   Tomo1	   and	   SV-­‐associated	   Rab3A,	   which	   together	   form	   a	   complex	   with	   Synapsin1	   proteins.	   Finally,	   we	  show	  that	  Tomo1	  phosphorylation	  and	  thus	  regulatory	  actions	  are	  activity-­‐dependent	  and	  that	  Tomo1	  is	  necessary	  for	  compensatory	  enhancements	  in	  SV	  release	  induced	  by	  chronic	  silencing	  of	  neuronal	  activity.	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3.3	  Results:	  	  
Tomosyn1	  inhibits	  evoked	  but	  not	  basal	  synaptic	  transmission	  	  To	   determine	   the	   specific	   function	   of	   Tomo1	   on	   presynaptic	   physiology	   and	   to	  define	   its	   sites	   of	   action	   on	   each	   of	   functionally	   defined	   SV	   pool	   at	   excitatory	   central	  synapses	  experiments	  were	  conducted	  on	  cultures	  of	  rat	  hippocampal	  neurons.	  The	  studies	  focused	   on	   Tomo1	   since	   it	   is	   predominantly	   expressed	   at	   excitatory	   synapses	   and	   is	  presynaptically	   enriched	   relative	   to	   Tomosyn2,	   which	   is	   mainly	   postsynaptic	   [36].	   Our	  results	   also	   demonstrate	   localization	   of	   endogenous	   Tomo1	   at	   presynaptic	   sites	   within	  cultured	   hippocampal	   neurons	   as	   shown	   by	   colocalization	   analysis	   relating	   Tomo1	  immunofluorescence	   to	   that	   of	   the	   SV	   integral	   membrane	   protein	   Synaptophysin	   (Syp)	  (Figure	   1A).	   Moreover,	   fluorescence	   intensity	   profile	   of	   a	   straightened	   axon	   fragment	  shows	   that	   Tomo1	   immunofluorescence	   intensity	   spiked	   coincidently	   with	   that	   of	   Syp	  (Figure	   1A,	   A2).	   To	   examine	   Tomo1	   regulatory	   effects	   on	   electrically	   evoked	   and	   basal	  neurotransmission	   we	   applied	   treatment	   to	   specifically	   alter	   Tomo1	   expression	   levels.	  Relative	   to	   control	   (infection	   with	   shRNA-­‐scramble	   lentivirus	   or	   GFP	   alone)	   lentiviral	  infection	  of	  Tomo1	  led	  to	  significant	  protein	  overexpression	  (OE)	  (YFP-­‐mTomo1,	  mean	  (μ)	  =	   10.6	   fold	   increase,	   SEM	   =	   ±3.12),	   while	   shRNA-­‐mediated	   Tomosyn	   knock-­‐down	   (KD)	  strongly	   reduced	   its	   expression	   (μ	   =	   84.7%	   KD,	   SEM	   =	   ±0.02)	   (Figure	   1B).	   The	   shRNA	  constructs	   used	   to	   KD	   Tomo1	   were	   specific	   as	   the	   level	   of	   4	   other	   synaptic	   proteins	  measured	  was	  unaffected	  (Figure	  1—Supplement).	  To	  assess	  the	  effects	  these	  treatments	  exerted	   on	   release	   probability	   (Pr),	   paired-­‐pulse	   ratios	   (PPR)	   were	   determined	   from	  excitatory	  post-­‐synaptic	  current	  (EPSC)	  measurements	  recorded	  under	  whole-­‐cell	  voltage	  
104	  	  
clamp[1,37].	   As	   shown	   in	   Figure	   1C-­‐E,	   OE	   of	   Tomo1	   resulted	   in	   synaptic	   facilitation	  (EPSC2>EPSC1)	   over	   inter-­‐stimulus	   intervals	   (ISI)	   ranging	   from	   50	   to	   250	  ms	   that	   was	  significantly	   greater	   than	   of	   control	   (50	   ms	   PPR	   μ	   =	   1.96	   ±0.18	   vs.	   μ	   =	   1.11	   ±0.05).	  Conversely,	   PPR	   from	   Tomo1	   KD	   neurons	   demonstrated	   synaptic	   depression	   relative	   to	  control	   for	   the	   50	   ms	   ISI	   (μ	   =	   0.79	   ±0.13	   vs.	   μ	   =	   1.11	   ±0.05).	   As	   Tomo1	   OE	   increased	  facilitation	  while	  Tomo1	  KD	  depressed	   facilitation	   relative	   to	   control	   the	   results	   confirm	  that	   Tomo1	   likely	   serves	   as	   a	   strong	   negative	   regulator	   of	   release	   probability	   (Pr)	   at	  hippocampal	  synapses.	   	  Neuroendocrine	  cell	  secretion	  studies,	  as	  well	  as	  measurement	  of	  spontaneous	   miniature	   synaptic	   events	   at	   the	   C.	   elegans	   and	   Drosophila	   neuromuscular	  junction,	  have	  reported	  that	  alterations	  in	  Tomo1	  expression	  selectively	  affects	  stimulated,	  but	  not	  basal,	  secretion.	  To	  test	  for	  Tomo1	  effects	  on	  spontaneous	  release	  at	  hippocampal	  synapses,	  we	  recorded	  miniature	  EPSCs	   (mEPSC)	  under	  Tomo1	  OE	  and	  KD	  conditions	  as	  compared	  to	  control.	  The	  recordings	  were	  conducted	  in	  the	  presence	  of	  the	  voltage-­‐gated	  sodium	   channel	   blocker	   tetrodotoxin	   (TTX)	   in	   order	   to	   prevent	   AP	   firing	   and	   network	  activation.	   Consistent	   with	   the	   prior	   reports	   [30,32,38],	   our	   data	   demonstrated	   no	  significant	   changes	   in	   frequency	   or	   amplitude	   of	   mEPSCs	   among	   the	   conditions	   tested	  (Figure	   1F)	   .	   Taken	   together,	   the	   electrophysiological	   assessments	   indicate	   that	   Tomo1	  inhibition	  of	  neurotransmission	  in	  hippocampal	  synapses	  is	  restricted	  to	  evoked	  release.	  	  
	  
Tomosyn	  inhibits	  multiple	  vesicle	  pools	  To	  specifically	  determine	  if	  Tomo1	  participates	  in	  active	  partitioning	  of	  SVs	  between	  the	   RRP,	   TRP	   and	   RestP	   we	   employed	   a	   direct	   optical	   reporter	   of	   presynaptic	   vesicle	  cycling,	   VGLUT1-­‐pHluorin	   (vGpH)	   or	   VGLUT1-­‐pHluorin-­‐mCherry	   (vGpH-­‐mCH).	   Field	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stimulation	  protocols	  applied	  to	  elicit	  AP	  firing	  [4,39]	  were	  used	  to	  drive	  release	  of	  the	  RRP	  (20	  Hz,	  40	  AP)	  [40-­‐43]	  and	  TRP	  (20	  Hz,	  900	  AP)	  [9,39,44],	  with	  a	  subsequent	  alkalinization	  by	  application	  of	  ammonium	  chloride	  to	  measure	  remaining	  vGpH	  that	   is	  associated	  with	  non-­‐releasable	  RestP	  vesicles	  [45]	  .	  All	  experiments	  were	  carried	  out	  in	  the	  presence	  of	  the	  V-­‐type	   ATPase	   inhibitor	   bafilomycin-­‐A1	   to	   prevent	   reacidifcation	   of	   vesicles	   and	   restrict	  measurements	  to	  net	  exocytosis	  [45].	  	  Initially,	  the	  role	  of	  Tomo1	  was	  evaluated	  in	  neurons	  transfected	  with	  shRNA-­‐meditated	  Tomo1	  KD	  or	  recombinant	  mCh-­‐m-­‐Tomo1	  OE	  together	  with	  the	  vGpH	  reporter.	  Relative	  to	  control	  (vGpH	  +	  empty	  vector),	  Tomo1	  KD	  resulted	  in	  a	  significant	   enhancement	   in	   the	   estimated	   size	   of	   the	  RRP,	  while	  Tomo1	  OE	   resulted	   in	   a	  significant	  decrease	   in	   the	  RRP	   size	   (Figure	  2A).	   These	  data	   are	   consistent	  with	   the	  PPR	  results	  which	  indicated	  that	  Tomosyn	  KD	  and	  OE	  alter	  Pr	  (Figure	  1C-­‐E)	  and	  also	  line	  with	  membrane	   capacitance	   (Cm)	   measurements	   from	   adrenal	   chromaffin	   cells	   where	   OE	   of	  Tomo1	   reduced	   the	   RRP	   component	   of	   release	   by	   87%	   [27].	   We	   next	   tested	   whether	  Tomo1	  affects	   the	  distribution	  of	   SVs	   among	   functionally	   defined	  pools	   beyond	   the	  RRP.	  	  Remarkably,	  as	  shown	   in	  Figure	  2B-­‐D	  Tomo1	  KD	  results	   in	  an	  overall	  greater	  TRP	  at	   the	  expense	  of	  the	  ResP	  using	  two	  distinct	  shRNA	  sequences,	  (μ	  =0.678	  ±0.044	  &	  0.744	  ±0.036)	  compared	  to	  Tomo1	  OE	  and	  control	  (μ	  =0.367	  ±0.043;	  0.516	  ±0.036).	  Regulation	  by	  Tomo1	  on	   the	   fraction	   of	   TRP	   vesicles	   was	   distributed	   across	   the	   entire	   population	   of	   synaptic	  boutons	   as	   evidenced	   by	   cumulative	   frequency	   distributions	   of	   TRP	   size	   (Figure	   1D).	  	  Notably,	   Tomo-­‐1	   KD	   demonstrated	   a	   significant	   right-­‐shift	   toward	   greater	   TRP	   fractions	  (Median	  =	  0.67	  &	  0.72)	  and	  mCH-­‐Tom1	  a	  left-­‐shift,	  toward	  smaller	  TRP	  fractions	  (Median	  =	  0.41)	   relative	   to	   control	   (Median	   =	   0.54).	   No	   statistically	   significant	   differences	   were	  observed	  between	  conditions	  in	  TRP	  depletion	  kinetics	  (t,	  con	  μ	  =18.2	  ±3.15;	  KD	  μ	  =18.12	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±4.96;	  OE	   μ	   =17.36	   ±6.05);	   or	   total	   SV	   pool	   size	   (f	  NH4Cl	   –	   f	  0,	   	   con	   μ	   =7007	  ±1325;	  KD	  μ	  =6622	  ±2278;	  OE	  μ	  =12191	  ±1813).	  These	  data	  demonstrate	  a	  previously	  unknown	  site	  of	  inhibitory	   action	   for	   Tomo1	   within	   the	   SV	   cycle	   at	   central	   excitatory	   synapses.	   That	   is,	  Tomo1	  is	  not	  limited	  to	  inhibiting	  priming	  of	  SVs	  into	  the	  RRP	  pool;	  but	  is	  also	  involved	  in	  a	  molecular	  mechanism	  that	  acts	  to	  clamp	  vesicles	  into	  the	  release-­‐recalcitrant	  ResP	  (Figure	  2	  B-­‐D).	  	  Tomosyn	   was	   discovered	   as	   Syntaxin1A-­‐binding	   protein	   [23]	   that	   is	   capable	   of	  forming	   	  a	   ternary	  complex	  with	  Syntaxin	  and	  SNAP25	  that	  mitigates	  VAMP	  on	  secretory	  vesicles	   from	   forming	   into	  SNARE	  complexes	   [24,25,46].	  Therefore,	  we	  next	   tested	   if	   the	  VAMP-­‐like	  SNARE	  domain	  was	  required	  for	  Tomosyn’s	  inhibtory	  action	  on	  TRP.	  	  For	  these	  experiments	  we	  expressed	  a	  C-­‐terminally	  truncated	  m-­‐Tomo1	  (Tomo1-­‐ΔCT;	  m-­‐Tomo1	  (1-­‐1069))	  deficient	  in	  the	  SNARE	  motif	  and	  assessed	  changes	  in	  the	  fraction	  of	  SVs	  in	  the	  TRP	  and	  ResP.	  Immunoprecipitations	  (IPs)	  from	  PC12	  cell	  lysates	  expressing	  Tomo1-­‐ΔCT	  vs.	  wt	  Tomo1	   confirm	   that	   Tomo1-­‐ΔCT	   fails	   to	   interact	   with	   SNARE	   proteins	   Syntaxin1A	   and	  SNAP25	   (Figure	  2F).	  Expression	  of	   the	  Tomo1-­‐ΔCT	   in	  neurons	   significantly	   inhibited	   the	  TRP	  relative	  to	  control	  (Figure	  2E,F)	  to	  a	  similar	  degree	  as	  wt	  Tomo1.	  Taken	  together	  the	  data	   demonstrate	   that	   Tomo1	   regulates	   fractional	   changes	   in	   the	   TRP	   and	   ResP	   in	  hippocampal	  neurons	  independent	  of	  its	  VAMP-­‐like	  SNARE	  motif.	  The	  ability	  of	  Tomo1	  to	  allocate	  vesicles	  to	  a	  non-­‐releasable	  ResP	  may	  reflect	  an	  evolutionary	  conserved	  function	  with	   its	  yeast	  homolog	  Sro7,	  which	  when	  overexpressed	  results	   in	  non-­‐fusiogenic	  vesicle	  clusters	  independent	  of	  the	  cognate	  SNARE	  sec9	  [34].	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Activity-­‐dependent	  Cdk5	  regulation	  and	  Tomosyn	  phosphorylation	  The	  partitioning	  of	  vesicles	  at	  nerve	  terminals	  between	  the	  TRP	  and	  the	  ResP	  may	  be	   dynamically	   regulated	   in	   response	   to	   neuronal	   activity.	   For	   example,	   in	   cultured	  hippocampal	  neurons	  NMDA-­‐receptor	  dependent	  potentiation	  of	  neurotransmitter	  release	  drives	   an	   increase	   in	   the	   fraction	   of	   recycling	   vesicles	   [7].	   In	   addition,	   engagement	   of	  homeostatic	   plasticity	   in	   response	   to	   strong	   elevations	   or	   decreases	   in	   global	   network	  activity	  has	  demonstrated	  compensatory	  shifts	  in	  SVs	  to	  and	  from	  the	  ResP,	  respectively,	  in	  both	   acute	   hippocampal	   slices	   and	   hippocampal	   and	   neocortical	   neuron	   cultures[8-­‐10].	  While	   numerous	   pre	   and	   post-­‐synaptic	   mediators	   of	   homeostatic	   plasticity	   have	   been	  identified,	   the	   specific	  presynaptic	   signaling	  pathways	   that	  direct	   changes	   in	   the	   SV	  pool	  distribution	   during	   plasticity	   remain	   poorly	   defined.	   Among	   those	   exerting	   established	  effects	   on	   the	   TRP	   is	   Cdk5,	  which	   has	   been	   demonstrated	   via	   pharmacological	   blockade	  with	   roscovitine	   (rosco)	   to	   drive	   populational	   increase	   in	   the	   TRP	   concomitant	   with	   a	  decrease	  in	  the	  ResP	  in	  hippocampal	  brain	  slices	  and	  cultured	  hippocampal	  neurons	  [9,21].	  Cdk5	  is	  a	  proline-­‐directed	  Ser/Thr	  kinase	  whose	  activators	  (p35,	  p25	  and	  p39)	  are	  mainly	  brain	   specific[47-­‐49].	   	   Cdk5	   has	   been	   ascribed	   functions	   primarily	   as	   a	   neural-­‐specific	  kinase	  critical	  to	  neurite	  development	  and	  synaptogenesis,	  synaptic	  function	  and	  plasticity,	  and	   dysregulation	   of	   its	   activity	   has	   been	   linked	   to	   the	   pathology	   of	   neurodegenerative	  diseases	   such	   as	   Alzheimer’s,	   Parkinson’s	   and	   Huntington’s	   [50-­‐53].	   	   Important	   to	   the	  current	   investigations,	   the	   reported	   extent	   to	   which	   Cdk5	   modulates	   TRP	   size	   closely	  mirrored	   the	   distributional	   changes	  we	   observed	   upon	   alterations	   of	   Tomo1	   expression.	  	  	  Therefore,	  we	  next	  evaluated	  if	  the	  state	  of	  Cdk5	  activation	  is	  sensitive	  to	  synaptic	  activity	  and	  if	  Tomo1	  serves	  as	  a	  Cdk5	  substrate.	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Unlike	  other	  cyclin	  dependent	  kinases,	  Cdk5	  is	  not	  activated	  by	  cyclins	  but	  rather	  by	  necessary	  interaction	  with	  non-­‐cyclin	  regulatory	  partners	  (p35/p25,	  p39)	  [53].	  In	  addition,	  although	   T-­‐Loop	   phosphorylation	   of	   Cdk5	   is	   not	   required	   for	   full	   catalytic	   activation,	   its	  phosphorylation	  at	  Ser159	  elicits	  a	  marked	  increase	  in	  Cdk5	  activity	  [54,55].	  	  Therefore,	  to	  initially	   test	   if	   neuronal	   activity	   modulates	   the	   activation	   state	   of	   Cdk5	   we	   used	   anti-­‐phospho-­‐Cdk5-­‐Ser159	  antibody	   in	   immunocytochemistry	  of	  hippocampal	  cultures.	  Figure	  3A	  shows	  that	  relative	  to	  immunofluorescence	  intensity	  of	  controls,	  treatment	  of	  cultures	  (30	  min)	  with	  rosco	  (100	  μM)	  demonstrated	  lower	  averaged	  immunofluorescence	  intensity	  (μ	   =0.75	   ±0.021),	   while	   cyclosporine	   A	   (CSA)	   treatment,	   an	   inhibitor	   of	   the	   presynaptic	  serine/threonine	  phosphatase	  calcineurin	  that	  opposes	  the	  functional	  effects	  of	  Cdk5	  on	  SV	  pools[9],	  showed	  higher	  averaged	  intensity	  (μ	  =1.234	  ±0.148).	  Together	  these	  data	  indicate	  that	   anti-­‐phospho-­‐Cdk5-­‐Ser159	   immunofluorescence	   reports	   the	   relative	   activation	   of	  Cdk5.	  To	  assess	  the	  role	  of	  neural	  activity	  on	  Cdk5	  activation	  in	  hippocampal	  cultures	  the	  immunostaining	   studies	   were	   repeated,	   comparing	   TTX	   treatment	   (1	   μM	   ,	   24	   hours)	   to	  block	   global	   AP	   firing	   to	   vehicle-­‐treated	   controls.	   The	   results	   showed	   that	   blocking	  neuronal	   spiking	   with	   TTX	   led	   to	   strong	   reductions	   in	   phosphorylated	   Cdk5	  immunofluorescence	   intensity	   (μ	   =0.7	   ±0.004)	   relative	   to	   control	   (Figure	   3B).	   Thus,	   the	  data	  strongly	  suggest	  that	  Cdk5	  activation	  is	  sensitive	  to	  neuronal.	  	  To	   determine	   if	   Tomo1	   is	   a	   Cdk5	   phosphorylation	   substrate	   we	   first	   tested	   for	  intermolecular	  interaction	  by	  co-­‐IP	  from	  hippocampal	  neuron	  culture	  lysate.	   	   	  The	  results	  established	  that	  Cdk5	  co-­‐IPs	  with	  Tomo1,	  and	  that	  the	  co-­‐precipitation	  was	  independent	  of	  whether	   Cdk5	   or	   Tomo1	  was	   the	   primary	   IP	   protein	   (Figure	   3C).	   Next,	   we	   investigated	  whether	  Tomo1	  is	  a	  phosphorylation	  target	  of	  Cdk5,	  as	  Tomo1	  contains	  several	  consensus	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sequences	   for	   Cdk5	   phosphorylation.	   	   For	   this,	   in	   vitro	   phosphorylation	   reactions	   were	  conducted	   using	   active	   p25/Cdk5	   in	   the	   presence	   of	   γ-­‐[32P]-­‐ATP,	   together	   with	   biotin-­‐tagged	   m-­‐Tomo1	   protein	   that	   was	   affinity	   purified	   from	   transfected	   HEK-­‐293	   cells	   for	  proper	   folding.	   Analysis	   of	   the	   reactions	   by	  Western	   blotting	   showed	   direct	   correlation	  between	  32P-­‐radiolabeling	  and	  Tomo1	  immunoreactivity	  (Figure	  3D).	  	  32P-­‐phosphorylation	  of	  Tomo1	  was	  mediated	  by	  Cdk5	  as	   radiolabeling	  was	  not	   observed	   in	   the	   empty-­‐vector	  control	  samples	  or	  in	  Tomo1	  p25/Cdk5	  samples	  containing	  rosco	  (1mM)	  (Figure	  3D).	  An	  in	  
silico	   analysis	   of	   the	   Tomo1	   protein	   sequence	   for	   Cdk5	   phosphorylation	   motifs	  ([S/T]PX[K/H/R])	   yielded	   a	   total	   of	   11	   predicted	   sites	   using	   the	  Group-­‐based	   prediction	  system	  3.0	  with	  a	  high-­‐threshold	  allowing	  only	  a	  2%	  false	  positive	  rate	   [56].	  The	   in	  silico	  studies	   were	   then	   followed	   up	   by	   mass-­‐spectrometry	   analysis	   of	   in	   vitro	   Cdk5	  phosphorylated	   mTomo1	   protein,	   which	   confirmed	   phosphorylation	   of	   3	   sites	   from	   the	  prediction	   list	   (S269,	   S867,	   T1004).	   Altogether	   results	   from	   these	   biochemical	   studies	  further	  strengthen	  the	  hypothesis	  that	  Tomo1	  is	  a	  Cdk5	  phosphorylation	  substrate.	  	  	  
	  
Tomosyn	  and	  Cdk5	  share	  a	  common	  pathway	  in	  regulating	  SV	  pools	  To	  determine	  if	  Tomo1	  actions	  on	  the	  TRP	  were	  under	  specific	  regulation	  by	  Cdk5	  we	   evoked	  presynaptic	   release	   in	   control	   and	  Tomo1KD	  neurons	   under	   conditions	  were	  Cdk5	  was	  pharmacologically	  inhibited	  As	  shown	  in	  Figure	  4,	  inhibition	  of	  Cdk5	  with	  rosco	  (100	   μm,	   30	  m)	   enhanced	   the	   fraction	   of	   recycling	   vesicles	   relative	   to	   that	   observed	   in	  carrier-­‐treated	  (0.1%	  DMSO)	  controls	  (Figure	  4A,	  black	  trace	  left	  vs.	  right;).	  	  These	  findings	  are	   similar	   to	   those	   previously	   reported	   [9].	   Importantly,	   however,	   the	   effect	   of	   Cdk5	  inhibition	   was	   specific	   to	   the	   presence	   of	   Tomo1,	   as	   a	   further	   enhancement	   in	   the	   TRP	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proportion	  was	   absent	   in	   the	  Tomo1	  KD	   condition	   (Figure	  4A,	   blue	   trace,	   right	   vs.	   black	  trace,	   right).	   	   Note	   also	   that	   Tomo1	   KD	   alone	   led	   to	   an	   enhancement	   in	   the	   fraction	   of	  recycling	  vesicles	  (Figure	  4A,	  blue	  trace,	  left),	  similar	  to	  that	  observed	  with	  Cdk5	  inhibition	  	  (Figure	  4A,	  black	  trace,	  right).	  	  As	   a	   complement	   to	   these	   studies,	   we	   next	   compared	   the	   effects	   in	   control	   vs.	  Tomo1	   KD	   neurons	   when	   Cdk5	   activity	   was	   genetically	   depressed	   by	   expression	   of	   the	  catalytically	   inactive,	   dominant-­‐negative	   Cdk5	   mutant	   (Cdk5(D144N)).	   Notably,	   we	  observed	   an	   enhancement	   in	   the	   TRP	   fraction	   on	   Cdk5-­‐D144N	   expression	   that	   was	  comparable	  to	  that	  observed	  upon	  treatment	  with	  rosco	   	  (Figure	  4A,	  magenta	  trace,	   left).	  Moreover,	   application	   of	   rosco	   in	   the	   Cdk5-­‐D144N	   expression	   condition	   did	   not	  significantly	   increase	   the	   TRP	   size	   (Figure	   4A,	  magenta	   trace,	   right),	   confirming	   that	   the	  effects	   of	   rosco	   on	   the	   TRP	   are	   specific	   to	   Cdk5.	   These	   results	   confirm	   previous	   data	  demonstrating	  that	  Cdk5’s	  catalytic	  activity	  inhibits	  the	  size	  of	  the	  TRP.	  	  More	  importantly,	  the	   results	   demonstrate	   that:	   1)	   Tomo1	  KD	   or	   ablation	   of	   Cdk5	   catalytic	   activity	   lead	   to	  significant	   increase	   in	   fraction	   of	   SVs	   in	   the	   TRP,	   and	   2)	   down-­‐regulation	   of	   Tomo1	  expression	  or	  Cdk5	  activity	  occludes	  the	  increases	  in	  the	  TRP	  that	  are	  normally	  mediated	  by	  the	  other	  (Figure	  4B).	  Finally,	  analysis	  of	  cumulative	  frequency	  distributions	  of	  TRP	  size	  from	   bouton	   ensembles	   across	   cells	   show	   that,	   genetic	   or	   pharmacological	   inhibition	   of	  Cdk5,	  KD	  of	  Tomo1,	  or	  downregulation	  of	  both	  proteins	  result	  in	  a	  comparable	  right-­‐shift	  (towards	   greater	  TRPs)	   relative	   to	   non-­‐treated	   control	   cells	   (Figure	   4C).	   Together,	   these	  results	   strongly	   support	   Tomo1	   and	   Cdk5	   as	   acting	  within	   the	   same	   signal-­‐transduction	  pathway	  that	  regulates	  the	  fraction	  of	  SVs	  in	  the	  ResP.	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Identification	  of	  a	  novel	  Tomo1	  effector	  complex	  regulated	  by	  kinase	  activity	  We	  next	  examined	  how	  Tomo1	  may	  participate,	  independent	  of	  its	  SNARE	  motif,	  in	  the	  regulation	  of	  vesicle	  availability	   for	   release.	   	   In	   the	  rat	  brain,	  Tomosyn	   is	   localized	   to	  the	   cytosol,	   plasma	  membrane	   and	   SVs	   [23,32,57].	   As	   a	   non-­‐integral	  membrane	   protein	  Tomosyn’s	   association	   with	   the	   plasma	  membrane	   has	   been	  well	   documented	   to	   be	   via	  interaction	  with	   Syntaxin1A	   [58],	   yet	   the	  mechanism	  by	  which	  Tomosyn	   associates	  with	  SVs	  is	  unknown.	  However,	  the	  yeast	  homologs	  of	  Tomosyn	  (Sro7p/77p)	  interact	  with	  Rab	  GTPases,	   which	   are	   vesicle-­‐associated	   proteins	   important	   in	   tethering	   and	   docking	   of	  vesicles	  at	  sites	  of	   fusion.	  At	  central	  synapses,	   the	  primary	  exocytotic	  Rab	  GTPases	  are	  of	  the	   Rab3	   family,	   comprised	   of	   four	   Rab3	   isoforms	  A-­‐D	   that	   compensate	   for	   one	   another	  functionally	   [59].	   Based	   on	   a	   potential	   for	   evolutionary	   conservation	   of	   effector	  interactions	  we	   tested	   if	   Tomo1	   interacts	  with	   Rab	   GTPases	   by	   conducting	   co-­‐IP	   assays	  using	  cultured	  hippocampal	  neuron	  lysates.	  As	  shown	  in	  the	  representative	  Western	  blot	  in	  Figure	  5A,	  Rab3A	  was	  observed	  to	  co-­‐precipitate	  with	  endogenous	  Tomo1,	  as	  well	  as	  with	  YFP-­‐Tomo1	  resulting	  from	  lentiviral	  OE.	  Moreover,	  as	  confirmation	  of	  the	  specificity	  of	  the	  interaction,	   we	   did	   not	   observe	   co-­‐IP	   of	   other	   synaptic	   (RIM1/2,	   actin)	   or	   integral	   SV	  (Synaptophysin)	   proteins	   with	   Tomo1	   (Figure	   5A).	   Interestingly,	   while	   Rab3A	   normally	  binds	  and	  co-­‐precipitates	  with	  RIM	  proteins	  our	  results	  suggest	  that	  it	  may	  not	  do	  so	  when	  bound	   to	   Tomo1,	   since	   it	   was	   not	   apparent	   in	   co-­‐precipitates	   containing	   Rab3A.	   	   As	  GTPases,	   Rab3	   proteins	   cycle	   between	   an	   active	   effector	   interacting	   GTP	   state	   and	   an	  inactive	  GDP	  bound	  state;	  being	  present	  on	  SVs	  only	  when	  GTP	  bound	  [60].	  To	  test	  whether	  the	   nucleotide	   state	   of	   Rab3A	   affected	   Tomo1	   binding	   we	   conducted	   IP	   assays	   from	  hippocampal	  lysates	  where	  Rab3A	  was	  freed	  of	  nucleotide	  binding	  and	  then	  locked	  into	  a	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GTP	   or	   GDP	   bound	   state	   with	   non-­‐hydrolysable	   nucleotide	   analogs.	   We	   observed	   that	  Tomo1	  bound	  preferentially	  to	  Rab3A-­‐GTP	  compared	  to	  GDP	  or	  nucleotide	  free	  (Figure	  5B-­‐C).	  	   To	   complement	   the	   IP	   results,	   we	   next	   tested	   for	   detection	   of	   Tomo1/Rab3A	  interaction	   within	   a	   cell	   context	   using	   a	   proximity	   ligation	   assay	   (PLA).	   	   For	   these	  experiments	   cells	  were	   submitted	   to	   immunocytochemistry	   using	   rabbit	   polyclonal	   anti-­‐Tomo1	   and	   mouse	   monoclonal	   anti-­‐Rab3A	   antibodies	   prior	   to	   treatment	   with	   species-­‐specific	  PLA	  secondary	  antibodies	  that	  contain	  unique	  short	  DNA	  strands.	  Should	  the	  DNA	  strands	  from	  the	  PLA	  secondary	  antibodies	  be	  in	  close	  proximity	  (<40nm)	  they	  possess	  the	  ability	  to	  be	  ligated,	  amplified	  and	  fluorescently	  labeled	  to	  yield	  high	  intensity	  fluorescent	  puncta	  at	   sites	  of	  putative	  protein-­‐protein	   interactions.	   Insulin	   secreting	  Min6	  cells	  were	  used	   as	   they	   possess	   large	   (~270	   nm	   diameter)	   secretory	   granules,	   utilize	   exocytotic	  machinery	   similar	   to	   that	   of	   neurons	   and	   present	   a	   well	   resolved	   cell	   periphery	   that	  promotes	  quantitative	  analysis	  of	  the	  PLA	  fluorescent	  puncta.	  	  Robust	  PLA	  signals	  between	  Rab3A	  and	  Tomo1	  were	  observed	  (Figure	  5D,E;	  μ	  =0.378	  ±0.02	  	  puncta/μm)	  	  that	  appear	  localized	   with	   secretory	   granules	   (Figure	   5F).	   	   Analysis	   shows	   that	   the	   density	   of	   PLA	  fluorescent	  puncta	  was	  not	  significantly	  different	  from	  that	  of	  Rab3A	  and	  RIM2	  	  (μ	  =0.437	  ±0.015	   	   puncta/μm),	   for	   which	   an	   interaction	   is	   well	   established	   within	   presynaptic	  compartments	   [61,62].	   As	   PLA	   assay	   controls	   (Figure	   5E),	   negligible	   PLA	   signals	   were	  observed	  between	  Rab3A	  and	  the	  SV	  membrane	  protein	  Syp	  (μ	  =0.077	  ±0.008	  puncta/μm)	  or	  when	  cells	  were	  probed	  for	  Rab3A	  alone	  (μ	  =0.07	  ±0.007	  puncta/μm).	  PLA	  experiments	  in	  cultured	  hippocampal	  cells	  also	  show	  robust	  signals	  between	  Tomo1	  and	  Rab3A,	  Rim1/2	  and	  Rab3A	  but	  not	  Synaptophysin	  and	  Rab3A	  (Figure	  5G).	  The	  interaction	  between	  Tomo1	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and	   Rab3A-­‐GTP	   in	   hippocampal	   neurons	   provides	   a	   mechanism	   supporting	   vesicle	  localization	  of	  Tomo1,	  and	  reflects	  an	  evolutionary	  conservation	  to	  the	  yeast	  homolog	  Sro7	  interaction	  with	  Sec4-­‐GTP.	  In	  addition,	  this	  may	  serve	  as	  a	  candidate	  molecular	  mechanism	  for	  clamping	  vesicles	  in	  the	  ResP,	  as	  studies	  in	  yeast	  show	  that	  Sro7	  induced	  accumulation	  of	   non-­‐fusiongenic	   vesicles	   depends	   on	   Sec4-­‐GTP	   [34],	   while	   mammalian	   studies	   on	  exocytosis	  have	  revealed	  that	  Rab3A-­‐GTP	  can	  also	  clamp	  SV	  release	  [63-­‐65].	  	  
Kinase	  activity	  modulates	  the	  formation	  of	  a	  Tomo1/Rab3A/Synapsin	  complex	  Rab	  GTPases	  and	  Synapsin	  phosphoproteins	  are	   the	  major	   regulatory	  proteins	   for	  tethering	  and	  docking	  SVs	  at	  the	  AZ.	  While	  the	  association	  of	  Rab3	  to	  SVs	  is	  mediated	  via	  its	  GTPase	   activity,	   Synapsin	   proteins	   transit	   on/off	   vesicles	   depending	   on	   their	  phosphorylation	   state	   [66].	   Phosphorylation	   of	   Synapsin	   by	   PKA,	   CaMKs,	   Erk,	   or	   Cdk1	  decreases	  binding	  to	  SVs	  and	  conversely	  phosphorylation	  by	  Src	  enhances	  SV	  binding	  [67-­‐70].	  Importantly,	  because	  Rab3A-­‐GTP	  also	  binds	  to	  Synapsins	  [71];	  we	  next	  determined	  if	  Synapsin1	  was	  present	  in	  Tomo1	  IPs	  from	  hippocampal	   lysates,	  since	  such	  an	  interaction	  may	   be	   central	   to	   Tomo1	   exerting	   regulatory	   actions	   on	   the	   TRP.	   As	   shown	   in	   the	  representative	  Western	  blot	   (Figure	  6A),	  Synapsin1	  proteins	  were	  present	   in	  Tomo1	   IPs.	  	  As	  a	  control	  assessment	  for	  the	  specificity	  of	  co-­‐precipitation,	  use	  of	  a	  rabbit	  IgG	  isotype-­‐control	  yielded	  no	  detectable	  IP	  of	  Tomo1,	  Rab3A	  or	  Synapsin1	  proteins	  (Figure	  6B).	  Next,	  to	   determine	   if	   the	   Tomo1	   and	   Synapsin1	   interaction	   was	   direct	   or	   if	   it	   occurred	   as	   a	  function	   of	   Rab3A	   binding	   we	   conducted	   Tomo1	   IPs	   from	   neuronal	   lysates	   that	   were	  previously	   cleared	  by	   IP	  with	   a	  Rab3A	   antibody.	   Figure	  6C	   shows	   that	   in	   the	   absence	   of	  Rab3A,	  Synapsin1	  proteins	  no	   longer	  Co-­‐IP	  with	  Tomo1.	  These	  results	   imply	   that	  Tomo1	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Tomo1	  phosphorylation	   state	   is	   sensitive	   to	  neuronal	  activity	  and	   is	   important	   for	   synaptic	  
scaling	  	  Importantly,	  in	  a	  final	  series	  of	  investigations	  we	  tested	  if	  neuronal	  activity	  leads	  to	  changes	   in	   Tomo1	   phosphorylation	   by	   Cdk5	   and	   if	   Tomo1	   exerts	   a	   central	   role	   in	  homeostatic	   presynaptic	   changes	   in	   neurotransmitter	   release	   arising	   from	   alterations	   in	  neural	  activity.	  First,	  we	  assessed	  if	  Tomo1	  is	  phosphorylated	  in	  neurons	  by	  conducting	  IP	  assays	   from	   hippocampal	   cultures	   in	   which	   cytosolic	   ATP	   was	   labeled	   by	   32P	  orthophosphate.	   As	   shown	   in	   Figure	   7A-­‐B,	  we	   find	   that	   Tomo1	   is	   phosphorylated	   in	  situ	  and	   that	   treatment	   with	   rosco	   (100mM),	   to	   inhibit	   Cdk5,	   leads	   to	   a	   ~50%	   reduction	   in	  basal	   phosphorylation	   levels.	   Critically,	   our	   results	   also	   show	   that	   chronic	   elevation	   in	  neural	  activity	  induced	  by	  treatment	  with	  the	  GABAA	  receptor	  antagonist,	  picrotoxin	  (Ptx,	  50	  mM,	  4	  hrs),	   and	  an	  elevation	   in	  extracellular	   calcium	  (4mM)	   increased	   the	  amount	  of	  phosphorylated	   Tomo1	   relative	   to	   control.	   Inhibiting	   Cdk5	   by	   application	   of	   rosco	  (100mM)	  30	  minutes	  prior	  to,	  and	  throughout	  the	  pharmacologically-­‐induced	  elevations	  in	  neural	   activity	   did	   not	   completely	   abrogate	   the	   increase	   in	   Tomo1	   phosphorylation;	  however,	   it	   did	   result	   in	   a	   modest	   decrease	   compared	   to	   chronic	   activity	   alone.	   This	  suggests	   that,	   while	   Cdk5	   is	   an	   activity-­‐dependent	   kinase	   for	   Tomo1	   other	   kinases	   also	  phosphorylate	  Tomo1	  during	  elevations	   in	  neuronal	   spiking.	  Notably,	  Tomo1	   is	   a	  known	  substrate	  for	  PKA,	  thus	  potentially	  implicating	  it	  in	  activity-­‐dependent	  regulation	  [28].	  We	  next	  assessed	  if	  Tomo1	  was	  necessary	  for	  compensatory	  elevations	  in	  SV	  release	  that	  are	  reported	   to	   appear	   as	   a	   homeostatic	   presynaptic	   plasticity	   response	   following	   chronic	  silencing	  of	  neural	  activity[72,73].	  As	   shown	   in	  Figure	  7C-­‐D	  chronic	   silencing	  of	  network	  activity	   in	   the	   hippocampal	   cultures	   by	   the	   competitive	   antagonists	   of	   AMPA/kainate	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glutamate	   receptors	   (CNQX,	   40	  mM)	   for	   24	   hrs	   resulted	   in	   greater	   vGpH	   responses	   to	   a	  100P/10Hz	  stimulus	  relative	  to	  vehicle-­‐treated	  controls.	  .	  Importantly,	  Tomo1	  KD	  neurons	  lacked	   the	   ability	   to	   undergo	   these	   compensatory	   enhancements	   in	   neurotransmitter	  release	  relative	  to	  vehicle-­‐treated	  shTomo1	  neurons.	  .	  While,	  KD	  of	  Tomo1	  alone	  leads	  to	  a	  significant	   enhancement	   in	   SV	   release	   (Figure	   2);	   the	   results	   indicate	   that	   the	   ability	   of	  synapses	   to	   upregulate	   SV	   release	   within	   the	   context	   of	   prolonged	   activity	   blockade	  requires	  Tomo1..	  Considered	  together,	  the	  data	  indicated	  that	  the	  phosphorylation	  state	  of	  Tomo1	   is	   sensitive	   to	   neural	   activity	   and	   that	   	   Tomo1	   has	   a	   pivotal	   role	   in	   activity-­‐dependent	  compensatory	  synaptic	  scaling.	  	  
3.4	  Discussion	  The	  partition	  of	  SVs	  at	  small	  central	  synapses	  into	  distinct	  functional	  pools	  has	  been	  well	   established	   and	   in	   some	   cases,	   morphological	   and	   molecular	   correlates	   have	   been	  defined	   [4,5,74].	   The	   fractional	   distribution	   of	   SVs	   among	   pools	   (RRP,	   RP	   and	  ResP)	   has	  been	  shown	  to	  strongly	   impact	  presynaptic	  performance	  (namely,	  Pr)	  and	  the	  expression	  of	   Hebbian	   as	   well	   as	   homeostatic	   forms	   of	   synaptic	   plasticity	   [7-­‐9,20,75].	   Moreover,	  between	  individual	  presynaptic	  boutons	  of	  any	  given	  neuron,	  the	  fractional	  distribution	  of	  SVs	  among	  releasable	  (TRP)	  vs.	  non-­‐releasable	  (ResP)	  pools	  may	  be	  highly	  heterogeneous,	  raising	   the	  possibility	   for	   local	   regulation	  by	  signaling	  molecules	  and	  effector	  proteins	   in	  response	   to	   local	   activity	   [7,12,16,76-­‐79].	   Here	   we	   establish	   that	   Tomo1,	   a	   non-­‐integral	  membrane	   R-­‐SNARE	   protein,	   is	   a	   central	   molecular	   mediator	   of	   SV	   distribution	   within	  functionally	  defined	  presynaptic	  SV	  pools.	  	  We	  find	  that	  Tomo1	  inhibits	  not	  only	  priming	  of	  SVs	  into	  the	  RRP	  but,	  importantly,	  also	  defines	  the	  distribution	  of	  vesicles	  between	  the	  TRP	  and	  ResP,	  an	  effect	   independent	  of	   its	  C-­‐terminal	   localized	  SNARE	  domain.	  Moreover,	  our	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results	  link	  previously	  reported	  effects	  of	  Cdk5	  on	  dynamic	  changes	  in	  the	  TRP	  to	  Tomo1,	  which	   we	   demonstrate	   is	   an	   activity-­‐dependent	   phosphorylation	   substrate	   of	   Cdk5.	  	  Furthermore,	  we	  identify	  a	  novel	  protein	  interaction	  between	  Tomo1	  and	  Rab3A	  GTPases.	  We	   find	   that	  Tomo1	   interacts	  with	  SV	   localized	  Rab3A-­‐GTP,	  more	  strongly	   than	  GDP	  and	  promotes	   formation	   of	   a	   complex	   along	   with	   Synapsin1	   proteins;	   thus,	   providing	   a	  potential	  mechanism	  by	  which	  SVs	  may	  be	  appropriated	  into	  a	  release-­‐recalcitrant	  ResP.	  	  The	  molecular	  signaling	  pathways	  sensitive	  to	  neural	  activity,	  which	  confer	  precise	  yet	   dynamic	   structural	   and	   functional	   partitioning	   of	   SVs	   between	   the	   TRP	   and	   ResP	  remain	  poorly	  established.	  This	  information	  is	  of	  considerable	  physiological	  importance	  as	  small	  central	  synapses	  such	  as	  those	  of	  hippocampal	  neurons	  contain	  few	  total	  SVs	  (~200)	  [41,78,80],	   thus	   sequestering	  of	   SVs	   into	   a	  ResP	   can	   strongly	   limit	   synaptic	  performance	  during	   sustained	   activity.	   Most	   measurements	   of	   the	   TRP	   size	   from	   dissociated	  hippocampal	  neurons	  or	   in	  hippocampal	  brain	  slice	  show	  that	  on	  average	   it	  accounts	   for	  50%	  of	  the	  total	  SV	  population	  [7,12,77,78],	  though	  some	  report	  smaller	  percent	  recycling	  [21,81];	  and	  	  one	  recent	  study	  has	  reported	  that	  in	  organotypic	  brain	  slices	  all	  SVs	  are	  able	  to	   participate	   in	   exocytotic	   activity	   [8].	   In	   contrast,	   different	   structural	   and	   functional	  dynamics	   of	   SV	   partitioning,	   particularly	   with	   regard	   to	   the	   ResP	   may	   be	   found	   in	  presynaptic	  terminals	  that	  contain	  a	  substantially	  greater	  number	  of	  SVs	  and/or	  multiple	  AZs,	   such	   as	   frog,	  Drosophila,	  C.	  elegans	  NMJs	  or	   the	  Calyx	  of	  Held(see	   review	  by	   [5]).	   In	  terms	   of	   the	   morphological	   organization	   of	   the	   SV	   pools	   at	   small	   central	   synapses,	  structural	   analysis	   of	   hippocampal	   boutons	   from	   CA3	   Schaffer	   collateral	   fibers	   in	   brain	  slices	  revealed	  that	  TRP	  vesicles	  are	  spatially	  positioned	  closer	  to	  the	  AZ	  relative	  to	  ResP	  vesicles,	   and	   that	  ResP	  SVs	  do	  not	   appear	   to	  be	  part	  of	   the	  SV	   superpool	  of	   vesicles	   that	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dynamically	  exchanges	  between	  boutons	   [13,21].	  Moreover,	   the	   total	  number	  of	   SVs	   in	  a	  bouton	  does	  not	  correlate	  with	  the	  fraction	  that	  is	  in	  the	  TRP	  or	  with	  Pr;	  however,	  the	  TRP	  size	   is	  positively	  correlated	  with	  number	  of	  docked	  SVs	   in	   the	  AZ	   [21,82].	  Thus,	   it	  would	  appear	  that	  TRP	  SVs	  are	  more	  likely	  to	  be	  closer	  to	  the	  release	  site	  than	  ResP	  SVs,	  though	  spatial	  positioning	  does	  not	   strictly	  define	   them.	  Nonetheless,	   this	   implies	   the	  possibility	  that	   structural	   dynamics	   like	   remodeling	   of	   the	   actin	   cytoskeleton	   may	   contribute	   to	  defining	   spatial	   clustering	   of	   pools.	   Indeed,	   in	   cultured	   hippocampal	   neurons	  pharmacological	  stabilization	  of	  actin	  dynamics	  mitigated	  TRP	  clustering	  near	  the	  AZ,	  but	  did	   not	   alter	   SV	   pool	   sizes[21].	   In	   addition,	   the	   use	   of	   compounds	   that	   disrupt	   actin	  dynamics	   has	   been	   reported	   to	   leave	   SV	   clusters	   at	   synapses	   unaffected	   [83]	   and	  fluorescence	  imaging	  of	  eGFP-­‐tagged,	  as	  well	  as	  EM	  analysis	  of	   immunogold-­‐labeled	  actin	  have	  revealed	  that	  it	  predominantly	  surrounds	  only	  the	  distal	  edges	  of	  SV	  clusters,	  further	  supporting	  a	  role	  for	  actin	  in	  spatial	  clustering	  but	  not	  pool	  partitioning	  [66,84].	  Therefore,	  while	  actin	  may	  participate	  in	  positioning	  of	  SVs	  within	  functionally	  defined	  pools,	  distinct	  signaling	  pathways	  likely	  mediate	  the	  partitioning	  of	  SVs	  between	  the	  ResP	  and	  TRP.	  	  One	  such	  signaling	  pathway	  is	  mediated	  by	  Cdk5,	  which	  has	  been	  established	  as	  a	  regulator	  of	  the	   ResP	   size	   [9].	   It	   has	   been	   shown	   that	   Cdk5	   phosphorylates	   Synapsin1	   promoting	   its	  association	  with	   F-­‐actin	   resulting	   in	   a	   sequestration	   of	   vesicles	   to	   perisynaptic	   sites	   in	   a	  non-­‐releasable	   state	   [20].	   These	   studies	   account	   for	   how	   SVs	   may	   be	   silenced	   by	  morphological	   clustering	   at	   perisynaptic	   sites	   and	   how	   Synapsins	   can	   function	   as	  regulatory	  elements	  for	  controlling	  lateral	  vesicle	  sharing	  between	  synapses	  [22],	  yet	  they	  do	  not	  fully	  account	  for	  how	  SVs	  are	  partitioned	  independent	  of	  actin	  dynamics	  and	  within	  the	   SV	   cluster	   into	   distinct	   pools.	   Here	   we	   show	   that	   Tomo1	   is	   an	   activity-­‐dependent	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phosphorylation	   substrate	   of	   Cdk5	   able	   to	   define	   the	   TRP/ResP	   partition.	  Moreover,	  we	  determined	   that	   Tomo1	   bound	   to	   Rab3A	   is	   able	   to	   form	   into	   complex	   with	   Synapsin1	  proteins.	  	  Notably,	  this	  molecular	  complex	  is	  sensitive	  to	  S/T	  kinase	  activity,	  thus	  adding	  a	  novel,	   potent	   and	   activity	   regulated	   signaling	   system	   for	   reallocation	   of	   SVs	   among	  functional	   pools.	   Indeed,	   the	   diverse	   molecular	   actions	   of	   an	   SV-­‐associated	   complex	  containing	  Synapsin1,	  Rab3A	  and	  Tomo1	  may	  be	  more	  important	  for	  restricting	  the	  release	  capability	  of	  SVs	  within	  the	  AZ	  cluster,	  as	  each	  of	  these	  proteins	  has	  been	  found	  capable	  of	  independently	  limiting	  SV	  release.	  This	  would	  represent	  a	  multifaceted	  inhibitory	  complex	  for	  restricting	  SV	  transition	  from	  ResP	  to	  TRP	  since	  clamping	  could	  occur	  at	  distinct	  stages	  of	  the	  SV	  cycle.	  	  For	  example,	  ResP	  SVs	  could	  be	  defined	  by	  tethering	  functions	  of	  Synapsin1	  dimers	  [85-­‐87],	  Rab3A	  binding	  to	  docking/priming	  factors	  like	  RIM	  and	  Munc18	  [88-­‐90]	  or	  Tomo1	  interactions	  with	  Q-­‐SNAREs	  [24,25,91]	  all	  which	  localize	  SVs	  to	  the	  AZ	  but	  can	  exert	  a	  regulatory	  brake	  on	  release-­‐competence.	  In	  accordance,	  in	  this	  study	  we	  find	  that	  while	  Tomo1	   is	   able	   to	   inhibit	   the	   size	   of	   TRP,	   it	   had	   no	   effects	   on	   TRP	   release	   kinetics.	   By	  comparison,	  phosphorylation	  of	   Synapsin1	  proteins	  delays	  depletion	  kinetics	  of	   the	  TRP.	  Thus,	  specific	  components	  of	  this	  complex	  in	  theory	  could	  confer	  distinct	  ResP	  dynamics	  as	  they	  clamp	  at	  different	  stages	  of	  the	  SV	  cycle.	  	  Tomosyn	   proteins	   have	   been	   well	   characterized	   as	   potent	   inhibitors	   of	   evoked	  transmitter	   release	   in	   neuroendocrine	   cells	   [24,27,58,92],	   rat	   superior	   cervical	   ganglion	  [28],	   hippocampal	   dentate	   gyrus	   mossy	   fibers	   [29],	   C.	   elegans	   [32,93]	   and	   Drosophila	  [30]NMJs.	   The	   predominant	   mechanistic	   model	   of	   Tomosyn	   action	   is	   that	   it	   exerts	  inhibitory	   effects	   via	   its	   C-­‐terminal	   R-­‐SNARE	   domain,	   which	   competes	   with	   VAMP	   and	  Munc18	   for	   interaction	   with	   reactive	   syntaxin1A.	   The	   interaction	   with	   syntaxin1A	   and	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SNAP25	  leads	  to	  non-­‐fusogenic	  SNARE	  complexes	  that	  have	  been	  proposed	  to	  limit	  vesicle	  priming	   [24,25,91].	   Remarkably,	   in	   spite	   of	   their	   key	   importance,	   there	   have	   been	   few	  evaluations	  of	  Tomosyn	  effects	  on	  SV	  cycling	  at	  small	  central	  synapses.	  Our	  results	  present	  a	  completely	  novel	  site	  and	  mechanism	  for	  Tomo1	  inhibition	  of	  SV	  release	  that	  provides	  a	  remarkable	   shift	   in	   the	   conventional	   view	   of	   Tomo1,	   as	   we	   observe	   that	   it	   not	   only	  regulates	   priming	   into	   the	   RRP	   (i.e.	   RPàRRP)	   but	   also	   transitions	   from	   the	   ResP	   to	   the	  TRP.	  These	  findings	  help	  explain	  previous	  data	   from	  mouse	  chromaffin	  cells	  and	  NMJs	  (C	  elegans	  and	  Drosophila)	  that	  indicate	  inhibitory	  actions	  of	  Tomosyn	  beyond	  the	  RRP	  pool.	  In	  addition,	  our	  data	  indicate	  that	  the	  large	  N-­‐terminal	  WD-­‐40	  repeat	  domain	  of	  Tomo1,	  as	  opposed	   to	   the	   C-­‐terminal	   VAMP2	   homologous	   SNARE	   domain,	   comprises	   the	   region	  specific	  for	  its	  effects	  on	  SV	  ResP	  to	  TRP	  transitions.	  	  Little	  has	  been	  previously	  established	  concerning	   functional	   roles	   the	   N-­‐terminus	   of	   Tomosyn	   plays	   in	   SV	   release,	   although	  Tomo1	   based	   on	   a	   structural	   homology	   model	   closely	   aligns	   with	   the	   yeast	   Tomosyn	  homologue,	  Sro7	  [38].	  	  Here	  we	  show	  that	  Tomo1	  is	  also	  a	  binding	  partner	  of	  Rab3-­‐GTP,	  a	  discovery	  that	  implicates	   evolutionary	   conservation	  with	   an	   interaction	   occurring	   in	   the	   budding	   yeast	  where	   the	  secretory	  Rab,	  Sec4-­‐GTP	  and	   the	  Tomo1	  homolog,	  Sro7p	  act	   to	  coordinate	   the	  tethering	   of	   vesicles	   to	   fusion	   sites	   and	   priming	   for	   release	   [33-­‐35,94].	   In	   fact,	  overexpression	  of	  Sro7p	  in	  yeast	  results	  in	  a	  pronounced	  growth	  defect	  and	  the	  formation	  of	   a	   large	   cluster	   of	   ‘ResP-­‐like’	   non-­‐releasable	   post-­‐Golgi	   vesicles	   within	   the	   cell,	   in	   a	  manner	  dependent	  on	  Sec4-­‐GTP[35].	  Consistent	  with	  this,	  in	  mammals	  overexpression	  of	  a	  GTP-­‐locked	  point	  mutant	  of	  Rab3A	  (Q81L)	  impairs	  the	  size	  of	  the	  recycling	  pool	  [65];	  and	  as	  shown	  here	  expression	  of	  Tomo1	  leads	  to	  an	  increase	  in	  the	  ResP.	  Moreover,	  structural	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analysis	  of	  the	  C.	  elegans	  NMJ	  show	  that	  a	  loss	  of	  function	  mutation	  of	  Tomosyn	  leads	  to	  an	  increase	   in	   the	   number	   of	   SVs	   contacting	   the	   plasma	   membrane	   [95].	   Altogether	   these	  results	  suggest	  that	  the	  Tomo1,	  Rab3-­‐GTP	  interaction	  may	  form	  the	  central	  components	  of	  an	  SV	  clamping	  mechanism.	  One	  of	  the	  most	  prominently	  observed	  ResP	  functions	  has	  been	  as	  a	  functional	  locus	  for	   presynaptic	   scaling	   of	   neurotransmission	   in	   response	   to	   chronic	   changes	   in	   synaptic	  activity.	  ResP	  pools	  size	  dynamically	  shrinks	  or	  expands	  leading	  to	  changes	  in	  presynaptic	  strength	   that	   counter	   strong	   or	   chronic	   changes	   in	   synaptic	   activity	   [8,9,20,75].	   Neural	  networks	   commonly	   encounter	   strong	   variations	   in	   synaptic	   activity	   during	   sleep	   [96];	  stroke	  and	  trauma[97];	  and	  in	  early	  formation	  of	  neural	  circuits	  when	  massive	  numbers	  of	  synapses	   are	   added	   or	   pruned	   [98-­‐100].	   Cdk5	   was	   one	   of	   the	   first	   identified	   critical	  presynaptic	  substrates	  that	  can	  regulate	  the	  fraction	  of	  ResP	  SVs	  in	  hippocampal	  cultures	  for	   synaptic	   scaling.	   Its	   effects	   on	   synaptic	   scaling	   in	   response	   to	   chronic	   silencing	   have	  been	  evidenced	  by	  findings	  showing	  that	  long	  term,	  TTX-­‐induced	  silencing	  of	  the	  activity	  of	  hippocampal	  neurons	   in	   culture	  or	   of	   excitatory	  hippocampal	  CA3	   recurrent	   synapses	   in	  brain	  slice	  lead	  to	  a	  compensatory	  upregulation	  of	  neurotransmitter	  that	  depends	  on	  Cdk5	  [9,101].	   Interestingly,	   Kim	   and	  Ryan	   (2010)	   note	   in	   their	   study	   that	   chronic	   silencing	   of	  neurons	   with	   TTX	   results	   in	   a	   50%	   reduction	   of	   Cdk5	   protein	   levels	   [9].	   While	   other	  presynaptic	   proteins	   were	   largely	   unaffected,	   the	   next	   greatest	   change	   was	   a	   15%	  reduction	  of	  Tomosyn	  proteins.	   	  Here	  we	  discover	   that	  Tomo1	  proteins	   are	   subjected	   to	  Cdk5	  phosphorylation	  in	  an	  activity-­‐dependent	  manner	  and	  moreover,	  that	  compensatory	  enhancements	   in	   release	   after	   chronic	   dampening	   of	   network	   activity	   require	   Tomo1	  proteins.	  This	  provides	  a	  coherent	  conceptual	  model	  for	  how	  neuronal	  activity	  is	  linked	  to	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fractional	   changes	   in	   the	  ResP.	   This	   is	   further	   supported	  by	   findings	   in	  C.	  elegans	  where	  synaptic	  scaling	  was	  shown	  to	  occur	  by	  coordination	  of	  presynaptic	  SV	  release	  and	  post-­‐synaptic	  receptor	  activity	  [102,103].	  Specifically,	  scaling	  was	  mediated	  by	  a	  trans-­‐synaptic	  signaling	   mechanism	   in	   which	   the	   cell-­‐adhesion	   molecules	   Neurexin	   and	   Neuriligin	  mediate	  a	  retrograde	  signal	  to	  shunt	  neurotransmitter	  release.	  This	  signal	  was	  engaged	  by	  the	   inactivation	  of	  a	  muscle	  microRNA	  (mir-­‐1)	  and	  results	   in	  a	   specific	   inhibition	  of	   less-­‐calcium	   sensitive	   (i.e.	   EGTA-­‐sensitive)	   SVs.	   Importantly,	   the	   presynaptic	   effects	   of	   the	  retrograde	   signal	   (i.e.	   inhibition	  of	   SV	   release)	  depended	  on	   the	   actions	  of	  Tomosyn	  and	  correlated	   to	   increases	   in	   the	   protein	   levels	   of	   both	   Tomosyn	   and	   Rab3	   [102,103].	   In	  accordance,	   increases	   in	  neurotransmitter	   release	  associated	  with	   synaptic	   scaling	  at	   the	  Drosophila	   NMJ	   require	   the	   function	   of	   Rab3-­‐GAP	   presumably	   because	   it	   releases	   Rab3	  from	  a	  synaptic	  repressor	  by	  promoting	  GTP	  to	  GDP	  cycling	  [104],	  a	  finding	  consistent	  with	  a	  model	  positing	  Tomo1	  as	  the	  repressor.	  Thus,	  several	  reports	  have	  coalesced	  to	  implicate	  Cdk5,	  Rab3	  and	  Tomosyn	  as	  conserved	  regulators	  of	  presynaptic	  scaling	  in	  distinct	  model	  systems	   further	   strengthening	   observations	   that	   TRP/ResP	   partitioning	   is	   a	   primary	  mechanism	  for	  altering	  presynaptic	  efficacy	  in	  response	  to	  neural	  circuit	  activity.	  The	   data	   presented	   here	   together	  with	   previous	   reports	   detailing	   the	   function	   of	  Tomosyn	  proteins	  demonstrates	  that	  they	  play	  a	  significant	  role	  in	  regulating	  the	  efficacy	  of	  evoked	  synaptic	  transmission.	  However,	  in	  addition,	  and	  perhaps	  related	  to	  their	  cellular	  function,	  Tomosyn	  proteins	  are	  important	  for	  learning	  and	  implicated	  in	  disease	  pathology.	  	  Two	  recent	  studies	  stress	  this	  importance:	  (1)	  a	  homozygous	  mutation	  in	  the	  Tomo1	  gene	  explains	   an	   infantile-­‐onset	   neurodegenerative	   disorder	   characterized	   by	   sensorimotor	  axonal	   neuropathy,	   optic	   atrophy	   and	   cognitive	   deficit[105].	   (2)	   The	   Tomosyn	   gene	  was	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identified	   as	   a	   novel	   disease	   locus	   found	   to	   be	   commonly	   deleted	   in	   a	   cohort	   of	   families	  with	  at	  least	  one	  child	  with	  autism	  who	  also	  had	  facial	  dysmorphology,	  limb,	  digit	  or	  ocular	  abnormalities[106].	  While	  the	  specific	  mechanisms	  underlying	  Tomosyn’s	  participation	  in	  these	   diseases	   remains	   unknown,	   recent	   evidence	   has	   demonstrated	   that	   Tomo1-­‐overexpression	   in	   dentate	   gyrus	   neurons	   of	   the	   mouse	   hippocampus	   results	   in	   modest	  impairments	   in	   spatial	   learning	   and	   memory	   retention	   [29].	   In	   addition,	   the	   labile	  component	  of	   cAMP-­‐dependent	  associative	  memory	   in	  Drosophila	   requires	  Tomosyn	  and	  Synapsin	  proteins[30,107,108].	  Further,	  outside	  the	  CNS,	  Tomosyn	  function	  appears	  to	  be	  critical,	   for	   example,	   it	   was	   recognized	   as	   an	   important	   susceptibility	   gene	   for	   type-­‐2	  diabetes	   due	   to	   its	   integral	   role	   in	   regulating	   insulin	   secretion	   and	   insulin-­‐dependent	  GLUT4	   exocytosis[109,110].	   In	   the	   cardiovascular	   system,	   Tomosyn	   was	   shown	   to	   be	  required	   for	   normal	   platelet	   secretion	   and	   hemostasis[111].	   Thus,	   there	   appears	   to	   be	   a	  certain	  degree	  of	  intolerance	  to	  perturbations	  in	  Tomosyn	  function	  and/or	  protein	  levels	  in	  several	  physiological	  systems.	  	  In	  agreement	  with	  this,	  it	  is	  known	  that	  the	  mRNA	  levels	  of	  Tomosyn	   are	   developmentally	   regulated,	   as	   is	   the	   expression	   of	   many	   Tomosyn1	   &	   2	  protein	   isoforms	   [38,112].	  Moreover,	   in	   the	  3xTgAD	  mouse	  model	  of	  Alzheimer’s	  disease	  Tomosyn	   protein	   levels	   are	   enriched	   [113].	   Taken	   together,	   these	   studies	   suggest	   that	  future	   investigations	   aimed	   at	   discovering	   the	   links	   between	   Tomosyn	   function	   and	  learning	  and	  memory	  or	  disease	  pathology	  have	  the	  potential	  to	  be	  a	  worthwhile	  challenge	  as	   it	   concomitantly	   provides	   the	   opportunity	   to	   answer	   fundamental	   questions	   of	   how	  regulation	   of	   SVs	   and	   the	   efficacy	   of	   synaptic	   transmission	   feeds	   into	   greater	   behavioral	  phenomena	  and	  neuropathology.	  	  Moreover,	  while	  developmental	  processes	  have	  not	  been	  addressed	  in	  these	  studies,	   it	   is	   important	  to	  consider	  that	  Tomosyn	  has	  a	  role	   in	  neurite	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development	  likely	  by	  using	  it	  SNARE-­‐binding	  capabilities	  to	  localize	  to	  sites	  of	  extension	  as	   its	   counterpart	   Sro7	   does	   during	   yeast	   growth	   [33,114].	   Thus,	   it	   is	   possible,	   since	  partitioning	  of	  the	  ResP	  was	  shown	  to	  be	  developmentally	  refined,	  that	  SV	  pool	  partitioning	  dynamics	  could	  play	   integral	  roles	   in	  defining	  or	  at	   least	  safeguarding	  activity-­‐dependent	  wiring	   of	   neural	   circuits	   during	   early	   synapse	   development	   [8,14].	   Especially	   when	  considering	  that	  the	  catalytic	  activity	  of	  Cdk5	  [51-­‐53]	  and	  the	  GTPase	  activity	  of	  Rab3	  [115-­‐117]	   have	   also	   been	   linked	   to	   strong	   neurodevelopmental	   deficits.	   Clearly,	   further	  work	  will	   be	   needed	   to	   detail	   the	  molecular	  mechanisms	   and	   triggers	   for	   SV	   partitioning	   and	  future	  studies	  should	  consider	  the	  developmental	  and	  pathophysiological	  implications.	  	  	  
3.5	  Materials	  and	  methods	  
Antibodies	  	  The	  following	  primary	  antibodies	  were	  used:	  anti-­‐Synapsin1	  (SYSY,	  Göettingen	  ,Germany;	  rabbit,	  #106011,	  1:1000),	  anti-­‐Tomo1	  (SYSY,	  rabbit,	  #183103,	  WB	  1:1000,	   ICC	  1:400;	  BD	  Biosciences,	  mouse,	  #611296,	  WB	  1:400),	  anti-­‐Rab3A	  (SYSY,	  mouse,	  #107011,	  WB	  1:1000;	  SYSY,	  rabbit,	  #107003,	  ICC	  1:1000),	  anti-­‐Cdk5	  (Santa	  Cruz,	  Dallas,	  TX;	  rabbit,	  #SC173,	  WB	  1:200;	   mouse,	   #SC6247,	   WB	   1:	   200;	   anti-­‐phospho-­‐specific	   Cdk5,	   (Santa	   Cruz,	   rabbit,	  #SC12919,	   ICC	  1:100),	   anti-­‐synaptophysin	   (Sigma-­‐Aldrich,	   St.	   Louis,	  MO,	  mouse,	  #S5768,	  ICC,	  WB	  1:250	  	  ),	  anti-­‐RIM	  (SYSY,	  rabbit,	  #140003,	  WB,	  ICC	  1:500),	  Proximity	  ligation	  assay	  (Sigma-­‐Aldrich,	   DUO92102),	   anti-­‐actin	   (Sigma-­‐Aldrich,	   mouse,	   #A2228#,	   WB	   1:5000),	  IRDye800CW	  and	   IRDye680LT	   (LI-­‐COR,	  Lincoln,	  NE	  1:5000)	  and	  Alexa488	  and	  Alexa594	  (Life	   Technologies,	   Grand	   Island,	   NY),	   Vectashield	   with	   DAPI	   (Vector	   Laboratories,	  Burlingame,	  CA,	  #H-­‐1200).	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cDNA	  constructs	  and	  lentiviral	  vectors	  The	  pCAGGS	  super	  ecliptic	  vGLUT1-­‐pHluorin	  construct	  was	  obtained	  from	  Robert	  Edwards	  (UCSF)	   [44].	  mCherry	  was	   subcloned	   in	   frame	   to	   the	   C	   terminus	   of	   vGLUT1-­‐pHluorin	   to	  create	  vGLUT1-­‐pHluorin-­‐mCh	  with	  mCh	  exposed	  to	  the	  cytoplasmic	  region	  on	  expression.	  Recombinant	   constructs	   were	   used	   in	   expression	   studies	   included:	   pLP-­‐mCherry	   vector	  (CMV	  promoter);	  pLP	  vector	  (CMV	  promoter)	  containing	  mCherry	  fused	  to	  N-­‐terminus	  of	  mouse	  m-­‐Tomo1	   ;	   pDNR	   (CMV	  promoter)	   containing	   a	  deletion	   (residues	  1067-­‐1131)	  of	  the	   C-­‐Terminal	   SNARE	   domain	   of	   m-­‐Tomo1	   (MTomo1	   DCT)[38];	   pCDNA	   CAPTEV-­‐CT	  Gateway	  vector	  containing	  rat	  m-­‐Tomo1	  ;	  and	  pLentih	  (Synapsin	  promoter)	  containing	  YFP	  fused	  to	  the	  N-­‐terminus	  of	  m-­‐Tomo1	  [29].	  	  Lentiviral	  vectors	  encoding	  a	  short	  hairpin	  RNAi	  for	   targeted	   knockdown	   of	   all	   Tomo1	   isoforms	   or	   a	   non-­‐targeted	   scrambled	   RNAi	   were	  obtained	   from	   Origene	   (Rockville,	   MD).	   The	   RNAi	   sequences:	   	   KD1	  ACTGCTTCAGCCAGTGATTGTGTCTCCAA,	   KD2-­‐CCGTATGCTGTGGTTGTTCTCCTGGAGAA,	   or	  a	  scrambled	  control	  Scr-­‐	  CAGGAACGCATAGACGCATGA	  were	  expressed	  by	  a	  U6	  promoter	  in	  either	  pGFP-­‐C-­‐shLenti	  or	  pRFP-­‐CB-­‐shLenti.	  Cdk5	  (D144N)	  [118].	  Lentiviral	  plasmids	  were	  submitted	   to	   the	   University	   of	   Michigan	   Vector	   Core	   for	   the	   production	   of	   high-­‐titer	  lentiviruses.	   Briefly,	   HEK293T	   cells	  were	   transfected	   by	   Lipofectamine	   (Invitrogen)	  with	  vectors	   encoding	   REV,	   MDL,	   pvSVG	   and	   a	   lentiviral	   plasmid	   containing	   expression	  construct.	   Forty-­‐two	   hours	   post-­‐transduction,	   the	   medium	   containing	   the	   viruses	   was	  collected,	   filtered	  through	  a	  0.45	  mm	  filter	  to	  remove	  cell	  debris,	   then	  ultracentrifuged	  at	  42,152xG	   	   at	   4	   °C	   for	   2	   h.	   The	   supernatant	   was	   discarded	   and	   virus	   pellet	   gently	  resuspended	   in	  10	  mL	  of	  Nb4Activ.	  Aliquots	   containing	  500	  ml	  of	  NB4Activ	  with	  viruses	  were	  quickly	  frozen	  and	  stored	  at	  -­‐80	  °C.	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Primary	  neuronal	  culture	  and	  transfections/infections	  Neuronal	   cultures	  were	  prepared	   from	  postnatal	  day	  1-­‐2	  rat	  hippocampi	  of	  either	  sex	  as	  previously	   reported	   [119].	   	   Briefly,	   the	   hippocampi	   were	   dispersed	   into	   a	   single	   cell	  suspension	  via	  enzymatic	  treatment	  with	  papain	  (Sigma,	  2mg/ml)	  in	  HBSS	  without	  Ca2+	  or	  Mg2+	  (Life	  Technologies)	  with	  L-­‐cysteine	  added	  (1	  mM)	  followed	  by	  mechanical	  trituration.	  Hippocampal	  neurons	  were	  plated	  on	  poly-­‐D-­‐lysine	  coated,	  22mm	  diameter,	  #1.5	  thickness	  coverglass	  (Neuvitro,	  Vancouver,	  WA)	  or	  on	  14	  mm	  microwell	  glass	  bottom	  35	  mm	  culture	  dishes	   (MatTek,	   Ashland,	   MA)	   at	   a	   density	   of	   400	   cells/mm2.	   Neurons	   were	   cultured	   in	  NBActiv4	   (Brain	   Bits,	   Springfield,	   IL).	   Cells	  were	  maintained	   in	   a	   37°C,	   95%	  O2/5%	   CO2	  humidified	   incubator	   and	   half	   the	   media	   was	   exchanged	   every	   3-­‐4	   days	   with	   fresh	  NBActiv4	  media.	  	  	  	  Neuronal	   cultures	   were	   transfected	   at	   10-­‐14	   days	   in	   vitro	   (DIV).	   Transfection	   was	  achieved	   using	   Lipofectamine	   2000	   (Life	   Technologies)	   according	   to	   the	   manufacturers	  recommendations,	   except	   that	   culture	  media	  was	   exchanged	  with	   fresh	  NBActiv4	  media;	  0.8-­‐1μg	   of	   selected	   plasmid	   DNA	   was	   mixed	   with	   1μL	   of	   Lipofectamine	   in	   200μL	   of	  NBActiv4	  media	  per	  dish	  and	  allowed	  to	  stand	  for	  30	  minutes	  prior	  to	  being	  dripped	  onto	  the	   cell	   cultures.	   Cultures	  were	   incubated	   for	  1hr	  with	   the	  Lipofectamine/DNA	  mix	   after	  which	  media	  was	  exchanged	  with	  fresh	  NBActiv4	  media.	  	  For	  lentiviral	  infections	  the	  stock	  virus	   (~1x107MOI/ml)	   stored	   at	   -­‐80	   was	   thawed	   and	   diluted	   1:10	   in	   NBActiv4	   culture	  media	  and	  added	  to	  neuronal	  cultures	  (5-­‐9	  DIV).	  	  12	  hours	  later,	  additional	  NBActiv4	  media	  was	  added	  diluting	  the	  virus	  1:2.	  After	  2	  days	  the	  culture	  media	  was	  exchanged	  with	  fresh	  NBActiv4	  and	  neurons	  were	  used	  for	  experimentation	  between	  7-­‐14	  days	  post-­‐infection.	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vGpH	  imaging	  and	  analysis	  	  vGpH	   imaging	   was	   performed	   on	   individual	   neurons	   3-­‐10	   days	   post-­‐transfection	  and	   14-­‐24	   DIV.	   	   Glass	   coverslips	   containing	   the	   neuronal	   cultures	   were	  mounted	   into	   a	  chamber	  outfitted	  for	  field	  stimulation	  (RC-­‐49MFS,	  Warner	  Instruments)	  and	  perfused	  (0.5	  ml/min)	   for	   rapid	   solution	   exchange	   (chamber	   volume,	   100	   ml)	   with	   temperature	  controlled	  (37oC;	  TC-­‐324B,	  Warner	  Instruments)	  physiological	  saline	  containing	  (in	  mM):	  NaCl	  136,	  KCl	  2.5,	  Hepes	  10,	  Glucose	  10,	  CaCl2	  2,	  MgCl2	  1.3,	  AP5	  0.05	  (TOCRIS,	  Minneapolis,	  MN),	  CNQX	  0.01	  (TOCRIS),	  that	  was	  adjusted	  to	  pH	  7.4.	  	  Action	  potentials	  were	  evoked	  by	  field	  stimulation	  with	  2	  msec	  current	  pulses	  applied	  through	  platinum-­‐iridium	  electrodes	  spatially	  placed	  within	  the	  chamber	  to	  achieve	  10	  V/cm	  fields.	  	  The	  frequency	  and	  period	  of	  stimulus	  application	  was	  controlled	  by	  a	  Winston	  Electronics	  A65	  Timer	  that	  was	  gated	  by	  and	   synchronized	   to	   Metamorph	   image	   acquisition	   software	   (Molecular	   Devices,	  Sunnyvale,	   CA).	   	   Transfected	   neurons	  were	   spatially	   localized	   on	   coverslips	   by	  mCherry	  fluorescence	   of	   vGpH-­‐mCh	   expression	   [9].	   The	   effectiveness	   of	   each	   applied	   stimulus	  within	   a	   train	   to	   evoke	   action	   potentials	   was	   confirmed	   on	   initial	   sets	   of	   Fluo4	   treated	  neuronal	   cultures	   by	   measurement	   of	   time-­‐synchronized	   alterations	   in	   intracellular	  calcium.	   vGpH	   responses	   to	   field-­‐stimulation	   were	   always	   conducted	   in	   the	   presence	   of	  1μM	   Bafilomycin-­‐A1	   (BafA1,	   LC	   Laboratories,	   Woburn,	   MA)	   to	   isolate	   exocytosis	   from	  endocytosis.	   Acquired	   vGpH	   fluorescent	   signals	   preceding	   and	   during	   stimulation	   were	  normalized	  to	  maximal	  vGpH	  fluorescence	  (FMAX).	  	  	  This	  was	  done	  by	  brief	  application	  of	  a	  bath	  solution	  containing	  (in	  mM):	  NH4Cl	  50,	  NaCl	  86,	  KCl	  2.5,	  Hepes	  10,	  Glucose	  10,	  CaCl	  2	  2,	  MgCl2	  1.3,	  adjusted	  to	  set	  	  pH	  at	  7.4	  and	  osmolarity	  	  of	  290-­‐300,	  which	  leads	  to	  alkalization	  of	   the	  total	  vesicle	  pool	   [45].	   	  Fluorescence	   imaging	  was	  carried	  out	  on	  an	  Olympus	  IX81	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microscope	  with	  Plan-­‐Apochromat	  100x	  1.4	  NA	  or	  ApoN	  60X	  1.49	  oil	  immersion	  objectives	  (Olympus	   America,	   Center	   Valley,	   PA).	   	   Illumination	  was	   provided	   by	   a	   Lambda	   LS	   300	  Watt	   Xenon	   arc	   lamp	   (Sutter	   Instruments,	   Novato	   CA)	   coupled	   to	   an	   electronically	  shuttered	   liquid	   light	   guide	   for	   controlled	   transmission	  of	   light	   to	   the	  microscope	  optics.	  	  Images	   were	   acquired	   using	   an	   ImagEM	   EM-­‐CCD	   Hamamatsu	   (	   Hamamatsu	   City,	   Japan)	  camera.	   Optical	   filter-­‐sets	   designed	   for	   mCherry	   and	   eGFP	   respectively:	   Ex,	   472/30;	  416/25	  and	  Em,	  520/35;	  464/23	  we	  used.	  vGpH	  time-­‐series	  images	  were	  acquired	  at	  5	  Hz,	  using	  a	  40ms	  integration	  time,	  not	  binned	  (512x512),	  with	  gain	  settings	  set	  to	  achieve	  the	  full	   dynamic	   16-­‐bit	   depth.	   A	   single	   image	   in	   the	   mCherry	   channel	   was	   acquired	   at	   the	  beginning	   and	   end	   of	   the	   time	   series.	   Microscope,	   camera,	   and	   stimulus	   gating	   were	  controlled	  using	  the	  MetaMorph	  software	  (Molecular	  Devices,	  Sunnyvale	  CA).	  	  Analysis	  of	  spatial	  and	  temporal	  changes	   in	   fluorescence	   intensity	  within	  acquired	  vGpH	  time	  series	  image	  stacks	  was	  carried	  out	  using	  FIJI	  [120],	  an	  open	  source	  distribution	  of	   ImageJ	   (http://imagej.nih.gov/ij/)	   focused	   on	   life	   sciences.	   	   Regions	   of	   interest	   (ROI)	  were	   defined	   as	   puncta	   of	   fluorescent	   intensity	   localized	   along	   neuronal	   processes	   in	  images	  during	  NH4Cl	  treatment.	  Binary	  ROI	  masks	  were	  created	  by	  manual	  thresholding	  of	  a	  ΔFNH4Cl	  image.	  The	  ΔFNH4Cl	  image	  was	  calculated	  as	  	  FNH4Cl	  –	  Fpre,	  where	  FNH4Cl	  is	  defined	  as	  an	  average	  of	  10	  frames	  during	  NH4CL	  application	  and	  Fpre	   is	  defined	  as	  an	  average	  of	  10	  frames	   prior	   to	   application	   of	   any	   electrical	   stimulus	   in	   normal	   physiological	   saline.	   The	  resulting	  ΔFNH4Cl	  image	  was	  then	  subjected	  to	  a	  watershed	  protocol	  to	  create	  distinct	  ROIs	  for	  closely	  adjoining	  puncta.	  The	  resulting	  ROIs	  were	  then	  applied	  to	  each	  image	  within	  the	  time	   series	   and	   the	   average	   fluorescent	   intensity	   within	   each	   ROI	   per	   image	   was	  determined	   using	   a	   custom-­‐built	   plugin	   [121].	   The	   resulting	   time	   series	   of	   averaged	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intensity	   for	   each	   ROI	   was	   imported	   into	   Igor	   Pro	   (Wavemetrics)	   and	   corrected	   for	  photobleach	  decay	  using	  a	  double	  exponential	  fit	  procedure	  [122].	  The	  baseline	  intensity	  of	  each	   ROI	   was	   then	   subtracted	   (Fpre)	   and	   the	   data	   of	   each	   ROI	   normalized	   to	   its	   max	  intensity	   (FNH4Cl).	  Time-­‐series	  data	   for	  ROIs	   in	   each	   cell	  were	  averaged	  per	   time	  point	   to	  identify	   fractional	   TRP	   and	   ResP	   sizes.	   	   	   ROI	   time-­‐series	   data	   were	   also	   grouped	   into	  ensembles	  for	  each	  treatment	  to	  generate	  cumulative	  frequency	  distributions	  of	  fractional	  TRP	  size.	  Data	  were	  plotted	  and	  statistical	  analysis	  performed	  using	  Prism	  6	  (Graphpad,).	  
	  
Immunoprecipitation	  	  Neuronal	   cultures	   (14-­‐26	   DIV)	   on	   glass	   bottom	   dishes	   were	   washed	   twice	   with	  phosphate-­‐buffered	   saline	   (PBS,	   Life	   Technologies).	   	   Cells	   were	   then	   lysed	   using	   a	   cell	  scraper	  and	  70μl	   IP	   lysis	  buffer	  per	   culture	  dish	  at	  4°C.	   	   Lysis	  buffer	   contained	   (in	  mM):	  Tris-­‐HCl	   25,	   NaCl	   50,	   MgCl2	   2,	   CaCl2	   1,	   0.5%	   NP-­‐40	   adjusted	   to	   pH	   7.4.	   	   	   Protease	   and	  phosphatase	  inhibitors	  were	  added	  immediately	  prior	  to	  lysis	  (Cell	  Signaling,	  Danvers	  MA).	  The	  lysates	  were	  pre-­‐cleared	  via	  centrifugation	  at	  2,000xG	  for	  3	  minutes.	  For	  IP,	  magnetic	  Protein	   A	   beads	   (Life	   Technologies	   #10002D)	   prebound	   to	   0.5	   –	   1	   μg	   of	   antibody	   was	  incubated	  with	   cell	   lysate	   and	   rotated	   at	   4°C	   for	   1	   hour.	   Beads	  were	   then	   collected	   and	  rinsed	  3X	  with	   ice	   cold	  PBS	  using	   a	  magnetic	   system	   (Invitrogen).	   IP	   pellet,	   supernatant	  and	   final	   wash	   samples	   were	   fractionated	   by	   SDS-­‐PAGE	   and	   Western	   blotted	   onto	   a	  nitrocellulose	   membrane.	   	   Immunoreactivity	   against	   the	   primary	   IP	   protein	   and	   co-­‐precipitated	  proteins	  was	  assessed	  (1	  hour,	  RT)	  by	  labeling	  the	  bound	  primary	  antibodies	  with	   infrared-­‐tagged	   species-­‐specific	   secondary	   antibodies	   (45	   min,	   RT)	   with	   imaging	  using	  an	  Odyssey	  CLx	  (Li-­‐Cor	  Biosciences).	  Fluorescence	  density	  was	  determined	  on	  ROI	  of	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images	   using	   the	   Gel	   Analyzer	   plugin	   in	   Fiji.	   For	   IP	   experiments	   that	   evaluated	   binding	  efficiency	  of	  Tomo1	  to	  specific	  nucleotide-­‐bound	  states	  of	  Rab3A,	  the	  cells	  were	  lysed	  in	  IP	  lysis	  buffer	  containing	  4.0	  μM	  EDTA	  to	  release	  endogenous	  nucleotide	  binding.	  Pre-­‐cleared	  lysates	  were	  then	  incubated	  at	  37°C	  fro	  10	  minutes	  with	  a	  saturating	  concentration	  of	  non-­‐hydrolysable	   GTP	   (GTP-­‐g-­‐S,	   200mM,	   Sigma-­‐Aldrich)	   or	   GDP	   (GDP-­‐b-­‐S,	   200mM,	   Sigma-­‐Aldrich)	  added	  to	  the	  supernatant,	  and	  MgCl2	  to	  a	  final	  concentration	  of	  20	  mM.	  	  	  
In	  Vitro	  phosphorylation	  of	  Tomo1	  A	  NativePure	  streptavidin-­‐agarose	  affinity	  purification	  procedure	  was	  used	  to	  purify	  biotin	   epitope	   tagged	   m-­‐Tomo1	   protein	   from	   HEK293	   cells	   transfected	   with	   pCDNA	  capTEV-­‐m-­‐Tomo1	   according	   to	   the	   manufacturer’s	   protocol	   (Invitrogen,	   Life	  Technologies).	  	  As	  a	  control,	  HEK293	  cells	  were	  transfected	  with	  the	  empty	  pCDNA	  capTEV	  vector	  and	  subjected	  to	  an	  identical	  purification	  procedure.	  	  In	  brief,	  five	  dishes	  (10	  cm)	  of	  HEK293	   cells	   at	   70%	   confluency	   were	   transfected	   with	   12μg	   of	   DNA/dish	   using	  Lipofectamine	  2000	  (Life	  Technologies).	  	  At	  48	  hours	  post-­‐transfection	  cells	  were	  collected	  in	   NativePure	   lysis	   buffer,	   subjected	   to	   3	   liquid	   nitrogen	   freeze/thaw	   cycles	   and	   then	  centrifuged	  at	  10,000	  x	  g	   for	  10	  min	  at	  4C.	   	   	   Streptavidin	  beads	  were	  added	   to	   the	  post-­‐nuclear	  supernatant	  and	  rotated	  for	  3	  hours	  at	  4	  C.	  Beads	  were	  then	  collected	  (1000xg	  for	  2	  min),	   rinsed	   and	   the	  purified	   tomosyn	  protein	   stored	   in	   lysis	   buffer	  with	  0.1mM	  sodium	  azide.	   SDS-­‐PAGE	   gel	   electrophoresis	   followed	   by	   commassie	   staining	  was	   used	   to	   assess	  protein	  purification.	  For	  in	  vitro	  Cdk5/p25	  phosphorylation	  reactions	  11.5	  μg	  of	  m-­‐Tomo1	  on	  streptavidin	  beads	  was	  rinsed	   in	  phosphorylation	  buffer	  containing	  (in	  mM)	  25	  MOPS	  pH	  7.2,	  12.5	  β-­‐glycerol	  phosphate,	  25	  MgCl2,	  5	  EGTA,	  2	  EDTA,	  0.25	  DTT	  and	  250μg	  of	  active	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Cdk5/p25	  kinase	  (Signal	  Chem,	  Richmond,	  BC,	  Canada).	  Reactions	  were	  initiated	  by	  adding	  50μM	  γ-­‐[32P]ATP	   (Perkin	  Elmer,	  Waltham,	  MA)	  with	   incubation	  at	  30°C	  and	   intermittent	  mixing	   for	   15	  min.	   Reactions	  were	   terminated	   by	   centrifugation	   at	   1,000	   x	   g	   for	   1	  min,	  followed	  by	  3	  washes	  of	  bead	  pellet	   in	   cold	  kinase	  buffer	   (4oC)	   lacking	  Cdk5/p25	  and	  γ-­‐[32P]ATP.	   	   	  Bead	  pellet	   samples	  were	   then	   fractionated	  by	  SDS-­‐PAGE,	  blotted	  and	   the	   32P	  labeled	  tomosyn	  detected	  using	  a	  Molecular	  Imager	  FX	  (BioRad,	  Hercules,	  CA).	  Tomosyn	  on	  the	   nitrocellulose	   membrane	   was	   subsequently	   immunolocalized	   by	   Western	   Blotting.	  Controls	   included	   reactions	   with	   purified	   Tomosyn	   protein	   containing	   1	   mM	   Rosco,	  purified	  Tomosyn	  with	  no	  Cdk5/p25	  kinase	  added,	  and	  streptavidin	  beads	  used	  in	  empty	  vector	  purification.	  	  	  	   	  
Mass	  Spectrometry	  Mass	   spectrometry	   analysis	  of	  Cdk5	  phosphorylated	  Tomo1	  affinity	  purified	  protein	  was	  conducted	  by	  the	  University	  of	  Michigan	  Proteomics	  Resource	  Facility	  (PRF).	  Samples	  were	  submitted	   after	   in	   vitro	   phosphorylation	   reactions	  were	   separated	   on	   a	   poly-­‐acrylamide	  gel,	  and	  proteins	  were	  visualized	  with	  colloidal	  Coomassie	  stain.	  The	  PRF	  conducted	  in-­‐gel	  digestion	   followed	   by	   identification	   of	   phosphorylation	   site	   mapping	   as	   described	  previously	  [123].	  Briefly,	  on	  trypsin	  digestion,	  peptides	  were	  resolved	  on	  a	  nano-­‐capillary	  reverse	   phase	   column	   and	   subjected	   to	   a	   high-­‐resolution,	   linear	   ion-­‐trap	   mass	  spectrometer	   (LTQ	   Orbitrap	   XL;	   Thermo	   Fisher	   Scientific).	   The	   full	   mass	   spectrometry	  (MS)	  scan	  was	  collected	   in	  Orbitrap	   (resolution	  30,000	  at	  400	  m/z),	  and	  data-­‐dependent	  MS/MS	   spectra	   on	   the	   nine	   most	   intense	   ions	   from	   each	   full	   MS	   scan	   were	   acquired.	  Proteins	   and	   peptides	   were	   identified	   by	   searching	   the	   data	   against	   Swissprot	   human	  
132	  	  
protein	   database,	   appended	   with	   decoy	   (reverse)	   sequences,	   using	   X!Tandem/Trans-­‐Proteomic	   Pipeline	   (TPP)	   software	   suite.	   All	   proteins	   identified	   with	   a	   ProteinProphet	  probability	  of	  >0.9	  (fdr	  <	  1%)	  were	  accepted.	  Spectral	  matches	  to	  phosphorylated	  peptides	  were	  manually	  verified.	  	  	  
In	  situ	  Tomosyn	  Phosphorylation	  Neuronal	  cultures	  plated	  on	  14	  mm	  microwell	  glass	  bottom	  dishes	  were	  rinsed	  3X	  in	  warmed	   phosphate	   deficient	   DMEM	  with	   high	   glucose	   (#11971-­‐025,	   Life	   Technologies).	  Cultures	   were	   then	   incubated	   in	   50	   μl	   of	   DMEM	   containing	   500mCi/ml	   of	   32P	  orthophosphate	  for	  4	  hours	  in	  a	  37°C,	  95%	  O2/5%	  CO2	  humidified	  incubator	  to	  achieve	  32P	  labeling	  of	  cytosolic	  ATP.	  	  Treatments	  included	  ±	  rosco	  (100	  μM,	  4.5	  hr)	  with	  	  ±	  picrotoxin	  (50	   μM,	   4	   hr).	   Picrotoxin	   was	   applied	   30	  min	   following	   treatment	   ±	   the	   Cdk5	   inhibitor	  rosco.	  	  Cultures	  were	  then	  rinsed	  3X	  with	  ice	  cold	  Tris-­‐buffered	  saline	  (TBS)	  containing	  (in	  mM;	   Tris-­‐HCl	   50,	   NaCl	   100,	   Na2HPO4	   20	   with	   pH	   adjusted	   to	   8.0)	   and	   lysed	   in	   IP	   lysis	  buffer.	   	   Tomosyn	   was	   immunoprecipitated,	   	   subjected	   to	   SDS-­‐PAGE	   fractionation	   and	  blotted	  onto	  nitrocellulose.	   	   	  To	  detect	  and	  quantify	   32P	   incorporation	   the	  Tomosyn	  blots	  were	  imaged	  using	  a	  Molecular	  Imager	  FX	  (BioRad)	  and	  subsequently	   immunoblotted	  for	  Tomosyn.	  	  	  	  	  
Electrophysiology	  Whole-­‐cell	  patch	  clamp	  recordings	  were	  performed	  with	  a	  HEKA	  10	  amplifier	  and	  Patchmaster	   Software	   (HEKA	  Elektronik,	  Dr.	   Schulze	  GmbH)	   from	  17	   to	  24	  DIV	   cultured	  hippocampal	   pyramidal-­‐like	   neurons.	   	   The	   extracellular	   bath	   solution	   for	   recording	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miniature	  excitatory	  postsynaptic	  currents	  (mEPSCs)	  contained	  (in	  mM):	  NaCl	  119,	  KCl	  5,	  CaCl2	  2,	   MgCl2	  2,	   glucose	   30,	   and	   HEPES,	   10	   that	   was	   adjusted	   to	   pH	   to	   7.4	   with	   NaOH.	  	  Tetrodotoxin	   (TTX,	   1	   μM)	   and	   the	   GABAA	   receptor	   antagonist	   bicuculine	   (10	   μM)	   were	  added	   just	   prior	   to	   use.	   	   The	   extracellular	   solution	   for	   recording	   evoked	   excitatory	  postsynaptic	  currents	  (EPSCs)	  was	  similar,	  with	  the	  exceptions	  that	  CaCl2	  was	  reduced	  to	  0.5	  mM,	  MgCl2	   increased	   to	  3.5	  mM	  and	  TTX	  and	  bicuculine	  were	  omitted.	   	   The	   internal	  pipette	  solution	  contained	  (in	  mM):	   	  Cs-­‐gluconate	  105,	  MgCl2	  5,	  EGTA	  0.2,	  ATP	  2,	  GTP	  0.3,	  and	  HEPES	  40	  adjusted	  to	  pH	  to	  7.2	  with	  CsOH.	  	  Pipette	  resistance	  ranged	  from	  2	  to	  5	  MΩ.	  	  Neurons	  were	  voltage	  clamped	  to	  -­‐70	  mV.	   	   	   	  Evoked	  EPSCs	  were	  produced	  by	  positioning	  25	  mm	  diameter	   bipolar	   stimulating	   electrode	   close	   to	   the	   neuron	   (100	   –	   200	  mm)	   and	  applying	   0.4	   msec	   current	   pulses	   of	   constant	   amplitude	   (WPI	   A360	   Stimulus	   Isolater).	  	  	  Measurement	  of	  amplitude	  and	   frequency	  of	  mEPSC	  and	  amplitudes	  of	  evoked	  EPSC	  was	  performed	   offline	   using	   Patcher’s	   Power	   tools	   (Dr.	   Francisco	   Mendez	   and	   Frank	  Würriehausen,	  Max-­‐Planck-­‐Institute,	  Göttingen,	  Germany)	  and	  Taro	  Tools	  (Taro	  Ishikawa,	  Jikei	  University	  School	  of	  Medicine,	  Tokyo,	  Japan)	  plugins	  for	  Igor	  Pro	  (Wavemetrics,	  Lake	  Oswego,	  OR).	  	  	  
	  
Immunocytochemistry,	  Proximity	  Ligation	  Assay	  and	  Image	  analysis	  	  Immunocytochemistry	   (ICC)	   was	   conducted	   following	   a	   published	   protocol[124].	  Briefly,	  cells	  were	  washed	  2X	  with	  ice-­‐cold	  PBS	  and	  fixed	  with	  4%	  PFA/Sucrose	  in	  PBS	  for	  10	  minutes.	  Fixation	  was	  quenched	  by	  replacing	  4%	  PFA/Sucrose	  with	  0.1M	  glycine	  in	  PBS	  (Sigma-­‐Aldrich).	  Next,	  cells	  were	  permeabilized	  with	  0.25%	  Triton-­‐X100	  (Fisher-­‐Scientific)	  for	  10	  minutes	  followed	  by	  1	  hour	  blocking	  with	  10%	  bovine	  serum	  albumin	  (BSA,	  Sigma-­‐
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Aldrich).	  The	  selected	  primary	  antibodies	  were	  added	  at	  the	  desired	  dilution	  in	  3%	  BSA	  for	  one	  hour	   followed	  by	  washes	   (3%	  BSA	   in	  PBS,	  5X,	  5	  minutes)	  and	  addition	  of	   secondary	  antibodies	  (diluted	  in	  PBS)	  for	  45	  minutes	  followed	  by	  five	  5	  min	  washes	  in	  PBS.	  The	  cells	  treated	   for	   ICC	  were	  maintained	   in	   the	   fluorescence	  antifade	   reagent	  Vectashield	  +	  DAPI	  (Vector	  Laboratories)	  until	  microscopic	  analysis.	  PLA	  reactions	  were	  carried	  out	  identical	  to	   ICC	   procedures	   through	   the	   addition	   of	   primary	   antibodies.	   In	   place	   of	   secondary	  antibodies,	  PLA+	  and	  PLA-­‐	  probes	  (Sigma-­‐Aldrich)	  were	  added	  for	  45	  min	  at	  37°C	  followed	  by	   three	   5min	   washes	   (0.2%	   BSA,	   0.1%	   Triton-­‐X100	   in	   PBS).	   Next,	   ligation	   and	  amplification	  solutions	  (Sigma-­‐Aldrich)	  were	  sequentially	  added	  for	  30	  min	  and	  100	  min,	  respectively,	  with	  two	  washes	  after	  each.	  	  Where	  indicated,	  colocalization	  analysis	  was	  carried	  using	  the	  JACoP	  plugin	  for	  FIJI	  [125].	  The	  Pearson	  R	  correlation	  coefficient	  and	  Mander’s	  overlap	  coefficient	  is	  generated	  for	   pairs	   of	   images	   using	   fluorescent	   intensities	   of	   spatially	   matched	   pixels.	   The	   pixels	  included	   in	   the	   analysis	   are	   determined	   by	   the	   Coste’s	   automatic	   thresholding	   method	  [126].	   For	   PLA	   density	   analysis,	   images	   were	   manually	   segmented	   using	   a	   bright-­‐field	  channel	  to	  create	  an	  ROI	  that	  demarcates	  MIN6	  cell	  boundaries.	  Next,	  the	  particle	  analysis	  plugin	  in	  FIJI	  was	  used	  to	  automatically	  count	  the	  number	  of	  fluorescent	  puncta	  contained	  within	   the	   ROI	   that	   were	   at	   least	   3	   x	   3	   pixels	   in	   size.	   For	   comparisons	   of	   pCdk5	  immunofluorescence	   intensity,	   ROIs	  were	   created	   around	  puncta	   positive	   for	   Synapsin1-­‐Alexa488	   immunolabeling	   from	   images	   that	  were	  background	  subtracted	  with	  a	  50-­‐pixel	  rolling-­‐ball	  radius,	  thresholded	  and	  converted	  into	  binary	  masks.	  ROIs	  were	  then	  applied	  to	  the	   alternate	   channel	   of	   the	   same	   image	   field	   containing	   pCdk5-­‐Alexa594	   to	   extract	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individual	  fluorescence	  intensity	  per	  ROI.	  Straightened	  axon	  images	  were	  generated	  using	  the	  Straighten	  plugin	  for	  FIJI.	  
	  
Statistical	  analyses	  
	   All	   statistical	   analysis	  was	  done	  using	  GraphPad	  Prism.	  Where	   indicated,	   one-­‐way	  analysis	  of	  variance	  (ANOVA)	   tests	  were	  used	   for	  comparisons	  of	  population	  means	  with	  significance	   set	   to	   a	   p	   <	   0.05.	   Post	   hoc	   t-­‐tests	   with	   Dunnett’s	   correction	   were	   used	   for	  multiple	  comparisons	  between	  specific	  groups.	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Figure	   3.1:	   Tomo1	   localizes	   to	   presynaptic	   boutons	   and	   inhibits	   evoked	  
neurotransmitter	   release	   in	   cultured	   hippocampal	   neurons.	   (A)	   Cytofluorogram	  comparing	  spatially	  matched	  Tomo1	  and	  Syp	  fluorescence	  (Pearson	  R=	  0.73,	  Mander’s	  M1=	  0.8,	   M2=	   0.85	   n=29	   (A1)	   and	   representative	   immunofluorescence	   image	   of	   straightened	  axon	  segment	  demonstrates	  colocalization	  between	  endogenous	  Tomo1	  (Tomo1,	  cyan)	  and	  presynaptic	   vesicular	   protein	   Synaptophysin	   (Syp,	   magenta)	   (A2).	   Intensity	   line-­‐scan	  analysis	  (A2,	  lower)	  of	  axon	  segment	  shows	  coincident	  immunofluorescent	  spikes	  between	  Tomo1	  and	  Synaptophysin.).	   (B)	  Western	  blot	  comparing	  Tomo1	  immunoreactivity	  (anti-­‐Tomo1)	   from	   lysates	   of	   lentivirus	   infected	   hippocampal	   neurons	   expressing	   GFP,	   YFP-­‐Tomo1	   (YFP-­‐Tomo1),	   shRNA-­‐Scramble	   (sh-­‐Scr)	   or	   shRNA-­‐Tomo1	   (sh-­‐Tomo1,	   upper).	  Lower,	   Tomo1	   expression	   quantified	   using	   immunoreactive	   band	   density,	   normalized	   to	  loading	   control	   (actin)	   and	   graphed	   relative	   to	   control	   GFP-­‐expressing	   cells	   (n=6).	   (C-­‐E)	  Effects	   of	   Tomo1	   expression	   and	   shRNA-­‐mediated	   knock-­‐down	   relative	   to	   sh-­‐Scramble	  control	  on	  Paired-­‐Pulse	  Ratio	  (PPR).	  (C)	  Representative	  EPSC	  responses	  with	  responses	  to	  the	   50	   ms	   and	   850	   ms	   inter-­‐stimulus	   interval	   (ISI)	   highlighted	   in	   alternate	   color	  (corresponding	  averaged	  PPR	  plotted	   in	  (D)).	   (E)	  Averaged	  PPR	   for	  all	   ISI	  values.	  Tomo1	  expression	  (n=11)	  led	  to	  significantly	  greater	  facilitation	  of	  PPR	  for	  the	  50,	  150,	  250	  ms	  ISI	  compared	  to	  shRNA-­‐Scamble	  control	  (n=8),	  while	  shRNA-­‐Tomo1	  resulted	  in	  depression	  of	  PPR	  (n=5)	  at	  the	  50ms	  ISI.	  (F)	  Representative	  mEPSC	  records	  (upper),	  and	  quantification	  (lower)	   show	   that	   the	   shRNA-­‐mediated	   knock-­‐down	   (n=15)	   or	   Tomo1	   overexpression	  (n=15)	   does	   not	   significantly	   alter	   the	   frequency	   or	   amplitude	   of	   spontaneous	   mEPSC	  relative	   to	  control	   (n=11).	  For	   this	  and	  all	   subsequent	   figures,	  graphs	  show	  mean	  ±	  SEM,	  asterisks	  denote	  statistical	  significance	  compared	  to	  experimental	  control	  (p	  <	  0.05).	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Fig.	   3.2:	   Effects	   of	   Tomo1	   expression	   on	   distribution	   of	   SVs	   among	   functionally	  
defined	  presynaptic	  SV	  pools.	  (A)	  Comparison	  of	  Tomo1	  overexpression	  (magenta,	  n=15)	  and	   sh-­‐Tomo1	  knockdown	   (sh-­‐blue,	   n=9)	   to	   control	   (empty	   vector,	   black,	   n=10)	   on	  RRP	  size	   defined	   as	   mean	   vGpH	   responses	   following	   40	   electrical	   pulses	   delivered	   at	   20Hz.	  	  	  Each	   vGpH	   measurement	   is	   normalized	   to	   vGpH	   maximum	   fluorescence	   to	   NH4CL	  application	  (total	  vesicle	  pool,	  TP).	  (B)	  Representative	  measurements	  of	  normalized	  vGpH	  response	  (Dft	  /	  TP)	  in	  single	  neurons	  to	  a	  20Hz	  pool-­‐depleting	  stimulus	  of	  900	  pulses.	  Total	  releasable	   pool	   (TRP)	   is	   defined	   as	  Df900/TP.	   (C)	   Comparison	   of	  mean	  TRP	   among	   given	  treatments	   (n=	   cell	   number,	   number	   of	   boutons	   given	   in	   D).	   (D)	   Cumulative	   frequency	  distributions	  comparing	  shift	  in	  TRP	  for	  bouton	  ensembles	  of	  each	  condition	  (n	  =	  boutons;	  dashed	  gray	   line	   indicates	  distribution	  median).	   (E)	  Comparison	  of	  representative	  Dft/TP	  (20Hz/900	  stimuli)	   in	  neuron	  overexpressing	  Tomo1	   lacking	   the	  SNARE	  domain	  (Tomo1	  DCT	  )	  with	  control	  neuron	  (empty	  vector).	  (F)	  Averaged	  TRP	  for	  control	  (black)	  and	  Tomo1	  DCT	  conditions.	  Note,	  that	  expression	  of	  Tomo1-­‐wt	  (lower	  dashed	  gray	  line,	  data	  from	  C)	  and	  Tomo1	  DCT	  result	  in	  comparable	  decrease	  in	  TRP.	  	  (G)	  IP	  of	  overexpressed	  Tomo1	  WT	  or	  Tomo1	  D-­‐CT	   in	  PC-­‐12	   cells	   shows	   co-­‐precipitation	  of	   Syntaxin1A	  and	   SNAP25	  SNARE	  proteins	  only	  with	  Tomo1	  WT.	  These	  data	  indicate	  necessity	  of	  Tomosyn’s	  SNARE	  domain	  for	  Q-­‐SNARE	  complex	  formation.	   	  For	  this	  figure	  and	  all	  subsequent	  Western	  blot	  images,	  lanes:	  supernatant	  (S),	  last	  wash	  (W),	  IP	  pellet	  (P).	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Figure	   3.3:	   Tomo1	   serves	   as	   Cdk5	   interacting	   partner	   and	   catalytic	   substrate	  with	  
Cdk5	   activation	   sensitive	   to	   neural	   activity.	   	   	   (A)	   Representative	   immunofluorescent	  images	  of	   straightened	  axon	  segments	   from	  neuronal	   cultures	   (A1)	   treated	  with	  CSA	   (50	  mM),	   rosco	   (100	  mM)	  or	  vehicle-­‐control	   (DMSO,	  0.5%)	   for	  30	  minutes	  and	  subsequently	  subjected	   to	   immunocytochemical	   analysis	   of	   endogenous	   Synapsin1	   (cyan,	   upper,	   for	  bouton	   localization)	   and	   phosphorylated	   Cdk5	   (pCdk5,	   lower,	   heat	   scale).	   (A2)	  Quantification	   of	   mean	   pCdk5	   immunofluorescence	   intensity	   relative	   to	   vehicle-­‐control,	  and	  (A3)	  cumulative	   frequency	  of	  pCdk5	  intensity	  across	  boutons	  show	  that	   inhibition	  of	  Cdk5	   by	   rosco	   significantly	   reduces	   pCdk5	   immunoreactivity,	   while	   treatment	   with	   CSA	  enhances	   pCdk5	   relative	   to	   control.	   	   (B1-­‐B3)	   pCdk5	   immunofluorescence	   images	  comparing	   chronic	   silencing	   of	   neural	   activity	   by	   TTX	   (24	   hrs,	   1mM)	   and	   control.	   (B2)	  Averaged	  pCdk5	  intensity	  and	  (B3)	  cumulative	  frequency	  of	  pCdk5	  intensity	  demonstrate	  that	  chronic	  dampening	  of	  neural	  activity	  significantly	  reduces	  Cdk5	  activation.	  In	  (A)	  and	  (B)	  immunocytochemical	  analysis	  was	  performed	  on	  45	  images	  per	  neuron	  preparation	  for	  each	  condition,	  and	  was	  repeated	  in	  3	  neuronal	  preparations.	  (C)	  Immunoblots	  showing	  co-­‐precipitation	  of	  Tomo1	  and	  Cdk5	  from	  cultured	  hippocampal	  neuron	  lysates	  regardless	  of	  primary	  target	  of	  IP	  (Tomo1	  or	  Cdk5)	  reaction.	  In-­‐vitro	  phosphorylation	  of	  affinity	  purified	  Tomo1	   by	   Cdk5/p25	   as	   measured	   by	   32P-­‐labeling.	   Upper,	   32P-­‐radioactive	   signal	   on	   blot	  corresponding	  to	  conditions	  indicated.	  	  Lower,	  anti-­‐Tomo1	  immunoreactivity	  for	  identical	  portion	  of	   blot.	   Conditions	   include:	   absence	  of	   Cdk5/p25	  kinase	   (H2O),	   Cdk5/p25	  kinase	  (Cdk5)	  and	  Cdk5/p25	  +	  rosco	  (Cdk5	  +	  rosco;	  1	  mM).	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Figure	  3.4:	  Tomosyn	  and	  Cdk5	  share	  common	  signaling	  pathway	  regulating	  the	  TRP.	  (A)	   Comparison	   of	   representative	   vGpH	   responses	   (Dft/TP)	   averaged	   from	   boutons	   of	  single	  control	  (black),	  sh-­‐Tomo1	  expressing	  (blue)	  or	  dominant-­‐negative	  Cdk5	  expressing	  (Cdk5	   (DN),	   magenta)	   neurons	   during	   stimulation	   (20	   Hz,	   900	   stimuli)	   in	   the	   presence	  (left)	   and	   absence	   (right)	   of	   rosco	   (100	  mM,	   30	  min	   pretreatment).	   	   (B)	   Comparison	   of	  mean	  TRP	  among	  expression	  conditions	  ±	  rosco.	  	  Lower	  dashed	  line	  illustrates	  mean	  TRP	  to	  Tomo1	  overexpression	  (Fig	  2C).	  (C)	  Cumulative	  frequency	  distributions	  comparing	  TRP	  for	  bouton	  ensembles	  of	  each	  condition.	  Dashed	  distributions	  represent	  treatments	  (color	  matched)	  with	  rosco.	   	  Notably,	   sh-­‐Tomo1	  and	  Cdk5	  DN	  expression	  resulted	   in	  significant	  enhancement	  in	  the	  TRP	  compared	  to	  control,	  which	  was	  not	  further	  increased	  with	  rosco	  treatment.	  	  B,	  n=	  #	  cells;	  C,	  n=	  #	  boutons.	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Figure	   3.5:	   Tomo1	   interacts	   with	   Rab3A-­‐GTP.	   (A)	   Western	   blot	   showing	   that	   IP	   of	  Tomo1	   from	   non-­‐transfected	   as	   well	   as	   YFP-­‐Tomo1	   transfected	   cultured	   hippocampal	  neuronal	   lysates	   results	   in	   co-­‐precipitation	   of	   Rab3A,	   but	   not	   Rim1/2,	   actin	   or	  synaptophysin	   (Syp).	   (B)	   Western	   blot	   comparing	   Tomo1	   co-­‐precipitation	   of	   Rab3A	   for	  neuronal	  lysates	  initially	  treated	  to	  drive	  GTPases	  into	  a	  GTP-­‐loaded	  (GTP	  ϒ-­‐S),	  GDP-­‐loaded	  (GDP	  β-­‐S),	  or	  nucleotide-­‐free	  state	  (n=	  3	  experiment	  from	  separate	  neuronal	  preparations).	  (C)	   Averaged	   Rab3A	   co-­‐precipitation	   normalized	   to	   the	   level	   of	   Tomo1	   IP	   for	   indicated	  nucleotide-­‐loaded	  conditions.	  (D)	  Representative	   images	  of	  cultured	  MIN6	  cells	  subjected	  to	  PLA	  to	  assess	  in-­‐cell	  interaction	  of	  Tomo1	  and	  Rab3A	  compared	  to	  putative	  interacting	  protein	   partners.	   	   Interactions	   tested	   by	   PLA	   as	   indicated.	   	   Upper	   row,	   DAPI	   staining	  overlaid	  on	  DIC	  brightfield	  to	  define	  cell	  cluster	  and	  plasma	  membrane	  periphery.	   	  Lower	  row,	   PLA	   fluorescent	   puncta	   for	   each	   interaction	   set.	   	   	   Insets,	   enlarged	   spatial	   region	   of	  cytosol.	  	  (E)	  Comparisons	  of	  mean	  PLA	  signal	  density	  for	  indicated	  protein	  interaction	  sets	  (n=	   number	   of	   cell	   clusters).	   (F)	   PLA	   signal	   for	   Tomo1	  +	  Rab3A	   interaction	   in	  Min6	   cell	  shown	  at	  high	  magnification	  demonstrate	  clusters	  of	  fluorescent	  puncta	  likely	  localized	  to	  dense	  core	  secretory	  granules.	  	  	  (G)	  Images	  of	  PLA	  fluorescent	  puncta	  resulting	  from	  assay	  of	  indicated	  protein	  interactions	  on	  hippocampal	  neurons.	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Figure	  3.6:	  Tomo1	   interaction	  with	  Rab3A	  and	  Synapsin1	   is	  regulated	  by	  Cdk5.	   (A)	  Western	  blot	  showing	  that	  IP	  of	  Tomo1	  from	  hippocampal	  neuronal	   lysates	  results	   in	  co-­‐precipitation	  of	  Synapsin1	  (a	  and	  b	  isoforms).	  (B)	  IP	  with	  isotype-­‐control	  Rabbit	  IGG	  does	  not	  pull-­‐down	  Tomo1,	  Rab3A	  or	  Synapsin1	  verifying	   the	   specificity	   co-­‐precipitation	  with	  anti-­‐Tomo1	  antibody.	  (C)	  Neuronal	   lysate	  pre-­‐cleared	  by	  anti-­‐Rab3A	  IP	  and	  subsequently	  with	  anti-­‐Tomo1	  IP	  eliminates	  co-­‐precipitation	  of	  Synapsin1,	  indicating	  Tomo1	  interaction	  with	  Synapsin1	   is	   via	  Rab3A.	   (D)	  Western	  blot	   comparing	   the	  effect	  of	  CSA	   (50	  µM)	  and	  rosco	   (100	   µM)	   pretreatment	   (30	   m)	   to	   vehicle	   control	   on	   Tomo1	   co-­‐precipitation	   of	  Rab3A	   and	   Synapsin1	   from	   neuronal	   lysates.	   (E)	   Averaged	   Rab3A	   and	   Synapsin1	   co-­‐precipitation	  normalized	  to	  Tomo1	  IP	  for	  each	  condition.	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Figure	   3.7:	   Activity	   dependent	   phosphorylation	   of	   Tomo1	   and	   its	   role	   in	   synaptic	  
scaling.	  (A)	  In	  situ	  phosphorylation	  assay	  of	  Tomo1	  in	  hippocampal	  neurons	  as	  measured	  by	  endogenous	  32P-­‐labeling	  (upper)	  of	  Tomo1	  by	  IP	  shown	  in	  western	  blot	  for	  ±	  rosco	  (100	  
µM,	  4.5	  hrs)	  and	  ±	  picrotoxin	  (PTX,	  50	  µM)	  with	  4mM	  Ca2+	  (4	  hours).	  (B)	  Graph	  showing	  relative	   levels	   of	   Tomo1	   in	   situ	  phosphorylation	   quantified	   as	   the	   32P-­‐band	   density	   from	  region	  corresponding	  to	  Tomo1	  for	  each	  condition	  on	   immunoblot	  and	  shown	  relative	   to	  vehicle-­‐treated	   control	   (0.5%	   DMSO,	   n	   =	   3	   experiments	   from	   separate	   neuronal	  preparations).	   (C)	   Sh-­‐Tomo1	   and	   control	   (empty	   vector)	   vGpH	   responses	   (Dft/TP)	  averaged	  from	  boutons	   in	  response	  to	  a	  10	  Hz	  /	  100	  pulses	  stimulus	  used	  for	  comparing	  changes	  in	  presynaptic	  release	  in	  response	  to	  chronic	  silencing	  of	  neuronal	  activity	  (CNQX,	  40	  mM,	  24	  hours)	  to	  vehicle-­‐treated	  controls	  (equal	  volume	  H2O).	  (D)	  Plot	  shown	  mean	  Df	  –	   f0	   	   for	  all	  boutons	  of	  specified	  condition	  (n	  numbers:	  con	  =	  121,	  con	  +	  CNQX	  =	  134,	  sh-­‐Tomo1	  =	  750,	  sh-­‐Tomo1	  +	  CNQX	  =	  409).	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Discussion:	  Rab	  GTPases	  and	  SNARE	  proteins:	  The	  dynamic	  duo	  orchestrating	  
vesicles	  to	  tune	  Ca2+-­‐mediated	  exocytosis	  	   Initial	   studies	   of	   membrane	   fusion	   proposed	   that	   the	   pairing	   of	   cognate	   SNAREs	  provided	   the	   targeting	   specificity	   of	   membrane	   trafficking	   [1,2].	   Indeed,	   the	   in	   vitro	  formation	  of	   SNARE-­‐complexes	  by	   reconstitution	  of	   cognate	   SNAREs	   localized	   to	  distinct	  membrane	   compartments	   show	   that	   they	   can	  provide	   the	   specificity	   required	   for	   fusion,	  but	   that	   it	   is	   not	   sufficient	   to	   match	   the	   Ca2+-­‐mediated	   fusion	   rates	   seen	   in	   cells	   [3].	   It	  appears	   that	   correct	   targeting	   and	   priming	   critically	   depends	   on	   other	   factors,	   including	  Rab	  proteins	  and	  their	  effectors	  [3,4].	  Yet,	  the	  functional	  relationship	  between	  Rab	  GTPases	  and	   SNAREs	   has	   yet	   to	   be	   determined.	   Rab	   GTPases	   are	   critical	   in	   the	   recruitment	   of	  tethering,	  docking	  and	  priming	  factors	  in	  a	  manner	  that	  is	  governed	  by	  their	  GTPase	  cycle	  [5].	  While,	  SNAREs	  located	  on	  distinct	  membranes	  can	  form	  stable	  complexes	  that	  enable	  overcoming	  the	  free	  energy	  barrier	  necessary	  to	  fuse	  a	  vesicle.	  The	  outstanding	  questions	  are,	  how	  do	  these	  two	  cycles	  coalesce?	  And	  importantly,	  how	  do	  they	  coordinate	  such	  that	  they	  coalesce	  in	  a	  spatially	  and	  temporally	  restricted	  manner?	  	  The	  studies	  presented	  in	  this	  dissertation	  begin	  to	  address	  such	  questions.	  First	  we	  establish	   unique	   functional	   activities	   of	   Rab3	   and	   Rab27	   proteins	   on	   late	   stages	   of	   the	  exocytotic	  pathway	  (Chapter	  2).	  Specifically,	  we	  find	  that	  Rab27A	  is	  critical	  in	  establishing	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the	  size	  of	  the	  IRP	  and	  RRP	  (Figure	  2.6),	  while	  Rab3A	  exerts	  a	  key	  and	  prominent	  role	  in	  rapidly	  refilling	  the	  RRP	  and	  modulatory	  role	  in	  building	  the	  size	  of	  the	  RRP	  (Figure	  2.7).	  This	   finding	   is	   significant	   in	   that	   it	   enables	   the	   possibility	   that	   distinct	   Rab	   GTPases	  together	  with	  their	  effectors	  may	  cooperate	  to	  confer	  specificity	  to	  distinct	  modes	  of	  fusion.	  This	  specificity	  may	  be	  conferred	  through	  several	  possibilities	   including:	  (1)	  Via	  different	  effector	   interactions,	   although	   it	   is	   known	   that	   Rab3	   and	  Rab27	   share	  many	   effectors,	   it	  appears	   that	   they	  may	   have	   significantly	   different	   binding	   affinities	   [6-­‐8].	   (2)	   Specificity	  could	   be	   attained	   by	   distinct	   spatial	   localization	   as	   one	   study	   has	   found	   that	   Rab3	   and	  Rab27	  co-­‐reside	  in	  only	  one	  portion	  of	  vesicles	  but	  are	  also	  present	  alone	  in	  distinct	  pools	  [9].	  This	   study	  remains	   to	  be	  confirmed,	  but	   in	  addition,	   future	   studies	   should	  address	   if	  vesicles	  containing	  Rab3	  alone,	  Rab27	  alone	  or	  Rab3	  and	  Rab27	  differ	  in	  recruitment	  and	  priming	  kinetics.	  (3)	  Another	  alternative	  is	  that	  specificity	  of	  their	  actions	  is	  related	  to	  the	  dynamics	  of	  their	  GTPase	  activity.	  For	  example,	  Rab3	  has	  been	  found	  to	  disassociate	  from	  vesicles	  rapidly	  upon	  stimulation	  and	  thus	  may	  be	  free	  to	  participate	  in	  rapid	  recruitment	  and	  refilling	  of	  vesicle	  pools	  [9-­‐12].	  Comparatively,	  Rab27	  is	  not	  as	  readily	  available	  to	  re-­‐enter	   the	   priming	   cycle	   as	   it	   remains	   with	   vesicle	   membranes	   longer,	   likely	   until	   the	  initiation	  of	  endocytosis	  [13-­‐16].	  	  Our	   second	   set	   of	   studies	   (Chapter	   3),	   provide	   evidence	   that	   a	   cytosolic	  R-­‐SNARE	  protein,	  Tomo1	  regulates	  the	  partitioning	  of	  synaptic	  vesicle	  pools	  in	  hippocampal	  neurons	  (Figure	  3.2).	  These	   findings	  are	  novel	   in	   that	   they	   indicate	   that	  a	  SNARE	  protein	  acts	  not	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only	   in	   the	   late-­‐stages	   of	   exocytosis	   but	   also	   upstream	   in	   regulating	   the	   fraction	   of	   SVs	  available	   to	   re-­‐populate	   RRP	   vacancies.	   Critically,	   our	   results	   indicate	   that	   Tomo1	   also	  inhibits	  the	  fraction	  of	  releasable	  vesicles	  via	  a	  mechanism	  independent	  of	  its	  SNARE	  motif	  (Figure	  3.2).	  Thus,	  unlike	  most	  SNAREs,	  Tomo1	  is	  a	  multifunctional	  protein	  able	  to	  regulate	  distinct	   steps	   of	   the	   vesicle	   cycle	   through	  multiple	   protein	  domains.	   In	   addition,	  we	   find	  that	  Tomo1	  binds	  to	  Rab3A	  proteins	  and	  forms	  a	  complex	  with	  SynapsinI	  (Figure	  3.5,	  3.6).	  This	   interaction	   is	   particularly	   notable	   because	   it	   represents	   a	  mechanism	   by	  which	   the	  SNARE	  and	  Rab	  cycle	  may	  coordinate	   the	   release	  process.	  However	   significant	  questions	  remain	   to	   be	   defined,	   for	   example,	   does	   Tomo1	   regulate	   Rab3?	   Or	   does	   Rab3	   regulate	  Tomo1?	  And	  does	  this	  regulation	  occur	  at	  the	  plasma	  membrane	  where	  other	  SNAREs	  are	  localized	  or	  does	  it	  occur	  upstream	  during	  docking?	  Functional	  studies	  conducted	  in	  yeast	  seem	   to	   indicate	   that	  Sro7,	   a	  Tomosyn	  homolog,	   coordinates	   the	   transition	   from	  docking	  (mediated	   by	   Rabs)	   to	   priming	   (mediated	   by	   SNAREs)	   [17,18].	   These	   studies	   show	   that	  overexpression	  of	  Sro7p	  leads	  to	  an	  accumulation	  and	  clustering	  of	  non-­‐releasable	  vesicles	  that	  eventually	   leads	   to	  cell-­‐lethality	   [17].	  This	  clustering	  phenotype	   is	  dependent	  on	   the	  actions	   of	   the	   Rab	   Sec4-­‐GTP	   [17];	   however	   the	   severity	   of	   vesicle	   clustering	   can	   be	  ameliorated	   by	   the	   interaction	   of	   the	   N-­‐terminal	   of	   Sro7p	   with	   the	   Qbc-­‐motif	   of	   the	   Q-­‐SNARE	  Sec9p	  [18].	  Thus,	  from	  the	  studies	  in	  yeast	  one	  may	  conclude	  that	  Sro7p	  bridges	  the	  targeting/docking	  process	  with	  priming	  and	  as	  such	  may	  act	  as	  a	  regulatory	  gate	  switching	  between	  priming-­‐permissive	  and	  intolerant	  states.	  Analogous	  to	  these	  findings	  are	  results	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from	  our	  studies	  showing	   that:	   (1)	  Tomo1	   leads	   to	  an	   increase	   in	   the	   fraction	  of	  vesicles	  that	  are	  release	  recalcitrant;	  (2)	  that	  it	  interacts	  with	  Rab3-­‐GTP;	  and	  from	  previous	  studies,	  (3)	   that	   it	   is	   able	   to	   switch	   off	   its	   inhibitory	   mode	   based	   on	   the	   conformation	   of	   its	  interaction	  with	  the	  Q-­‐SNARE	  Syntaxin	  [19,20].	  Thus,	  in	  keeping	  with	  the	  Sro7	  yeast	  model,	  it	  is	  possible	  that	  Tomo1	  may	  function	  as	  a	  regulatory	  gate	  that	  determines	  the	  fraction	  of	  vesicles	   amenable	   for	   recruitment	   and	   further	  priming.	   For	   this	   to	  be	   established,	   future	  investigations	  must	  determine	  functional	  reliance	  of	  Tomo1	  on	  the	  actions	  of	  Rab3-­‐GTP	  in	  controlling	   the	   transition	   of	   vesicles	   from	   ResP	   to	   TRP	   and	   characterize	   the	   spatial	   and	  temporal	  characteristics	  of	  this	  interaction	  as	  they	  relate	  to	  fusion	  events.	  	  It	   is	   believed	   that	   the	   release	   of	   chemical	   messengers	   at	   a	   synapse	   is	   one	   of	   the	  primary	  mechanisms	  for	  information	  transfer	  that	  gives	  way	  to	  complex	  forms	  of	  learning	  and	  behavior	  [21].	  One	  rationale	  for	  this,	   is	  that	  the	  great	  computational	  power	  of	  neural	  circuits	   may	   arise,	   in	   part,	   as	   a	   consequence	   of	   evoked	   SV	   release	   being	   stochastic	   and	  susceptible	  to	  change,	  which	  allows	  presynaptic	  boutons	  to	  act	  as	   filters	  and	  dynamically	  modify	  AP	  activity	  [22,23].	  Thus,	  a	  great	  amount	  of	  focus	  has	  been	  placed	  on	  studying	  the	  molecular	   mechanisms	   that	   may	   impart	   such	   variability.	   Moreover,	   many	   studies	   have	  shown	  that	  Pr	  can	  be	  locally	  set	  and	  regulated	  at	  the	  level	  of	  single	  connections.	  Therefore,	  in	   addition,	   a	   lot	   of	   emphasis	   is	   placed	  on	  determining	   the	   local	   signaling	  pathways	   that	  give	  rise	  to	  feedback	  control	  between	  two	  connected	  neurons.	  One	  emerging	  target	  of	  local	  regulation	   is	   control	   over	   the	   partitioning	   of	   SVs	   among	   functional	   pools.	   For	   example,	  
165	  	  
several	  studies	  have	  shown	  that	  the	  probability	  of	  vesicle	  release	  is	  positively	  correlated	  to	  the	   size	  of	   the	  TRP,	   especially	  during	  high-­‐frequency	  AP	   firing	   (e.g.	   10-­‐20	  Hz)[24-­‐27].	   In	  addition,	   a	   few	   studies	   have	   found	   that	   there	   may	   be	   strong	   feedback	   control	   of	   SV	  partitioning	  by	  retrograde	  signaling	  [26,28].	  For	  example,	  one	  study	  discovered	  that	  post-­‐synaptic	  NMDA-­‐receptor	  activation	  led	  to	  a	  presynaptic	  enhancement	  in	  neurotransmitter	  release	   caused	   by	   increasing	   the	   size	   of	   the	   TRP,	   but	   that	   this	   effect	   was	   blocked	   by	  inhibition	  of	  nitric-­‐oxide	  synthase	  from	  the	  cell	  media	  [26].	  Suggesting	  that,	  post-­‐synaptic	  changes	  were	  met	  with	  concomitant	  presynaptic	  enhancements	  and	  that	  they	  may	  depend	  on	  the	  release	  or	  presence	  of	  a	  retrograde	  signal.	  In	  these	  studies,	  we	  show	  that	  Tomo1	  is	  a	  strong	  modulator	   of	   the	   TRP/ResP	   partition	   and	   that	   its	   actions	   are	   likely	   controlled	   by	  Cdk5	  phosphorylation	  (Figure	  3.3,	  3.4).	  In	  addition,	  we	  find	  that	  the	  phosphorylation	  state	  of	  Tomo1	   is	  modified	  by	  neuronal	  activity	  and	  critically	   that	   long-­‐term	  silencing	  of	  post-­‐synaptic	   activity	   leads	   to	   compensatory	  enhancement	   in	  neurotransmitter	   release,	  which	  we	   find	  depends	  on	  Tomo1’s	   function	   (Figure	  3.7).	  This	   is	   fully	   consistent	  with	  previous	  reports	   showing	   that	   strong	   elevations	   or	   decreases	   in	   network	   activity	   lead	   to	  compensatory	  changes	  in	  the	  ResP	  size	  [29-­‐31].	  In	  addition,	  the	  protein	  levels	  of	  Tomosyn	  have	  been	  found	  to	  be	  reduced	  by	  neuronal	  silencing	  [29];	  and	  in	  response	  to	  the	  activation	  of	   a	   Neurexin-­‐Neuroligin	   retrograde	   signal	   in	   C.	   elegans	   [28].	   Taken	   together,	   there	   is	  increasing	  evidence	  to	  suggest	  that:	  (1)	  Tomosyn	  proteins	  levels	  or	  its	  activation	  state	  may	  be	   regulated	  by	  neuronal	  activity;	   (2)	  Tomosyn	  proteins,	  may	  be	  a	  key	   target	  of	  activity-­‐
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dependent	   retrograde	   signaling;	   (3)	   activity	   dependent	   changes	   of	   presynaptic	  neurotransmitter	   release	   may	   partly	   rely	   on	   Tomosyn	   regulation	   of	   the	   fraction	   of	  releasable	  vesicles	  at	  nerve	  terminals.	  	  	  
The	  potential	  for	  a	  molecular	  clamp	  regulating	  vesicle	  recruitment	  into	  releasable	  pools	  	   Tomosyn	   proteins	   are	   often	   characterized	   as	   inhibitors	   of	   secretion.	   Indeed,	   as	  shown	   in	   the	   studies	   presented	   here	   and	   in	   many	   before,	   high	   levels	   of	   Tomosyn	  expression	   leads	   to	   reduced	   secretion	   or	   reduced	   membrane	   fusion.	   This	   has	   been	  observed	  with	  in	  vitro	  systems	  [32-­‐34];	  in	  studies	  with	  yeast	  homologs	  of	  Tomosyn	  [18,35];	  and	   in	  Tomo1	  overexpression	   in	  neuronal	   cells	   [36-­‐40]	   and	   endocrine	   cells	   [41-­‐44].	   Yet,	  there	   are	   a	   few	   enigmatic	   findings	   related	   to	   Tomosyn	   function,	   which	   suggest	   that	  Tomosyn	   promotes	   vesicle	   secretion.	   For	   example,	   knock-­‐down	   of	   Tomosyn	   protein	  resulted	   in	   decreased	   neurotransmitter	   release	   at	   superior	   cervical	   ganglion	   neurons	   in	  culture	   [45],	   in	   reduced	   secretion	   from	   the	   rat	   β-­‐cell	   line	   INS-­‐1E	   [46],	   and	   in	   reduced	  numbers	  of	  SNARE	  complexes	  analyzed	  from	  Tomosyn	  deficient	  mice	  brain	  lysates[40].	  In	  human	  endothelial	  cells,	  Tomosyn1	  knock-­‐out	  paradoxically	  led	  to	  increased	  exocytosis	  of	  vWF	   and	   P-­‐selectin	   (suggesting	   inhibitory	   role),	   but	   knock-­‐out	   also	   inhibited	   platelet	  secretion	  (suggesting	  a	  positive	  role!)	   [47].	  Perhaps,	  one	  way	  to	  reconcile	   these	  apparent	  discrepancies	   is	   to	   view	   Tomosyn	   proteins	   specifically	   as	   priming	   clamps	   rather	   than	  general	   inhibitors,	   a	   subtle,	   but	   potentially	   important	   distinction.	   As	   defined	   here,	   a	  
167	  	  
molecular	  clamp,	  stalls	  or	  blocks	  priming	  at	  a	  specific	  stage	  without	  hindering	  or	  derailing	  progression	  upon	  clamp-­‐relief,	  whereas	  an	  inhibitor	  may	  derail	  progression.	  The	  purpose	  of	  a	   clamp	   then	   is	   to	  pause	  and	  regulate.	   In	  example,	  Syt1	  or	  complexin	  act	  as	   clamps	   to	  prevent	   rampant	   spontaneous	   fusion	   but	   rather	   direct	   synchronous	   release	   upon	   Ca2+	  influx.	  Perhaps,	  Tomosyn	  acts	  in	  the	  same	  way	  to	  limit	  priming	  until	  its	  clamp	  is	  relieved	  by	  yet	   to	   be	   identified	   signals.	   This	   speculation	   is	   not	   without	   warrant,	   as	   there	   is	   some	  evidence	   to	   suggest	   that	   a	   possible	   clamping	  mechanism	   exists	   for	   Tomosyn.	   These	   are,	  studies	  on	  the	  Tomosyn	  tail	  domain	  which	  show	  that	  it	  can	  switch	  its	  interaction	  between	  a	  region	   in	   the	  N-­‐terminal	  WD40	   repeats	   and	   the	  C-­‐terminal	  R-­‐SNARE	  domain	   [19].	  When	  bound	  to	  the	  N-­‐terminal	  WD40	  repeats	  the	  tail	  domain	  leaves	  the	  C-­‐teminal	  R-­‐SNARE	  motif	  of	  Tomosyn	  unencumbered	  to	  inhibit	  secretion	  by	  binding	  Syntaxin1	  proteins	  and	  forming	  non-­‐fusiogenic	  SNARE	  complexes	  [19,20].	  Conversely,	  when	  the	  tail	  domain	  is	  bound	  to	  an	  N-­‐terminal	  portion	  of	  the	  R-­‐SNARE	  motif	  it	  still	  permits	  binding	  to	  Syntaxin1	  proteins	  but	  it	  is	   more	   amenable	   for	   displacement	   by	   VAMP	   proteins	   [20].	   Thus,	   in	   this	   conformation,	  Tomosyn	  acts	  as	  a	  placeholder	  and	  using	  in	  vitro	  studies	  it	  was	  shown	  to	  accelerate	  fusion	  by	  promoting	  1:1	  binding	   stoichiometry	  between	  Syntaxin/SNAP25	   [20].	  Whereas	   in	  2:1	  Syntaxin/SNAP25	   complexes	   the	   second	   Syntaxin	   occupies	   the	   position	   of	   VAMP	   thus	  delaying	   SNARE	   complex	   formation	   [48,49].	   That	   being	   said,	   these	   studies	   do	   not	   fully	  address	  the	  functions	  of	  this	  tail-­‐domain	   in	  vivo.	  Nonetheless,	  these	  studies	  suggest	  that	  a	  potential	   clamping	   mechanism	   could	   exist	   which	   triggers	   the	   inhibitory	   activity	   of	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Tomosyn	   based	   on	   the	   binding	   of	   its	   tail	   region.	   One	   interesting	   possibility	   is	   that	   the	  GTPase	  activity	  of	  Rab3A	  serves	  as	  a	  potential	  trigger	  for	  displacing	  the	  R-­‐SNARE	  motif	  of	  Tomosyn	   or	   promoting	   conformation	   change	   in	   the	   tail	   domain.	   Especially,	   when	  considering	   that	   few	   studies	   now	   have	   suggested	   that	   the	   GTP-­‐form	   of	   Rab3A	   clamps	  secretion	  but	  that	  it	  can	  be	  relieved	  by	  transitions	  into	  GDP	  [50-­‐53]	  	  	  	  
4.2	  Limitations	  
Chapter	  2	  
	   Progressive	   loss	   of	   insulin	   release	   from	   pancreatic	   β-­‐cells	   is	   a	   central	   pathology	  associated	  with	   the	  development	  of	   type-­‐2	  diabetes.	  These	  deficits	  begin	  with	   the	   loss	  of	  the	   first	   phase	   of	   KATP/	   Ca2+-­‐induced	   insulin	   release.	   Next	   the	   amplifying	   pathways	   of	  regulation	  are	  compromised	   leading	  to	  a	  decreasing	  maximal	  capacity	  of	  glucose-­‐induced	  release.	   Eventually,	   a	   complete	   β-­‐cell	   failure	   ensues	   during	   which	   insulin	   release	   is	  completely	   abrogated	   followed	   by	   major	   cell	   loss,	   requiring	   patients	   to	   self-­‐monitor	  glucose	  levels	  and	  self-­‐administer	  insulin	  [54,55].	  Our	  studies,	  focused	  on	  determining	  the	  roles	  of	  Rab3A	  and	  Rab27A	  in	  regulating	  the	  first-­‐phase	  of	  insulin	  secretion.	  Moreover,	  we	  used	  electrical	  stimulation	  to	  drive	  release	  of	  LDCV	  from	  β-­‐cells.	  While	  these	  studies	  were	  primarily	   aimed	  on	  answering	  molecular	  questions,	   additional	   considerations	   could	  have	  led	  to	  better	  physiological	  conclusions.	  These	  notably	  include,	  the	  absence	  of	  assessments	  for	  the	  effects	  of	  loss	  of	  Rab3	  and	  Rab27	  on	  phase	  2	  of	  insulin	  release.	  Especially	  since	  Rab	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   The	  data	  from	  this	  chapter	  established	  that	  Tomo1	  could	  act	  as	  a	  central	  regulator	  controlling	  the	  population	  of	  SVs	  among	  the	  RRP,	  RP	  and	  TRP.	  For	  these	  studies	  we	  relied	  on	   optical	   methods	   for	   determining	   pools	   sizes.	   These	   offer	   the	   capability	   to	   directly	  measure	  presynaptic	  activity	  (compared	  to	  electrical	   recording	  at	  small	  synapses),	  but	   in	  some	  cases	  these	  are	  limited	  by	  the	  temporal	  sensitivity	  and	  signal	  detection	  capabilities	  of	  the	   equipment.	   This	   becomes	   particularly	   challenging	   for	   measuring	   signals	   with	   fast	  kinetics	  and	  small	  amplitudes	  such	  as	  the	  RRP	  size	  [64].	  Specifically,	   for	  these	  studies	  we	  estimated	   the	   size	   of	   the	   RRP	   using	   a	   20Hz,	   40P	   stimulus	   (Figure	   3.2).	   In	   hippocampal	  neurons	  in	  culture	  it	  has	  been	  established	  that	  up	  to	  30	  APs	  is	  sufficient	  to	  deplete	  the	  RRP	  pool	  [65,66].	  However,	  RRP	  pools	  display	  great	  variability	  between	  individual	  release	  sites	  and	  the	  amount	  of	  asynchronous	  release	  can	  also	  affect	  measurements	   [66,67].	  Thus,	   the	  most	  precise	  way	  to	  measure	  the	  RRP	  is	  to	  use	  a	  stimulus	  strong	  enough	  to	  empty	  the	  RRP	  rapidly	  before	   refilling	  occurs	   [65,68,69].	  To	  do	   this	   via	  use	  of	   pHluorins	   combined	  with	  optical	  detection	  methods,	  fluorescent	  changes	  to	  single	  APs	  delivered	  in	  high-­‐frequency	  is	  required	  [64,70].	  This	  is	  because	  one	  must	  be	  able	  to	  capture	  the	  amplitude	  and	  stimulus	  number	  during	  which	   the	   rate	  of	   exocytosis	  briefly	  drops	   to	  0,	   indicating	   the	  moment	  at	  which	   the	  RRP	   has	   been	   depleted	   but	   refilling	   has	   not	   occurred	   [64].	   Unfortunately,	   our	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camera	  was	  neither	  sensitive	  enough	  to	  capture	  fluorescent	  changes	  in	  response	  to	  single	  APs	  nor	  able	  to	  capture	  frames	  at	  the	  frequency	  needed;	  thus	  our	  measurements	  represent	  only	  an	  estimate	  but	  cannot	  be	  viewed	  as	  the	  true	  size	  of	  the	  RRP.	  	  	   Mechanistically,	  our	  studies	  identified	  that	  Tomo1	  is	  a	  phosphorylation	  substrate	  of	  Cdk5	   likely	   directing	   its	   functional	   activities.	   Moreover,	   we	   identified	   via	   mass-­‐spectrometry	   several	   residues	   that	   are	   phosphorylated	   in	  vitro	   by	   Cdk5.	   Yet,	  we	   did	   not	  establish	   these	   to	   be	   essential	   for	   Tomo1’s	   actions.	   Future	   studies	   could	   address	   this	   by	  creating	  phosphomutants	  of	  single	  predicted	  residues	  and/or	  combinations.	  Likewise,	  we	  did	   not	   directly	   address	   the	   possibility	   that	   Cdk5	   phosphorylation	   of	   Tomo1	   can	   lead	   to	  changes	  in	  its	  interaction	  with	  Rab3A	  or	  Syntaxin,	  something	  that	  may	  also	  be	  learned	  by	  the	  production	  of	  a	  Tomo1	  mutant	  that	  is	  Cdk5	  phosphonull	  or	  mimetic.	  Finally,	  despite	  the	  fact	   that	   Tomo2	   proteins	   levels	   in	   the	   hippocampus	   have	   been	   found	   predominantly	  localized	   to	   cell	   bodies	   and	   post-­‐synaptic	   compartments,	   a	   role	   for	   Tomo2	   in	   pool	  partitioning	  cannot	  be	  ruled	  out	  thus	  far	  [71].	  
	  
4.3	  Other	  experimental	  observations	  and	  future	  directions	  
Presynaptic	  vs.	  Postsynaptic	  roles	  for	  Tomosyn	  proteins	  in	  the	  CNS	  	   In	   situ	   hybridization	   data	   gathered	   by	   the	   Allen	   Institute	   (http://mouse.brain-­‐map.org)	  has	  demonstrated	  that	  Tomosyn	  gene	  expression	  is	  enriched	  in	  the	  hippocampus	  and	  cortex	  (Figure	  4.1,	  A).	  These	  are	  areas	  that	  have	  been	  established	  as	  highly	  critical	  for	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learning,	  memory	  and	  cognition	  [21].	  Furthermore,	  a	  study	  using	  confocal	  and	  two-­‐photon	  high-­‐resolution	   microscopy	   determined	   that	   Tomo1	   vs.	   Tomo2	   displays	   differential	  expression	  in	  the	  mouse	  hippocampus	  [71].	  In	  this	  study,	  Barak	  and	  his	  colleagues	  (2010)	  demonstrated	   that	  Tomo1	  was	  most	  highly	   expressed	   in	   excitatory	   cells	   of	   the	  hilus	   and	  mossy	   fiber	   regions	   and	   predominantly	   localized	   to	   presynaptic	   compartments.	   On	   the	  other	   hand,	   Tomo2	  was	  mainly	   expressed	   in	   the	   cell	   bodies	   of	   subiculum,	   CA1	   and	   CA2	  neurons	   with	   a	   postsynaptic	   localization.	   Thus,	   one	   may	   conclude	   that	   based	   on	   their	  localization	   to	   distinct	   compartments	   Tomo1	   vs.	   Tomo2	   have	   the	   potential	   to	   carry-­‐out	  different	  cellular	  functions	  in	  the	  mouse	  hippocampus.	  	   This	   notion	   is	   further	   supported	   by	   a	   study	   that	   assessed	   the	   developmental	  trajectory	  of	   the	  mRNA	  expression	   levels	   of	  Tomo1	  and	  Tomo2	   starting	   from	  embryonic	  day	  10	  to	  post-­‐natal	  day	  12	  in	  the	  mouse	  brain	  by	  real-­‐time	  quantitative	  PCR	  [72].	  These	  studies	  concluded	  that	  Tomo1	  levels	  were	  detectable	  earlier	  and	  were	  higher	  than	  Tomo2	  during	  embryonic	  stages	  (E14-­‐E18).	  Moreover,	  Tomo1	  mRNA	  expression	  was	  localized	  to	  the	  cortical	  plate	  during	  the	  developmental	  stages	  when	  layering	  is	  established.	  In	  contrast,	  Tomo2	  was	  more	  widespread,	  and	  its	  expression	  more	  highly	  elevated	  in	  postnatal	  stages	  compared	  to	  Tomo1.	  Given	  the	  differential	  regulation	  of	  Tomo	  mRNA	  it	  is	   likely	  that	  they	  play	   a	   developmental	   role	   in	   synaptic	   transmission.	   Further	   support	   for	   this	   notion	   is	  derived	   from	   a	   study	   that	   established	   a	   role	   for	   Tomosyn	   in	   neurite	   outgrowth	   via	  interactions	   with	   the	   Rho/RoCK	   pathway	   [73].	   In	   this	   pathway,	   repulsive	   chemokines	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induce	   Rho	   GTPases	   to	   bind	   and	   activate	   ROCK.	   In	   turn,	   ROCK	   proteins	   phosphorylate	  Syntaxin	   causing	   an	   increased	   interaction	   with	   Tomosyn	   and	   leading	   to	   inhibition	   of	  neurite	  outgrowth	  by	  preventing	   fusion	  of	  plasmalemmal	  precursor	  vesicles	   [73].	  During	  the	   course	   of	   my	   investigations	   on	   Tomo1,	   it	   was	   noticed	   that	   overexpression	   and/or	  knockdown	  may	  have	  effects	  on	  (1)	  the	  density	  of	  post-­‐synaptic	  spines	  and	  (2)	  the	  number	  of	   active	   vs.	   silent	   synapses	   and	   thus	   potentially	   play	   a	   role	   in	   structural	   plasticity	   and	  development	  (Figure	  4.1).	  The	  small	  protrusions	  emanating	  from	  dendrites	  of	  neurons	  are	  termed	  spines	  and	  were	  initially	  discovered	  by	  Santiago	  Ramon	  y	  Cajal	  by	  Golgi	  staining	  [74].	  Dendritic	  spines	  are	   considered	   the	   functional	   units	   for	   synaptic	   integration	   as	   they	   represent	   the	   site	   of	  connection	   for	   the	  majority	   of	   excitatory	   presynaptic	   boutons	   [75].	   Changes	   in	   the	   long-­‐term	  activity	  of	  synapses	  are	  related	  to	  changes	  in	  spine	  morphology	  or	  density	  [76].	  The	  Rho-­‐ROCK	   pathway	   has	   been	   shown	   to	   be	   sensitive	   to	   the	   activity	   of	   Ca2+/calmodulin-­‐dependent	  kinase	  in	  order	  to	  promote	  the	  growth	  of	  spines	  during	  long-­‐term	  potentiation	  of	  CA1	  pyramidal	  neurons	   [77].	  During	  my	  experiments,	   I	   found	   that	  Tomo1	  knockdown	  was	   often	   associated	   with	   a	   striking	   enhancement	   in	   the	   apparent	   number	   of	   spines	   in	  hippocampal	  neurons	  in	  culture	  (Figure	  4.1,	  B).	  At	  this	  point,	  inferences	  regarding	  the	  role	  of	  Tomosyn	  as	   a	  potential	  modulator	  of	   spines	   is	  purely	   speculative,	   but	   considering	   the	  following:	  (1)	  Tomosyn	  proteins	  have	  already	  been	  shown	  to	  interact	  with	  the	  Rho-­‐ROCK	  
174	  	  
pathway	  and	  (2)	  Tomosyn2	   is	  enriched	  post-­‐synaptically	  and	   its	  protein	   levels	   increased	  postnatally	  during	  a	  time	  of	  spinogenesis	  they	  may	  warrant	  further	  investigation	  [78].	  	   In	  addition,	  during	  the	  course	  of	  my	  experiment	  using	  vGpH	  as	  a	  measure	  of	  vesicle	  fusion	   at	   single	   boutons	   it	   also	   noticed	   that	   neurons	   overexpressing	   Tomo1	   had	   many	  fewer	   “active”	  boutons	   than	  control,	   or	  Tomo1	  knock-­‐down	  neurons.	  That	   is,	   despite	   the	  fact	   a	   bouton	   contained	   the	   vGpH	   reporter	   as	   detected	   by	   application	   of	   NH4Cl	   or	   the	  mCherry	  reporter	  on	  VGLUT1—no	  fluorescence	  changes	  were	  detected	  upon	  stimulation	  at	  20Hz-­‐900P.	   This	   observation	  was	   highly	   akin	   to	   one	   reported	   by	   Kim	   and	   Ryan	   (2010),	  wherein	  inhibition	  of	  Cdk5	  by	  application	  of	  roscovitine	  led	  to	  an	  unmasking	  of	  previously	  silent	  presynaptic	  boutons	  [29].	  Given	  that	  our	  studies	  (Chapter	  3)	  suggest	  that	  Tomo1	  is	  a	  phosphorylation	   substrate	   of	   Cdk5	   and	   that	   they	   share	   the	   same	   functional	   pathway	   for	  regulating	  the	  TRP,	  pilot	  studies	  were	  conducted	  to	  probe	  the	  role	  of	  Tomo1	  in	  regulating	  silent	   synapse.	  As	  shown	   in	  Figure	  4.1,	  C-­‐D,	  we	   first	   replicated	   the	   findings	  presented	  by	  Kim	   and	  Ryan	   (2010)	   and	   show	   that	   inhibition	   of	   Cdk5	   by	   roscovitine	   (100µM,	   30	  min)	  leads	   to	   an	   enhancement	   in	   the	   cell	   averaged	   vGpH	   fluorescence	   indicative	   of	   stronger	  neurotransmitter	  release.	  Next,	  we	  analyzed	  the	  number	  of	  active	  boutons	  contributing	  to	  the	   net	   vGpH	   signal.	  We	   defined	   “active”	   boutons	   as	   those	   that	   displayed	   a	   fluorescence	  change	  two	  times	  greater	  than	  the	  baseline	  fluorescence.	  The	  results	  show,	  that	  inhibition	  of	  Cdk5	  lead	  to	  a	  ~3	  fold	  increase	  in	  number	  of	  active	  boutons.	  Next,	  using	  some	  of	  the	  data	  from	  Chapter	  3	   (Figure	  3.2),	  we	  determine	   the	   fraction	  of	  boutons	   that	   responded	   to	   the	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TRP-­‐depleting	  20	  Hz/900P	  stimulus	  in	  Tomo1	  overexpressing,	  Tomo1	  knockdown,	  control	  and	   control	   +	   roscovitine	   cells	   using	   the	   same	   criteria	   just	   described.	   	  We	   find	   that	   the	  fraction	  of	  boutons	  that	  are	  silent	  is	  significantly	  reduced	  in	  Tomo1	  knockdown	  neurons	  in	  comparison	  to	  control	  and	  Tomo1	  overexpressing	  neurons	  (Figure	  4.1,	  E-­‐F).	  These	  results	  provide	   strong	   preliminary	   evidence	   to	   suggest	   that	   Tomo1	   plays	   a	   significant	   role	   in	  silencing	  synaptic	  release	  sites.	  	  The	  possibility	  that	  Tomo1	  may	  play	  a	  role	  in	  silencing	  synapses	  is	  also	  consistent	  with	  the	  findings	  that	  it	  is	  (1)	  presynaptically	  localized	  and	  	  (2)	  enriched	  prenatally.	  This	  is	  because,	   although	   the	   regulation	   of	   silent	   synapses	   has	   been	   recently	   linked	   to	   the	  expression	   of	   synaptic	   plasticity	   [79];	   it	   is	   also	   recognized	   as	   an	   important	   mechanism	  engaged	   for	   developmentally-­‐regulated	   synaptic	   pruning.	   It	   has	   been	   shown	   that	   the	  establishment	  of	  neural	  networks	  depends	  on	  massive	  production	  of	  neuronal	  connections	  followed	  by	  a	  50%	  loss	  or	  pruning	  [80].	  Moreover,	  it	  has	  been	  recently	  shown	  that	  the	  ResP	  size	   is	   also	   developmentally	   refined	   as	   the	   hippocampus	   matures	   [30].	   Therefore,	   it	   is	  possible	  that,	  early	  elevations	  in	  Tomo1	  level,	  which	  are	  enriched	  in	  cortical	  regions,	  play	  a	  significant	  role	  in	  pruning	  and	  neuronal	  integration	  during	  development.	  	  
The	  tripartite	  complex:	  Setting	  the	  stop	  and	  go	  of	  vesicle	  trafficking	  to	  priming	  sites	  	   The	  results	  of	  Chapter	  2	  provide	  direct	  evidence	  for	  a	  role	  of	  Rab3A	  in	  rapid	  refilling	  of	   vesicle	   pools.	   One	   likely	   mechanism	   by	   which	   vesicles	   containing	   Rab3-­‐GTP	   may	   be	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amenable	  to	  rapid	  recruitment	  is	  via	  the	  formation	  of	  a	  tripartite	  complex	  between	  Rab3A-­‐Rim-­‐Munc13	   [81].	   RIM	   proteins	   have	   been	   shown	   to	   bind	   VGCCs	   directly	   via	   their	   PDZ	  domain	   and	   the	   priming	   factor	   Munc13-­‐1	   via	   an	   adjacent	   zinc-­‐finger	   domain	   [81-­‐83].	  Importantly,	   RIM	   binding	   to	   Munc13-­‐1	   activates	   its	   priming	   actions	   since	   it	   can	  disassociate	   Munc13-­‐1	   autoinhibitory	   dimers	   [84].	   Active	   Munc13-­‐1	   can	   then	   drive	   the	  closed	  	  (inactive)	  Syntaxin	  to	  open	  and	  initiate	  priming	  [62].	  Munc13-­‐1	  is	  a	  multi-­‐domain	  protein	   with	   additional	   binding	   domains	   for	   calmodulin,	   diacylglycerol	   (DAG),	   and	  Ca2+.[85-­‐88]	   Interestingly,	   DAG	   is	   an	   effective	   second-­‐messenger	   for	   potentiating	  exocytosis.	  Its	  actions	  are	  mediated	  by	  protein-­‐kinase	  C	  (PKC)	  and	  separately	  by	  Munc13-­‐1	  [89].	   In	   regards	   to	   the	   Munc13-­‐1	   pathway,	   it	   is	   thought	   that	   potentiation	   occurs	   via	  increases	  in	  priming	  as	  application	  of	  β-­‐phorbol	  esters	  (functional	  analogs	  of	  DAG)	  induces	  translocation	   of	   cytosolic	   Munc13-­‐1	   to	   the	   plasma	   membrane	   [86,90].	   Based	   on	   this	  evidence,	  we	  conducted	  pilot	  studies	  in	  secretory	  PC12	  cells	  to	  address	  if	  translocation	  of	  expressed	  Munc13-­‐1	  induced	  by	  application	  of	  β-­‐phorbol	  esters	  could	  traffic	  RIM2/Rab3A	  proteins	  and	  potentially	  serve	  as	  a	  mechanism	  for	  rapid	  refilling	  of	  vesicle	  pools.	  As	  shown	  in	  Figure	  4.2,	  A,	  our	  results	  suggest	  that	  10	  minute	  applications	  of	  150	  nM	  β-­‐phorbol	  esters	  induces	   translocation	  of	   expressed	  CFP-­‐Munc13-­‐1	   together	  with	  YFP-­‐RIM2	  proteins.	   The	  translocation	   of	   YFP-­‐RIM2	   proteins	   seemed	   to	   occur	   via	   direct	   interaction	   with	   CFP-­‐Munc13-­‐1	   since	   translocation	   was	   eliminated	   in	   a	   YFP-­‐RIM2	   mutant	   (K97E/K99E)	   that	  lacks	   Munc13-­‐1	   binding	   capability	   (Figure	   4.2,	   B)	   [81].	   Furthermore,	   our	   initial	   studies	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suggest	   that	   Rab-­‐binding	   is	   not	   required	   for	   the	   translocation	   of	   YFP-­‐RIM	   to	   the	   plasma	  membrane	  since	  RIM	  mutants	  deficient	   in	  Rab	  binding	   (E36A/R37S)	  still	   trafficked	  upon	  stimulation	   by	  β-­‐phorbol	   esters	   (Figure	   4.2,	   B)	   [81].	   This	   preliminary	   data	   provides	   one	  potential	  mechanism	   by	  which	   vesicles	   could	   be	   rapidly	   refilled	   during	   periods	   of	   high-­‐activity.	  Future	  studies	  should	  test	   if	  β-­‐phorbol	  ester	  stimulation	   induces	  translocation	  of	  Rab3	   and/or	   vesicles	   and	   if	  mutations	   in	   the	   DAG-­‐binding	   domain	   of	  Munc13-­‐1	   hinders	  rapid	  refilling	  mediated	  by	  Rab3.	  	  In	  addition,	  we	  assessed	  the	  effect	  of	  overexpression	  of	  these	  proteins	  in	  the	  PC12	  cell	  line	  using	  human	  growth	  hormone	  (hGH)	  secretion	  assays.	  The	  co-­‐transfection	  of	  hGH	  along	  with	  a	  protein	  of	  interest	  allows	  for	  specific	  measurements	  of	  secretion	  from	  a	  small	  fraction	   (~	   10%	   in	   our	   case)	   of	   transfected	   cells	   [91].	   Figure	   4.2,	   C-­‐D,	   shows	   all	   the	  preliminary	  data	  gathered.	  In	  summary,	  we	  find	  that	  expression	  of	  RIM2	  and/or	  Munc13-­‐1	  lead	  to	  an	  enhancement	  in	  stimulated	  secretion	  (40mM	  KCl,	  10	  minutes)	  relative	  to	  empty	  vector	  controls.	  As	  was	  shown	  before,	  we	  find	  that	  expression	  of	  Rab3A	  leads	  to	  inhibition	  of	   secretion	   [50];	   and	   that	   co-­‐expression	  of	  RIM2	  and/or	  Munc13-­‐1	   is	   unable	   to	   remove	  Rab3A’s	   clamping	  activity.	  Thus	  even	   if	   our	  hypothesis	   that	  Munc13-­‐1	   translocation	  may	  serve	  as	  a	  mechanism	  for	  rapid	  targeting	  of	  Rab3A	  to	  priming	  sites	  were	  to	  receive	  further	  experimental	   support,	   these	   results	   suggest	   that	   an	   additional	   stimulus	   or	   modulator	   is	  required	  to	  remove	  the	  Rab3A	  clamp.	  On	  a	  related	  note,	  our	  findings	  (Chapter	  3)	  show	  that	  Tomo1	   can	   also	   act	   as	   a	   clamp	   on	   vesicle	   recruitment	   and	   that	   it	   interacts	   with	   Rab3A	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proteins.	   Similarly,	   studies	   done	   in	   C.	   elegans	   show	   that	   Tomosyn	   directly	   opposes	   the	  priming	  actions	  of	  unc13	  since	  deficiencies	  in	  unc-­‐13	  mutants	  can	  be	  rescued	  by	  deletions	  of	   Tomosyn	   [39,92].	   Taken	   together,	   these	  data	   support	   efforts	   to	   test	   a	  model	   in	  which	  rapid	   refilling	   of	   vesicles	   is	   promoted	   by	   the	   tripartite	   complex	   including	  Rab3/RIM/Munc13	  yet	  opposed	  by	  the	  actions	  of	  Tomosyn	  proteins.	  	  	  Interactions	  between	  Tomosyn1	  and	  Rab27A	  and	  potential	  functional	  roles	  The	  focus	  of	  this	  dissertation	  has	  relied	  heavily	  on	  the	  potential	  functional	  roles	  for	  RabGTPase	  and	  SNARE	  interactions.	  Mainly,	   it	  has	  been	  argued	  that	   interactions	  between	  Rab3A	  and	  Tomo1	   can	   serve	   as	   a	   regulatory	   gate	  on	   recruitment	   and	  docking.	  However,	  pilot	   data	   collected	   in	   collaboration	   with	  Woody	   Hoerauf	   shown	   in	   Figure	   4.3	   presents	  some	   evidence	   that	   Tomo1	   also	   interacts	  with	   Rab27A	   proteins.	   Our	   results	   show	   an	   IP	  experiment	   of	   expressed	   mTomo1	   in	   HEK293	   cells	   effectively	   co-­‐precipitates	   expressed	  CFP-­‐Rab27A	   (Q78L)	   and	   CFP-­‐Rab27A	   (T23N),	   which	   are	   GTP	   and	   GDP	   constitutive	  mutants	   (Figure	   4.3,	   A-­‐B).	   Moreover,	   membrane	   capacitance	   recordings	   from	   mouse	  adrenal	  chrommafin	  cells	  show	  that	  knockdown	  of	  Tomo1	  enhances	  the	  RRP	  size	  relative	  to	   a	   scramble-­‐control	   but	   only	   when	   the	   experiments	   are	   carried	   out	   in	   wild-­‐type	  mice	  (Figure	   4.3,	   C,	   black	   trace).	   Conversely,	   knockdown	   of	   Tomo1	   in	   Rab27A-­‐deficient	   mice	  does	  not	  lead	  to	  an	  enhancement	  in	  the	  RRP	  size	  (Figure	  4.3,	  C,	  red	  trace).	  Suggesting	  that	  Tomo1	   requires	  Rab27	   to	   exert	   inhibitory	   control.	  However,	   it	   is	   important	   to	   note	   that	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loss	  of	  Rab27	  alone	  leads	  to	  a	  significant	  decrement	  in	  the	  RRP	  size	  (Figure	  4.3,	  C,	  compare	  sh-­‐Scr	  condition	  between	  wt	  and	  Rab27	  null).	  Thus,	  we	  cannot	  rule	  out	  the	  possibility	  that	  these	   effects	   are	   unrelated	   to	   Tomo1	   function.	   Moreover,	   Rab27A	   has	   been	   shown	   to	  stimulate	  the	  GTPase	  activity	  of	  Rab3A	  during	  the	  acrosomal	  fusion	  reaction—therefore	  we	  also	  cannot	  rue	  out	  the	  possibility	  that	  these	  observed	  effects	  are	  related	  to	  Rab3	  function	  [93].	  	  
Final	  Remarks	  In	   summary,	   the	   data	   presented	   here	   hopes	   to	   have	   illustrated	   how	   molecular	  complexes	  associated	  with	  synaptic	  vesicles	  and	  SNARE	  proteins	  may	  act	  as	  determinants	  of	  neurotransmission	  modes.	  Decades	  of	  scientific	  research	  on	  vesicle	  fusion	  and	  secretion	  have	  shown	  that	  the	  strength	  and	  kinetics	  of	  release	  is	  determined	  by	  factors	  including	  but	  not	   limited	  to:	   the	  proximity	   to	  Ca2+-­‐channels,	  number	  of	  SNARE	  complexes	  on	  a	  primed	  vesicle,	   or	   the	   number	   of	   vesicles	   available	   to	   for	   priming.	   All	   these	   processes	   require	   a	  synaptic	   vesicle	   to	   interact	   with	   a	   specific	   subset	   of	   molecules,	   which	   are	   precisely	  equipped	   to	   execute	   a	  discrete	   function.	  Thus,	   a	   key	  node	  of	   regulation	   is	   carried-­‐out	  by	  protein	  mediators	   that	   coordinate	   the	   interactions	   between	   groups	   of	   molecules	   largely	  divided	   into	   vesicle-­‐associated	   proteins	   and	   plasma	   membrane	   proteins.	   	   Our	   studies	  present	  a	   strong	  case	   for	  one	  mediator	  being	   the	  Rab/Tomo	   interaction.	  This	   interaction	  appears	  especially	  critical	  since	  these	  two	  proteins	  together	  contain	  binding	  motifs	  linking	  them	  to	  all	  aspects	  of	  the	  vesicle	  cycle.	  We	  provided	  compelling	  evidence	  at	  least	  for	  their	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Figure	   4.2:	   β-­‐phorbol	   esters	   induce	   translocation	   of	   Munc13-­‐1	   and	   RIM2.	   (A)	  Representative	  confocal	  images	  of	  PC12	  cells	  co-­‐expressing	  CFP-­‐Munc13-­‐1	  (cyan)	  and	  YFP-­‐RIM2a	  (yellow)	  before	  (left)	  and	  after	  (right)	  treatment	  with	  β-­‐phorbol	  esters	  (150	  nM)	  for	  10	  minutes.	  B)	  Representative	  confocal	   images	  of	  cells	  expressing	  treated	  with	  β-­‐phorbol	  esters	  (150	  nM,	  10	  minutes)	  expressing	  CFP-­‐Munc13-­‐1	  and	  either	  the	  RIM2a	  (K97E/K99E,	  left)	  that	  is	  deficient	  in	  Munc13	  binding	  or	  RIM2a	  (E36A/R37S,	  right)	  which	  is	  deficient	  in	  Rab3	  binding.	  (C,D)	  Comparison	  of	  basal	  (gray	  bars)	  or	  stimulated	  (40mM	  KCl,	  black	  bars)	  secretion	   from	   PC12	   cells	   cotransfected	  with	   hGH	   and	   indicated	   protein(s)	   or	   an	   empty	  vector	   control.	   Secretion	   assays	   were	   performed	   48	   h	   following	   transfection.	   The	   bath	  solution	  containing	  the	  secreted	  hGH	  was	  collected,	  and	  cells	  were	  lysed	  (2%	  Triton	  X-­‐100)	  to	   determine	   total	   hGH	   content.	   Secreted	   and	   total	   hGH	   was	   measured	   from	   sample	  aliquots	   using	   an	  hGH	  enzyme-­‐linked	   immunosorbent	   assay	   kit	   (Roche	  Applied	   Science).	  bars	  represent	  mean	  hGH	  secreted	  relative	  to	  total	  hGH	  	  ±standard	  error	  of	  measurement.	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Figure	   4.3:	   Evidence	   for	   an	   interaction	   between	   Tomo1	   and	   Ra27A.	  Western	   blots	  showing	   that	   IP	   of	   overexpressed	   Tomo1	   leads	   to	   co-­‐precipitation	   of	   	   (A)	   CFP-­‐Rab27A	  (Q78L)	   and	   	   (B)	   CFP-­‐Rab27	   (T23N)	   from	  HEK293	   cell	   lysates.	   (C)	   Comparisons	   of	  mean	  high	  time	  resolution	  recordings	  of	  membrane	  capacitance	  changes	  in	  electroporated	  mouse	  chromaffin	   cells	   in	   response	   to	   flash	   photolysis	   of	   caged	   Ca2+	   for	   wild-­‐type	   (black)	   and	  Rab27A	  null	   (red)	  mice.	   (D)	  Quantification	  of	   data	   in	   (C)	   by	   fitting	   curves	  with	   a	   double	  exponential	  for	  each	  cell,	  amplitude	  of	  the	  first	  kinetic	  phase	  is	  taken	  as	  a	  measurement	  of	  RRP	   and	   averaged	   across	   cell	   for	   each	   indicated	   condition	  with	   error	   bars	   representing	  ±standard	  error	  of	  measurement.	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